var title_f13_30_13792="Fistula to hip area BE";
var content_f13_30_13792=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F52969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F52969&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fistulous tract to right lower quadrant on barium enema",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 316px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A barium enema in a 64-year-old man with three weeks of right hip pain reveals extravasation of barium from a perforated sigmoid diverticulum with collection of contrast material in an abscess cavity (white arrow) adjacent to the diverticulum. There is a fistulous communication extending from the abscess cavity toward the right lower quadrant to the region of the right hip (red arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13792=[""].join("\n");
var outline_f13_30_13792=null;
var title_f13_30_13793="Rectum endoscopy";
var content_f13_30_13793=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F83343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F83343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Rectum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 374px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Rectum seen during colonoscopy. The colonoscope is in a retroflexed position, allowing for visualization of the lower rectum. The colonoscope is visible in the upper right corner of the image (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13793=[""].join("\n");
var outline_f13_30_13793=null;
var title_f13_30_13794="Porphyria cutanea tarda";
var content_f13_30_13794=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74528&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Porphyria cutanea tarda",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Vesicles and erosions are visible on the dorsum of the hand in a patient with porphyria cutanea tarda related to underlying hepatitis C virus infection.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jean-Fran&ccedil;ois Dufour, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13794=[""].join("\n");
var outline_f13_30_13794=null;
var title_f13_30_13795="Algorithm septic appearing infant";
var content_f13_30_13795=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F66424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F66424&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 580px\">",
"   <div class=\"ttl\">",
"    Approach to the septic-appearing infant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 560px; height: 750px; background-image: url(data:image/gif;base64,R0lGODlhMALuAtUAAP///wAAAIiIiLu7u0RERCIiIpmZmd3d3TMzM2ZmZhEREe7u7szMzFVVVXd3d6qqqqCgoODg4NDQ0JCQkGBgYCAgIPDw8HBwcFBQUICAgLCwsBAQEDAwMEBAQMDAwL+/vz8/P39/fwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAwAu4CAAb/QIBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Tq/b7/i8fs/v+/+AgYKDhIWGh4iJiouMjY6PkJGSk5SVlpeYmZqbnJ2en6ChoqOkpaanqKmqq6ytrq+wggGztLW2t7i5uru8vb6/wMCxw8STAcVRx8jLzIbKzUvP0NPUeNLVRdfY29xq2qQHBQECV9/d5+hf5gsEswrkTAIEQvJt9VAE8EUO8035SebSCRxYxZwDBEIM9Ftyb1EDfUv+IQlIsKLFaEgOHiAyQFwAAwAIIJiV4ACtBPU6zoJochaCBQMCjCzAAIDMWSBVfgSQgBbI/3wECtQTSRLAgZGzBhD5d/OjAVotZcK8qYDBU5xHKF7cytUmkgUJFMgEqQDkAwUhGwBgEIDBvXrvhngEKcTkg5g1G6gdB0AA2rIAzhJJgFDkxqHzYh5ogNCm0iFMyQkoEJJlgLsBlBJIUBlg18+ghWgF8JRtrQMSP74lYHKjEQbtcMakRzkzAMW2DvidRVniUHKtC9C1DZmcbQO9ycH2OZsnZ4lZQ0vfau5hQgULABcPHEB3Y7gQhxAGsOBjcwScbTugrN3oZQDrO/ed96+13rXEhTBVirzz+PIGNJfAcw54Nt2BA5kzGW9K6dQbLcqJhVJiYvE1xABiiRMgLQhsRP9LAQ169GAABSRHD33AdceAOOI8pp9x/JmIIYnmKTMgaVgZMRqCPC6zIxLQXdHcEPl1wZZrZvzY45KwKGlEkFYMKZqLWsS0UhpOMqmlKlkW0+WWYJLy5TBjhmmmJ2U2eeaarqT5iptsxmlMMHTWaeedeOYJp5x8Trdnn4AG6o2ghBaqx5+GJqpoOYs26igaiD4q6aRERErppdboqemmnHbq6aegaoppaJaOmkWppr6ZKh2orspKq65KAWusqMxKqxO23iomoA2pQ2UXueoqijTsuBNeFhJBmcYDAXB2Wy3wIOfSr/SQxM8QBqDFRZC9XnHPfksdK1+RSgQrLCjSHJT/0EJbKMsGAQRg9+xhaDFLF0pI1HOkfgWK0a0V3ZILpLgYnZtOuh0SIZR7uhUg1ksxzVSTAC7V9JFHOOWTLT0INeDSAhx5JMBVzc5H8WIfI2HSijl1B59aDfTLUD8IpFhTEUfNolZsBEw1UlXw0QKbZLQkNldlQSnMm8VIGRBVAkw13RnFMlnlk20eB4BdbNqKZvDBRID1MEgLtzbZAgsIhRcAerFVE9Q2qSVfPtmRZYAALwFQMxFxFfHUApMphTfIex+B93zPnsQOXTNzjLgRDSx09gI1x6RZeg8Ux5bg8wAmmGFIFFAgX5M9HllfaOXjNk8oTjmZazGBnM3X6Jjz/3fZ3X2bQHOT9XdbbY8lKxkBD1DW00lDtIYtUrn3c3xRR2DcnWLkid6As42T15Zw0TN+Y1+728jZggmwMzJl80U1C2rhgYX8cZR9C+O8GqPf0bgDfC+EA1pDZC7tm5CGdUiztfE1zyhlOU8CVhc5x/DrRe5Z2OCO0DcAiI47uunHBIfQwAsFQHYEcAD10iYAZsEDXxU8EQcRIK8UdrAvBUCb2sTHN4UIgIGdY5x8sPVBvaUnRn1pDLjio7q2sI0+/crM64qwL68BkBvSWBCJGuSS3NFCLVaSyWEq5kAcfUQiYZFd1nZyoQoJgGriyCAHfQIABVApAXIjYBYD0ACQ7f8mAAQYAAPkNQSqOYtZnNmj7OqClJ3NomcCKl+FXvKP4yHAaLzZISF580PSUGaPzWIKg6bGxas8RTPuyCL2vPLEbWSpV1KywwPYZQUHEOwIrkzF/0p5iVOyK5W0jE4uqTFLAPZyl5L45deECcxHEPNcxywmI0LFzGY685nQhKYypymGZFLzmqawJja3GQptcvObnPAmOMdZS3KaE1fRTKc618lOdp7zVe+cgjjjaQ16JsOetcLnE+apzznwM1X/7CccAvoGVH7jX3hA6BZGdk+BjkJJ1GOdJCHorSt6EXo6olZnbIPLxwmhowptgsDCEFIirKYJD0DA9RKGK4c+9An/EYXbwLBQunCcDwsj7eMtD8pKKOT0CyXVqRRa0lCXogumLpMo3bhGsrtxESglIkd2MleE0rEtAb4r1wAiprWa5ON5T7no+HYqVhg+DGQ8A9nFEiAiBjxPN1y8WDuoOEi2fQyO/CLZWC2YogPo9WkpEQtgiFKylEaOpSI1ajeRWgsUxW47q4Mb6PqTVZNesiwkK1lWtmqbzWyUikT4m0FD+8HJCWVye6NjES5om8jOQ7XOiW0f81Y5FSUVR4CbB+6QJFoNdo4c2WJHYpLKUJ8q9qhOiGnr+BeXf/jufhLJzgAQoMM+Iq+yE+GsEG4ErtkYgHlq9CBpwKu77wmgku4r/wr8Pgq8jypAeeKpxXME4ADOfBcq9djtfde3Gvh2pz63ldVxPwHRpEpWH0cKIX7y0jqOaSuFVk0I+vrIxyklcqOZm80FmRXejx5jwwc8QFlMO7+/+dAmmcNhF0Oi0qrmDVsKcKMFC8ThoRgwHDTO3Xd+izrzMawgA0YTUl1zYFF60alV22F5IlTXCF+0ZAMkknZj20icHAONBxQvluGqM/0cUq1KyRmJOHM8LiPAYi5iFrXGSJcCaJA3B7TSSLicRkxO6DaC/UlfgRzkcLoBQyCLJRSyU1dHBJUQBO1zGZKJAJmZQsRUbUSiFT2GSVPK0pQGA6YltelMA8vTnfb0Fv/aSepSm/rUdBI1NUOt6lZbgdWujnVRZU3rRMC61rieSK6fiOpe+/rXpN61pEEt7GUSu9iKuHWilI1sXSd0FkvoaBykbQUotaOnRjh0kpptay/wjySFFukAyqOZV6ZSYD8FA7WP4K4iBOksYFbCb97AbG7Pjgtn2QgDEBsFtjRh3VJOA8CnwC1sG87gg7K3M7pwFipxlSZ9WZpdteYYj0CNaLO42bN+huZ96+ytVDuzTZAz12fVNa2WI+PGScQArlYluEEsFsX/QbW2gHWHUfmkyydWtI1KTSfHyNaVuFBvhTuRC3jr37Py0oA91sQBDykAkjLTnCJSy3Ih+eHhAu7/2rhtl8yjRK0AYhKetekF657lnnAe+6LNGWE8BbdwZxdom3mTjj0Fmo2C1WH0QsBqj5ihTWYLoD/HVP2mRrhwZlBGXQc+t714hu/X6RG+xCsjcDSUR/H2p/T6mbRCJhKq4cXnO7vHSHmzmS4eNa6FohvdUucF2R6njB6n91HqUj6824ugeBeV7j0qzo9I4kgbGY5dGwq8cHYKJ4QE35A4doFP6FU4+q+rGFz9iQvFiHC9T/d9EJZS/ZWymLCaP8cd1edkxsUbWyWyscwhR/MQ1PykL+OS/Ae4MHzkZWSaCy02JSJJ90B1NORIrbNeVyEOISFxRPd94EcGAzcH2nYE/wPXbhI4YZrmgLIAgaEGaVQAcMwSbnJANTJWTRoYCK4XKClobyvYJy3YbC8oJzFYbDPIJjW4a8CWgzq4g51ygqZygz6oT0AYhPY0hEQYT0Z4hKKwATzYhE74hLWghCg4YEkobFV4IFeYa1koHVsohV74hWAYhmI4hmfQaMVnVOsXVmQIB27jgWgYgGq4hgWlUlg0FzLXNeY0Du8QVjPSHnKIBg4DMp7jRj1ET6oxDscQFzD3h2hQD+rTHcz1Stv0EWmzPkkVYIxIBvfgh82HieC0E1fRRpJRYZmoif3gIEb2TmSkgH1YXaX4irAYi7I4i7RYi7ZIBV0IGrkoa7vYFf+96Gq/SB23mHCKFYyqZowWgYyjAoW+JhDM+Cl9powFUzvlFGTSWC7OWI1UyCXZaAnXSBDf6GzU6I3R+AdUwwQRmFhgwwQWuAXpiIvlWAQLMEaOth1oQG4TxXtXhnAttY7ySCL2KAapNI+0UCBCt3pzxI/h2I1EgAB5M13sJolf4G//9icLmYHZxkLBI5FZkEoOCTLTVR6ZM48bgiTYaI1MVIh1AT9NdXOExRliBpNIUSAyJRx3qDSZZBw/hzGI85JGwTx6VEj3No6rdV7O4pM+uYB4NBUx8RQW5xLu8TFSwhZ1tWQccVuUg0c6Eo8XgoHuAURQAnfDtRgwWRX3MXv/Nbkh4XZ4NiEZ7EEOs4EY88IYrtMYW+mPHgQT8kIAauE28DIvYkd2okEObHUAJuEidiEl9+M3sVE+czQANRdpR3dc19BEKwmW8HBHJhIctYAcdEEABpCWQZNCbAk/qLePnREcwzEAjFddF8l3RfA8O5EaNsQw5lV5U/I4mbEcsiENlimPjRZRETcLkklK21gEDrkREDmbvVEg0UdEfdV9HNSXSkQZGMI4llmaQKR9qAlgi0GdvueVr+kF1zBVjvMPHOadJDYkddcPmfEfNYKcCTNdA0AANUE5x4ckWdlT49kN2oAa7lAgIUcZngSAm9kdYoagM2kU4sBCG4JRzwJB/whYRT3ZVytCI5DJRpXCkNeRPG0RG3zhnUqJSM/QnhaWIfFJBACqNQ6AMl0mnCd5nJvwm3dJlJTQn1CkCVkkkTg6atpImdyIl8bAlafQo633o8UYpDY6pNb4jKfmjE7KKbVopNNApUIoo8O4bUCapWdgpc3gpUW4bFH6hGzChGN6pr8Ajl9qg6Sipq8IphjJpdQQAqFBp3J6p3iqCflWPRzJDRQjNwuDDWYIQyLYCjERQxLFJPehLlzhF4ARqNXQhgpQnLBwqGTGj6CRHfyTFx/jcbDlp0KBHRLERc2AN/ehEyDxbUaUCk35nhSiNa74GU8hGbR1RnZ5DmejAGz1fP9vg6mvEIhtZBZo8R6soBhBATeKSIqkohSyWRIe03jdUDpUg3iLWarz8IgN0yyFKgqKYRqscYkmuawxl21eWQ1WJQ68ekTTsImxyomlQD09wWN+sa3U8RhsVnOxuq7oM6vDKXLQcA8Okh0pw6ouYxKv6q55mrAKu7CV8AGh4bAM6yVt+npsqotu6iMV+xlw+mpruiYbS54XiwwfqwYQ0AEdEAAmCwEXUbInm7LdwLIo2wEqGwsw67JaIgG2oAEXgbO1oLPcwLO04LOwALSzILRMYqbQthVIO7JPsLTF4LRgggG00AFcIbWzQLXnYLUoWwxai7VbMgG0kAFcAbazILb/50C2AWC2w4C2aqslEUALEsAVbzsLcXsOcxsAdTsMd5u3W1IBAbABn+G3gJsOgrsMhWsmFBAAGPAZibu46dC4ywC5ZgIBATABn0G5lpsOmLsMm2smFhAAEfAZnxu66TC6y2C6Z+K4n6G66cC6XMsmpPsZsZsOs1sMtZsJaJq7USgruqtO8tS7OhgNwJsncsC08nS8soS8zKAVvyhOxitg0JtP0YuxMYoJzlsRX9Kj2QsNzBtAxYu9yluk4Suy02i93xuy+4RoGuV9s0YH1eqOzLu+1atLT9COVTIr14u+/SgaECJP8pubODVlV3mk0RsTzmLATaBtcelbSIAvXQBw/wT4OCHVvUpQHhNmvx1ZnvS4e4RnE/1rIAMFvtO7EyHoK6eyvu9YvunrYT3UE6O0UJiaHeGawdHge75qnOKYLxpJUQJ5DR95GwhxNoxKwipZo/R2v6uwvUQCEn4hBFnzEgd5fBIzek3ZVm+VViPnZhylkgmqXVEsIimHZDRxk6qqcUr8LHSjAOjxO1jhk0OBFDJJC5wFWPNQxqTxZixnEzu5EjFpVlKxcxYkcQRIx0GzfpNJv6FjlPoBxzDUoGhlf5nxETTSLFAZFRDjm0WsH/HiGjvRxCB8xLHZmUrQHCnsvSM8LeNaM3u3dGyzF5wVHqwlODGEn14XW4XXQRG8yv+kzBe2B3Vsh2JGvMLPghzn5VmDGBJjKZeKQZfVd1LEKgQIkGJAA3VtCUOiyEFl6RazPEOXozCjo13OTKkUjASxA2hpsWCvUzeBaSF8UZiH6aGB15UUGAAywyH/m7+D8cJJsMtJHL4fAXg8IV+qZ5+8AzzNkV4lYxu32UUYInkWtJqpNxIErQzNMXij6ZbaSiTKqxjiABslkRvq2TqqKXcSPA/kswB7lBC10F7IIXnSczf9sBmJhNA/tMAqdNIaPb+hzEa0eQ/CcZvsyTlTwpsp2okz/Eir+s+TqtNsoA2FF8bygjdgTBU8l8eT7EhRKRWRcMYjFxhVsUHch5trHMH/uHVi70FiKzZ8RXCWZO3E4QOSymB7KYkk7XHGimFjwRouDDNv9gGecbljNeQA/SLXuZl9+iCdKiRiG/J1JjbW4AzYQ1DXKhw2Sx1EnVFj/SAc61miQu0Y8LnYDTmfCBEf8dHVZ8F6QwnKg9GZgvnQD73Ll9PLe0GYUvfOK0mpi8DVZPQ6bAaALcchHjJlYtbBZYbF+UF/RHChI6Fdvp2VIPIM5idKAqvVh7y/wulZDpKaB+SdF9ois2Fn8jDdLwE01aJeQDQj45CgXKZaiTTcNX0M4N0zizRI42wEG7OSRD08QsA9KMfZurlVKAraycM1IrSqHbzbuIfIbuDUozQk/5pnnRRNeivtQAOoRyCar902vVFQylAwgSao4RPpiUiQUjC8aJNdCfgsHg3+DMsHlz2USIRN4e6ZPwgBIFs9vlDA4U7ghguO4/A7dGrg4RzL1Dd6vqvNHOkiL859YeYn4ydKIxiOCFydTT5OJide5HHQJRgsviC+K11u5UTOpCEMBSUM5u1bClMusWEeTEbOofs0vNLEu3DejOUy53bS5kL6gBTbCd9QPKi9WR2l4zd+CM97Ecj4DQWA2xkV6N0JD1teBcLTRekWBitY6MkoZH5zq1rF6HpdBlAy6WRQ6X136G8nM1mDFmiEZrORlgvcVEuFfobjEQ5JnIGcx6qKr/9fBRW7KZQmTuijjulLQRdLtBbT7MqrntmLPW+V8cuxbpjtzC6sFWmRThxKpOmhLuW/zudPci/YY9ERzOqNDkGRmC8zPh80DUPaOu2PsXjPGuUNiCV2jieD2wwnG+++gO2x2S/DHuMRXDrXadN7Bx1HsnvU156NPUplEfDGQVX54WQfDikEVqXm6+uZDhno1+QRHA4ykUCoWaDHVxTdUuHpgxSEJ94L4PEB3R3ulyPXngZ22gkvv7wTv3BGkOhqgAD/i+8nmIuibgR+jg2zsqcktAl/ut99OoaWLsxgsKjWbgmOSjZHPwpueB+UUPR8pfNu7gWaakRPjNK8/giTMa//o5pkq3A2e1r1MQb1WI8F7SjoSfDoUbB1PjoG/DpBNSP3kZCru9p1rLAZYz/GXLMIYS+qGOevgBApbR/uK4YPUR8FcK+Olcas8tWaeR8/K/F4rWCwxP50DcDsiaD3QsH3h78tkigljx+RYLB5cx/541pV5Sr46IOuKtYKzjXh464I0nr59vP6e4B8eYbuMoEUmYOUjGzJUzEfTbXrXXYELsnIUTxxqL40nlpHga89f85nrD9xh8jyhravpEOqfR8hf06jhXCu4zD7o18EyQo4tf3s5+yXYwnPAA8P1e4EcEedsCEz+17scg8Eg8ACUCwWBkblktksBpxR6ZRatV6x/1ntltv1fpsEQVEQMCeEZ/CaLSgUDYFxOYBgsPFVqPIQODwPBAiekgQBxJ4MEPsOGAjMAgyEAAwRAQIGDhrqDJwEFMzeLCMHEAIIGBISjOIgCzQ5ARwCFMaOktj28qg+dn1/l3qBh4mLjY+RkXWNaikVFgwvCwcRH/wW/RIQABZIoSodCI3cnImK+h5kRces/4oaEtzcGRTulsiLGPy4A+zXlpUlE4gF4ECDBxEmVKil4ABQCjpFw0SJGqQx2A44DFDAG0UAreIMoBMJQANbRh5tFGXxUKg7KRVQghQPkqSZRR68wVPQGM+FA33+FJol6NBdRY1OQTrF0q8FzxI2/f+XDAIkMxOSHqtqNUNWr1G2QsL6lU3Yq2T1eJGKdouAbXmW4olgNYAEtr/mWrV7l2xeSHv5cvFrBnDgJXEN80XMpgKkDYnzNDbzGHJWyQEoV85yObPmS55BL15DARIG0F8ulD4tlLQZ06urtA7wOjRsyKLBaIAEwfYW3WZ490b4O0Bw4U6IG/eM+/hB5l4sQIrQ/Ep0M9OpC7QeAHt2Jdu7L/dO9rkXDgEqjK9yPr16ZOzdK4G/unx8YPW5ZAhAwX4U/fz7I+a/AAekL0Ch8NvCgwA0OJCJBRt08BcIA6TQQF8mwSInf7YgIBy0EtwiAAskPIzEEn0Z8UAVLzTiAaj/AOiDQyYyVKJGKwpIRwh3EhiEAVM4cWAQOGJ6CpevQtSiKxSNWJLJPJzsL8raloCIjLeyuJEKA97asYgeAUDgQwES0McdD4twYBXynmzTzTcTKkjII8bYpI4FfjSjgUkOAHJPKPpUwwBQ5FAigQ+9BABMBIY0AoExZMQpJjapoMvSSzHNVNNNreqC009BDVXUUZOslNRTUU3V0lxUJTWpgvRZwCFoECDiUbeMmKSBRnVd5YB60GSCgE4ASAMSHxMwAxVKtokmxlJ/iQvaaD0NcNoorvWq1GyxfbWJR1VR1KoEYEHAJgAKILZYKDiqqZRTOBy2iETBNHSbbhhI14g+/0BMq18uuEXymICN2jYZgkVswg0FCqmVCTd05RUKeJqg2IhD591H0UHM/XLIBhCAEYAX/1WKrfoQ9ran+AwOqOAmutGppJpGOjfQAP6MEchrXFKCy4x5HGQWMxBwx5o100RaW38pTViPI8Vb2b2WB1b5pxy/MLJkKRZbyxd5jUBZiZGQOGQMTLRMBpGJpLki5SdYzmVsSBrQwmsl3iZoqA3V+rBprpd4lJ8x8L0bj1/NgRvgsXUioO6woY4zcivyzlshqil544ACTpL7ZTirrnQJB+p+sfSYDG9D6c8WH0cnwdcegE8gw6k33QVgMvRxD28Oxw2igUxHjGTN6EP2Ov9ouWOkRiuPeyrX30mAc24UeMB2m4RQZIx2C+DQcspBD91kJUh24BNZ6iYAyDXtdLj9BdoNYJX388T5lsOqHceVi84+vqS66TGA6wkhcbnyg5kaAECGyaMPYwBT7AghhCQQoEwBSIezmqc/PRkkdfkDwzLIQQ8DGOANJNzYEWxiC6kUwG+sG8r33iQtJtTDDjW8yCB25BZbCUCHYbKFQxjQw1thaWREVJzTyKATfTwgdpPQ1yEMcD1Z0KJzZlMTuog1LIlMw2xtk0aGVGFCjxyRGCDU3PRsg7mRrMJIHRugLsSwAOLJD29WC98wZLgEk8TEfEPoIiPmKL9AroKEdxj/ZLk6YRImiA16ANDHAJo4MQBighwOUZeZfKYAhv3PkZQc0kQqcbZ0fHEPqtDHHXYVNvFlLnpu4IjD6NC9OHxpFQRoly1p8Qc62OESQOoEIrg3IyR+wYz3CFkSiwWRGokhDrZSGgxFd8cyMm0cCjjdWzDSwysljoTu0CbjulFAMhJlbiyJpM7MEI7N1UGZN1lCAYbUuzGCkhoOLB7aSrkK4sFTlVJDpgjl8RQD0OMOpJulomo5iJCgSwCnPGGhyLHCFrbug4xbQjdssc6QnasIYrhZAZ5pxzw4CwsIWN1x8qgEfRAuAB/CyMzMkMiaWGUQdopEzQTwOPxRNDsWc+E0/zVIx2ikqxWhOGi4EJEhZupkAG+YiAnjOMeTMsRzUZjV8174MDNMDguGYFsVfma3KgosmgtBwCh3OkzhpKRo/SxGMccxpHQR1IAH6FMtx6DUhvajJIN46jqaGaapkhOrThBTVRHkhK+2pVFXwJpYFUPNpfF0aqvEBxnkGpGbPEIBJu2iXmVShzv81WwfHazeCvtWkUKuD0STY2aFYIp6hPYU0rhZ3d63Lz+KK6a0zRekIkGznq22CdAkrFrVk8HkIla1n1vkkdDxxglWkIuYSOU2fZgrmV3MDl+dHiMQQVfSZSWlZEXueJSLXuYCNavFHYAjavJGWorRq01V1yC1W/9No273u9cYQ1E3Ql7JSoGkqzyu85q73NSyN7FMMJ42+GGASraTlg5NpXUb9U3dEgEd6ngkSlZRhgOgia7mBZwVCuxPhrSKxS0OlYGzsy0Xg0qkrcAhKDhiAI1SGKG8ZZRt/QRTkhjhsSkpwBtGwoA0mOIAIFmjgMtKhRQn2DDGdZmCEWLloyQlrN4pL0XKUNQQ47BdnRgaX+FSGS2r2MuXS2NWPNvmKGcOas00hJVIZsH7qFm9XukgarP8ZmniUbLR4BIkAkGA1iL6dwkQZ0Vv02dWtAsBXAVDKJ3wZ7e5GTZrLtGXhxqOdtxZXUqwUpojLWecDDkexDCcpsEXJ0H/K+Fui43ClJGRNhslyNZ8eGxaTxxXMoTCD4Zoaiie4totpzrGSmjAROXpyjvRlsy9RR5JBFFUEvYM1gMWiKfXK5X64lrY5T6Grg3YIVv02kYic2uwTRwYcBMaJaXmZAADCpElegTPMYEokuv5znB0e85AmTVKxurFKZDbGOjOmLrFIYWOAbtbW5O3pEuyuidqMbP0VTRdjPcRgHdRjptN+HkPdvCOrs8jnjSbLfsbiAKAolaVYLmzXStt95khJu9b2J1im7xF12oSGrGS+tQwxxHO1JeDIgKu0LdIbzu3yhi3hi3ikcBOiiSzFh7EqcVhQnB8xI+eJfj4At1pYU0y/4h+5foh2hpzNywAfjykBg41xqwd5lvCr8DurQpAd85J8BBIQ8ckmuF0x3XSHxAexRzeoK8nKkLqBSfuyTDuDGVlgnZj1Nc+qx1g0hoCJEACaRcX/G2Vo/6mbsc0Q5+V6I7GI+CMuNi4hhpFpA0yGhQEY5lS4g3bX2LE65YwodYRdoDnhBWNHadiMc9s6kDLp1Q3yLwhTWt2FNv1AS+8TGT/KwnXPu/fzL08sIvZGPFYFRDuxrma8Qncbb/DDhDFh0j7FMGlSafvrvjfLk7VuoCt3OHyruw0CiL45qD7UG/Jio1uPOKljMCmxg+FWoIWhEzCIPD3NCLHiu4hfsmcQv+hhGKKtGRBZCaujizP+iJLAF3Q4NRuNRjuCs5uCZriqihOsWZsBztF+poD+xjs+lavMmbQCmrQRXZrc9BKBVWvTYAwRcbG+XbC0qhMCGNw0KgFBo1iA3iwC2esM7JQ/QCGCvFJC51jCLEw9arwJ55wDZdNDEWEDKkwCM2QStLwDVPOAKePynSOCN5n6GQFE0BuX3bGfwbFDOrEtQCxfuomloSp8tKuRe5wJ6zQKITBPi5xz1znAARKiE7i8ApF4d7hk/wnWPQuu87BgqDOkWZrvNDuDK9wEteLzWRR+nJvkOArpmrE1p6oDN8FFXAx+HRsE8wFwLYL+mQtFo3CARz/5ieKMNaa8CBe5A/qzj2EIPBOiMHOrxkV5V464gmW8N7KcALjgRvdb8gyp8Sm7gDtsJxwpgDZwOHWDx6HYRJw7RnXkd4QQuuYMT6uUZ+kEA9zLwM78Bt5qwDzBXlKsWcosCA1sLee7BUrEQGZwP7uYMTm8BcwRiDuMSBRjg4F4ilmAZVcixFtI3swAUyMzt6yL/PqMGpMbQlDjoCCqZd6ayU/glAEYBIOMRSPAK3sBHWUhQiurROOzQzQSaiODOj8YCbEbIxakh0NIg7mwGGG6Dh2xJbAJPHcLSqbLRklERCWIFzChcjC4d8AgCtxx28mwRTxxpv8LnPoTnDQUgHC/6FX1i+IXkGg7NH57Mwjqeolry8JDokYWVIzdkQfTmH48k4NUYrTwjIt7c0hGKHk1OCvGDMjTAEVim4zvYdHdm9NyKRtumkfnMgqKhCL+hIOdkb2HFMfJecU7+EYPcNLkuXr5qAriQnBYDEy7S8JMBLu6iawPIu04k9k4OFGqu+x0E8uq9E452BilCb37PEtWGhkuG8W3RAocIECa+Yk96EPbowWDtML2jAMe5MimUCq/sAagNP0VoG0cNLIlAwK6NNQ/CZ3UoIAiDIJTKgVOCIps1M1oYAe5CeWBtQrabEWq66ywFI9pQwwd+FX6DELLosFF1QhMtE9NhQKHTQSIf9UCn4lHImBGR9NynguI9NTKhfiPGEzWrwwRlMFMkOUQc1zIhvMPlzURp9PM3bUJTP0QT+UR/WwQbXvF+RRR3E0ISaALqbkOJqUK4gUQ/nMBk/uaZxgNT9tSRFCAujCA8bDS60CTKc0R2sU9eIwS3+URbfzIC5jTdfgTcu0vSIT6egIpmrlKQWhDIKvAI/yG4QGEhjgZgjpJnoyEactAKPxJ2SDNryjUefUTNuxo/AuEKzyJOysbEQxLfMKUC8BKH1ltuBgCEzRE400D4UiLMZiPFQ1Utlw9TBikA6teDAIamxvNRsNflBzVv3gF1NhXE6VTQ/CLwojO4jVQWQ0Wb//cLKOlBG+6TpHjXnCMf48lRkMYDlFLe/gQcOuy+JgTCHmwz3C1VqexEUTELj+wDuJzTUPkhWIBlCT7U5u5gE3gmc2giR7a5Oib1F/IjUAxD38VULgtE2FFDSYqAX5dSF0QznGY2ElBASeBGKhzFUBDVWFIjrCYzwwlmI59qc6ViK/VSEuIEBGVj2mkRvQ6ECukQjqpUg/1v9CNiFOxD5mdjz40Yj64x+z0WUpR0W5oNZ8FgyUUEEJ9jCU9WhXBVuQdmkTQiT5in6CLDtQUoDGE+wKliBwgd3WAGiP1Dy5Cgc9yGJBNjKZUBkHgipP8SrVIytBCjdz8kQTFmsj7msS/05rfyEFKStmIbE3imJgN+1yCHNcEMk7ElNZMrNFheWWOEIBdMkl5qgPfKlYyuwQFDeXQouXlqeLdmm0IndtIpdQKVdZFvcPMAEQ+W83BRMZhaNvV7dFG+bRLhQr9+E2ObUcENcGFWoiOEe86oZt6rITSIYAcjcJdpevemTfQsmhwASiUOdsIC/j8lJ4yY54+0e3RonybjR1iwviqOAIs1d1zZY730G4ektqw7O2cPJ2j1SvjNGLMBPkkmoPlmpe0kUnQkmMmqptsrJ6TSh+IiF+O6p/cnHIsDdshXVvi2D/FKX/ArgKvNeAc3BSX7Z1rXRdAlgdP1X5JHN95XevUP8JFZ62nryubeyvi0ir+gDYhAXIG4nFFSE4SBGYlaiHRGHtgfO2bJ+Arw7qHiTUQns4Hw2iQw9EiNUX4SxYc2+CeELOhI4y+UBrc3mLnxABil1hgvhXc1ozhZsIx4YMbz/yReGtCLrBP2NiPgVgUK5kiddBjafIDB7xhWFWJchOYX5Ye1cUWZnVK6pPIcD2hosWh99h4MZALePISiCCjT2KtPTMQ8H3CT7hjAGFdhbtmdqFeLBpKBNgd8yHGlhuXjMS+/TDKlbVPqIUEp70aheCAIViaFE3bhtZUhghM6eYAJgPkQWAjXMV1V75puRAkljx7Q7DgV7BeOZuAR6lcGX/T3p3BGTm9pUPYkH04kDEFBLIVFIneHvtOILT8sdqV/6wAY1IwpZM+Je2y2qJ9vkiQVfZJYtSE2+4SBrKcjTF4IowjRF68ZNfCBLa40DklEqvGWZhWJtngVjM+EtgZJeSD6HjlRtfsyBIohXEUSRwlp4IoZinZ1A2qZ79QOs+LIwTAgMg4V8DBFL9+Z89Vm+1WYIBecgCVJ4M9JneeSL20xz4KQLRNSE5Ap+FopQZ1j5ataT/2bgWw28rNoa9ApM8ukulQ0KOFaivWaj/loKdeSiM5UoBGiG4kANQZFwRZGm9+qtPhUunWqWv2keNgjRKVkIC1qTvcKh/MKlh8ieq/yJCJMRh2ToN3fox/y98EWIuavZANvausTCvpRqbryBJp0BLtRMh0rpEGluw74iwIWPKWBcLELsK8BEaL/ZJ/hqyQUeyh+1OB3PhArKyy6l7PsGuIIJ7JIiX7/USKplo1mXRHiEJCMiPKQesUQVgdFtGPftM99rcRpvASjuMeVcWEEBwMkQIxuC4C0V67KoMo4EsT2sFNRsAo5qvfxthLU8iIvcoIVkN9nSjeS60uucSSEh6HJfReiZzjdr/2hddumQPMqR9KZqUxogyG/PAAnNf+Ru4t5u7x1YinrcZliBTCyEunZuBr3MiePfDKNu4RTVNbKlTiSBDMPi+pRtL1P9nkoIWkIs63rKbbAP8LkBbDN+3AHnVNcuS7FyhbSyTjp7KKuoXDkEcZtdo7vTBAIx5I2rkyTTcf14aO9/5v0M8j488rktcUbubFEWudo8gW12zOTPcP8suPtNBHUf4vXvUIKKh0r7Yup16rGkkb46QqJe8rGOYDuLTP99AI+QAQdk1d4D8PUNBn2g1iYmmuIP7IEa0lZHLWZ4ISZeiPIpioB/OGM48zRPjxEm8y80aggW9PMV2xJXgKaT3iIth0SO1t8Ha0h/9pMn6uqFSXyIBpHDyzAaV5X4uT3WSJ3WSy8eWSG4Vec67KJOJPF+OcygteHgrnK2azGURzQO6SoX/3Qir945DfNIv4XHUcpGh91f0UvAEgS3tc6Ju3LrRJH5RqXcL/L+eQX10aZifu7EcL9gNu0yJ/Y99MKWxAIKwoGW7toJlveCcpXraJjNz1X9T0/c8szPhpd77PBVfPEPIIcUBwRK2yCM+IRTQFNRtdN3p8LJFPNvfPdmHoda+FwmtnHRx4TgTByKqzxDEjxyV86QM3RPe4ikeIEOK0827OdxtYeEFof6Sz8gj/rPLvAsoHj0RGHd4jmSMIFYKeiLeJ+gmXFwGAYo9N6a0zd0tb2hOjW1WcqEXYF4DAQLpsy2Hy+LhOmUz2VjaSj5BEPVoviLkmNPnVOLBuOcnNt3X/8Uc8KWbcqp2Fa9/PJHwKIiHlTfg0FLj4RgPMvvYCZ/Jp5TtNXHXZOsOjrITTr1HWI4n3Ulv5YSKfMhcMvmWNca/4Hlcfo+H8Tf5SAvwcbsN6hiuxbzdeRTxfX5dpmuD82x3KvVGAovyncBMPmEVNOkOQD52vunzo3CEIQiqsF3UIZ5n4R7A0cvTWczEdx6hFu2ecAEjeLI1DxggjGUVPqyEc/3oqrch84mHL/clrtjF7Q0//Dbl+RaPI91bP99q2Yb62UXKr38htO6cgdiaST3RIQcIAMIhsQgQEIzKJZMZaEKj0ilVCqpis9Wrtqt9FgfgRAIwKAQCBUBgICQIAP+HwEF8TKMPXix42d93GQQouAGy7aUlKi4yNjo+Qjp2/RHZEbVVIRlSUW56foKGio5ykppCdV6erhalsr4auloOYVJpwrrCniI4CAkULOgaCgQ0CBXECWflKnsyMzcjRk/zLYkhqDGwuRGkEQR3B3zfeetCUxsyBDAcKDygZwkoKBgAIMNHneNXPe9v6vtTJmsdgAbG2vxasACBgIQLBahzc+sVwICZEBg0gyZAPQeJtFn8JW/BPWIBEIAMWNGikyYrWbaC6W+grzVtyPgiU+ZIAgNrjiTBJfNTAQXB6AF4oIDNO5kJFSRApk5bgqAqh05yibXaVmo0ASAogxAYyYb/ZKUSbGCV1cuuRjTNUXTgV4AEwUKuMSnAp5AzLCMBDix4cGCXhA8jTrzI7bSBaRDowRRu3ORgCR6vXdWW8ZBbSI18DvjrWACIaTNzTo1vs+qurGG+ZnzrDJ4FCh7fFf1TUByTKFsDhxc7+F/iRoYbT658OVvmxpHPdC59OvXq1v85h56aS2vu179HUaqnLHjOAGsN1W4+uPrywTM6QOCe8flCy+zTwv8m2bL5tNj7FyARtnmkTQO4MYBNMQKiUx8o6GEXYHvmMMggb0cgEAxDAshXYYNMHDgIGwrWQxtHABCwUYqDRDZAgmk0cFkac/hUVW94MLBAOEv5MV8Gi0zA/xgEi1Dg4XyYyJhGAgcciEA9Rgq0xC96CFHaEWsgpRSKSQjixj0IdVhlIQuiCJEC2jjQgBi59eieB4tIwJgFi2gAZXmYcMhmTXYK4wpO+QHgU1yJHACHGWAY2gaTJ9VTSy1wCJLIGh4pwN9x/ilSQWocKGIBn9/VEiJHJp34KUVSFkDlNoFi+eR+h76K3mgBNPWomSkNoY6qMc2HQSJFcnZBIhyYWqyxo+Sy46p8mbiGoZYkOgCp9cg4RyGGkpqAGEq2NN8EiUCQmgaJZHCsuedKw9yEWEmQiKepJeIButatO2+by9U7VAUBEKtaB2nYW12+AauiboAUBHBBa99iQP/wdAM7fIjB/g1Zp2rtBhnxxBqLopjHHxfmXwQQm7JBnBwrRzLKp66shMLAAdsycSrLbArNNeM87805P8izzz9D8a0i5QK91c6agZy00okYtrTTixX9SbuKyBt1etlh3e3VVnuyL9Ncy3T0KWLbrBVWZGuMcBoNgw1b1viavXXbewyZRsYBP5330xvA+7YSaJcy9x4jp3Ey3u4B/oXfl6Ki3yiz/Cf4Hpxq6nDiFK5XRDhWCuS4FP0UsYAagK4CeZWS7yFszIff2bfmZYiBq9Fxd4YAIWKyYrrEqGsxbriWu/eB60QQsBM9BChYxgHJA1DVMQaIgYYCIfayfBq9XDP/iDaKJpLh57QfI8CfJ6VRD/LcoujNAmKIIchGMso3aIa6X07wnBFELDzvU3RSfKB0ECAJYmCS8s7kPHtADxMF4NITMsIAQrAPRWKxzxyaggrwrWkARmFDb5YSwEPNhSwMEUMyrBSVA1hrCBWk3/668LIWAq1/iTBfHOZwgI2U74AFSOCr7LDDN/CweRNkwOZcBT5eDSFJJ8LEAA1lwz+JbxZ4CkobiDhDFsIQC+/Kos/6t5NX2TBGRBiNBoP4rAYaIyKWwMlN5CM6I2rtbwNyhy/kgwkHOKuGdHAIMqQoESoOIAFu5AgWuWjI1kTPMqg5mxH8NwQn0sF6M7rhSegB/6042EGS2BvDBDWohlJdMI4G4JEc1iEpbuhRD5XxI1DE5Ek0BLFgx9IbLWsZMnTERwhT+U70ynBA+iwOiWE7V/0YCQ/y8AI87buJAG8TGrdtTI7GnKXO9qFBPC5AkmUYZRosFZwmFsB5lQrUBocZTcbJzVjFTCc6LuMGMbaDiL1gzgDVIQ4bVmlXFllnhO5lTmqii5+WwCEhsUEA2QFngM0TBwDGORJ2dsxzx5Eo/46YBUMhi5jVtCYYxGgEjxpHoXNo5iDguM9Gdk+f9yGeN135hFtMxKKR20O0QsHPkwbUH5aQJABxdMjdPbIMtmkpHyh6CfvE9Htx7AJGO6bRof80tRk3/WlFXyeHM7GhRp5Eyi/Q4L0QLYV8J8LWY7Y3gAEmIgGa8EgaEApUdPZlI3tJK1CIsahubkN+wQBrf8yVigEo6DdhUFm0LKE7p1J1eI/sXqOM0dA4jHIBU7KNAaZEi97kcZfOa4MdYJoEWsn0dEQYZxEEIdkCSCRVZVqVECpoWcX51Qjt2EmK9HTYUDT1tqSYaoW845pG7oQYonMDPtkwl6Ds8E+44wukfuIXzr40KJqgi12k6c/iBkpBewzKn6JlxRx+sa8AHWOYGvqAFxVjI2sIkfdW+cnpXc8ecbDNA0xEw22o1w7c5FzPhuJbein2DcE1Si0capRb7PD/tcvK7Gm20dkOxfSZM7WuEEhrj148YLs1UciXAjnIyqoWtuNN4loSHCZL5AksZlHICBXIQFbBOEsejAN0+/IEAswzoxAVWIDTh4dGFWKr9UCw+dIQVjcw90YnMasdHlgXJNgGNxSGqxluUxqT5OEWCxlEh185ViOLV51vKa87FuWkNSpCJzm5JKxsA1gDDGpGhQWDHQArDrcCgreyBFWPZxbafeh5NbKtyxuA0RnUBiAYKd5wWdiMYttV2IhzDgbkQPqJQIsWPJie8nP+LOjYGsHOSyYHR7a83hn6+BuOBoPoktGs1bbB1HYIRwHwnK5/Vkdo5HLLprniT2iOuBka/9RTdHbsnKnFi9fB3DOwxUyNZOK6ON/xGsCU/YpuLBJWt+Y0ToPt7GhTR20BYNtvrVpKo/5NP0ohtoOHAzpj26nXH4I3c+oWgLvNztwp5Id+kjrYPHtaOE8deLOrQ7gAGC7fxNtJCtmbze6trw2LoNKgfOLTGuswge3DMkLfHdfy3bAX8SHJxd/3mEsT3NtXAQ/lMke8RUjLewxRIa1IiLsxZqYAvcA4chMYhweiybHMFmZD66GldjQgxMfYeRxOuO9YpNwf/o4SvZmjOpcHtbU3SfN3CdkHCLVyAUnq5BMybolI4YHKwowzHf73DrHTdYo3hzqoi8DWurD739qOh/90s91uGyMW3NTxHdYFrPWY50aQAHijFC3oCwZqiOxXqnIQgb5Uoj8T6akyLVgm2ErW0t3b4gFAglQaauR4Fgq67WfBq3O/wkvw8AW54m1gOYtqdSYJkgzn3ylpu1hmS+3MbtYN49AAlCiI93IHPcDrPgSl6Mfhv7hNhvL7BEkKfaHlK9PmnlwAr0Z8mc3Sr5WJ6uvWV+eF1obb5bv9bfIOojcyX3Gj6dxAvzdPPsjTA0xTRVmb/x2s4BjKVR1zbNH6pUzAzZvK5Yo7KJFaBUXxGNYT/NBbWFkePV4GIpAfTaAZGJStBY7gNY0tkaBiUB37/Zq0eZv4BMMDIV7uXVX/AlHa/Q3aO+DRamGIBu4QByba3hVEeGVFARJd6/TJsk0Y+vFJJ4ga54hKZSWCMcja9SlI9tEaBpLebUDg8/hRFPpYrYUeErYfnxXhOQ2h+xXLZkzdw0xTVWGKQJTgGyrCCMJhYkSdFKShdGzaS8ibTSWWFBCN4OxhY6yhUrVhH4YSIG6UCIbhdQRiEqJOI0rVIOaDgEAilFSin+WUEA7d3VVXUWkiVV0igGSiIv7a6JWeGhqiAvKMvG0LugUeGJbi7RCB9BXFSSwAeh2Ei0zhyoHKHPriLyIG32AiEcTZT7SCK7rEWZ3DzFHB6oUgLHIah8QfhmgI/SEDhxwVNqog/yO2UCgeYSmZHunsgTM2FDIOATkSIjQKny45YJrdQvGYGZDFIy9y4/54Y6bRnKqIwTuERZLQSDjZF4qoiPS0iHrdA30lER4gATGgnfJMoXoJghCwkVZthEm9lRlO4hhVlwsuWiu1g6vMClIZ46d9h/7wjkkCRycUY1JMDyBViWPJ2Jb8j5fQmDIKAV/wxVFdCX6YllqcIxhEpBCxAUwaHSkNHT2mowcmQjI0IakYw7RsA1QWWyr+lEq2HRFcxl04CnFN3BnFik0uHiE4yTF+ngFo1w25ytlx0qqwnUrl4flNwR2WG3PkEukRBCASRFAOYz4SwQMsEBXVSiE8k1fCmv8y3gWHGCXuIBiG0YFP2tgMolBYsJaEleFUsqEt4J/CLQcy5djcqMEa6KUoEqMiIFqO8F611MKrEWa0mNri8RegwBQeRNIUtmY3KIBkpqZ6cZtlJiUROsc1AYM2kRNedZE8zJUcKEhnIiA6DBtSYuQhHgl1uNMPXpU8Rc2olAYaXaE5Apo/QBtvPqcqGmFIgQFBQc8H/kypbQQCAVGfmcpb8gMlUoclWNoQ1GfNnEikFEQagZ1mMmB3xqeEzCcY8FSh+FQXPQkaIGd8uadkNgG29Se/mYI2wmV4LqJNGVVU7RZVgqISmOWrGMG6BSDO5QN+aKjsYcGJZiQpcpqoCVb/LGSo+QFe83GoIaVCATieEtxChH5eMp6CX4bZNiblbBVa3nkiE6goH4LHf80Nk8LeHNxFopBIxdUY9qWVcPKUidLYlKbBAATlRC4QE/Wg6IDgbgLoM+bgEDigY+GYcC5kMWQfNopViVQkrJncScBKV9ni7BHnhZKhZ3ZaGBhjomDW59WYY34ePJ2JY0IIoU7eNnypWDgWTigXalWoc0Jn85RYAh2ArigqA/yCG2iJ8zQAjRVqTDqq09XYZNGDPKiSjOIjgNljoFbCoNYkjO2oTVbg55lnBTbqreZkG0Qqa2kQdllqgLIolVGoeZWJA5SBeWoZreDYKJkVq7RlTeVq/2f1XHfB6kU6h66lwR9yDbgGgLg+aQ8WJq4Ckh0gqjZamgP96oK5VGR63htgxBCQ6aWCZ6bOAW0Z2ijdjqVNRAPQwwPxCCbwxWDearZG1/PwUbfeYxQgWxpUDdhMbABUbJ/h6Feqq0staDE42ZKcJQN4Vbwi7E9IxiDgpn1kGMuO5GUK6YqeY2ClxAK11llOxEM56MlqRNph67o2LAJtmRpA7LQlgjDODbUhrWqkwoeyxC5BQUwlqXhGIrIqB0lY5FE6h7iRW9twrWgWgYP6Axpk5lVZ0LKiqYWmYEqWQ6ZOh73hG9jALdj+J0nCrG8aXCIkHNgc3N7C3hlKottqGv/LBUDlSE7L0e37xazgYsHUacLUnqB1XB3qTG5KJqI6VuZPRu1aaCsO2m11EB7qhC7bAmPpekzgUq2ULNLjdivmXMfroQ7s1mg9omkCsKkDaCtD0lVMda6Ubp9w3h0D7Ffrpi11qJ/kHO/sUoceDlan0kFnHetNJhrvNqyjjsangtYbKCfrKW/3GiLzao4AOGueBoVZEgr1tlJN8QW0ooFd2NlBEeAymO780u/XXEL94q8Jeu+29SbAukHnXlhSaJjmsq683mfR2ScQ8m/xgk0nRGw0PDDrFK/Nkq8vyOZxVUL1Ausa8JST2SKtlanVijCgZu4o7q+I3e3gojAilnD/HZ5wCqduAq4wCWvt5b7wCDMu7eor1zgwykSwvYBvIQYpDX+jBN8wDsdwcrBGoJkOjwKCXMZvEQPxEQ9xDstqkC6AqGyvM4Dl6ZGlFtxhAZdNC8sWGhADd6YbS00CGnvBD9uwzCJOEA4BAngPYJ3CbTUxG8Og6rLM0JmEAgOAAwDtW5RtvH6BlirB01UxFaeuGzOwzKqDnviGNpwPoWUpn84P+WBVG6iXXjUxifTsiSQJDXVfeJFKEsCBjoBZQKpXjihLQA5hKqRhqc5dEUAx80GujzYHIz/y2ophmPkFEWgWKgtQY3YImFRjBPlPjY1mfVGClYxGTCaR/kFGj+qS/9zBwZqoaVESgc5pc6SxpNrJMhWRCNpZSyZN4ZUyzyU/0jozT0N+rMlyqbCuJUeE00HSkRTzspn68hJQ0hkjAiIfMgxD8lXepHNhoA35aiCl2RpJHukVUR5b68TJg88mQ1LlZAFTigCwHQOMXSDHX1vGso5SUaFi1KFaxS18KqOaaDETUHUOQU+65COZ6qPSs0RK6kHDWA3vMxkT3R8rgSB7rC0XskCvVG/CLB3rAWDtkk9CEpPw5wvOKBsZZv65ZiwtV6vQnA1aIdo2NSrzh66EBueJrVhn7UWOc1bjYI3tKoIpgk88Sbwq9Fub74wstBrzLKTWcyG42VjydE/rc/8KznIJSdQtG/JRwzGaGugg9MIkr5YNkewnvdMV7bWs1Z7XkSWz6GYV4mDIYiVmlMm2EBrxJZ+20NWrjTQhq/VJ22S7dsi7RrUah1F46ZwAQ7VdInJeQxe9gh5iriNg/7Xa7Wg5E0qNmUi2YKl2mag7cws8s3NiE3QW6MobdwJQ8yxrozOMhGyBRjY2ILINFSiW0UF3myySoSw3qGy9umZLObILX96OmjRh24GFqXQBMQBLE49Lf2pMJxp+I/V/V4FoE6+R9HCAQG0TNKdP93QQ7/F1yzcdGLRbz9Bd0zQ4mmdd0wGFQzeAW02BzwfZSsF3BjdgM7gGOrjH0vdrhxf/vH53Y9I2Y952RER3EsuMh0dMeztfUlq3ea+1TXpSaWz3yJZsi0fm+V4weZvjEs+qggMucDeyfM5w29g48Di5n/72Fe/wKtwyKo644lZ5lwc2j63w6ITly35CAYsplscqweB43fKzmAdpGryD+5BCTDkxGb7EP2sBOi5BLu/yl1/5my+vHFfJByFAishXWNaXM9UD9nmyxDlhOcDBKD/B8OL5W6CP3ZUtiGquLjfSrUIwoAs60d1WaCYuzJaGOyADaLL6Y5FTFqPGClmJjKP5/97YFtNqEQ/2FGioM/Kon2uGqAf6sHM5XHLEZZhFWL5ZcWW4q3RdEGU0WK9KnaEn/wrqOjmXjzm38ohkO6rZGDZ44ST744lX0S5+Ul2cnJIKe5hTGfSCn37egw2xD0dsENqeqbEbwAOdVh3xiIHB+jRftSV8Nay9Q6UBsuWWIXxPnobWNjRb4U8aSAMMM1uSe8xdQtOliiJzr7CXOPQeAGXBSrw/L+f80K5ialKC0misd18w+seqyWXHEvxIu4xEJAhfumrLq6HAHbeceAbXRE4+F1fyeLTM4/LdeZQDescH7Q/5UCrNAhIAKeaOepUZKZUfZa7CmKGQtecxl3JaQlgMfPaOFQbKik38US1vvKgrPa+WyI2VgV3Ngm0w4+JyOBGIeMtMOTlwfUKXtrxGSv9aphQ5/Ea1+AbZSwuqGb0eW7GTrz2Rwcq2YEMd/IEDlBPdbzgPE7uXq32W23Ji9vmAV+0iYz6Tv+e6g/maJ3KfMkGGVf0Ccn7R5L0Rr3uJ4y0Sj/7pf0qbaz6N76Xtd3jmN7npeyvvn3rdP47uJzbyj7Hw074KxzkeoNvRW4MGc/qgk37uCz/qEz/Cx/mQeb4nQA6wyzDuO2L2N/8v47tdzgWOzHuX8OlSbLs9awsOAQXaGUAqK0swKWHgMwEQDAIAYtF4NAoISGbT+YRGjUNp1XrFZrVbbpdq/XbF42u4fAwYAIkCQ8EAOBpCATEwEBQOyIIDEGggUqgTAlACIKj/QxQQWiB7fDT7QxLaIwh0KoTc5CyS7AQNFR19+iwlRcUyjTILcG0zcH3V/BtISChaSJDFvQM4CNgrPEwkKnYIGExdlpSsNNRDcMVVEpANKIglul0gcFWIk2U4RHaFW/ZCV19nr1ptekc6KAhQxKLNKhaLd2pVI3JzDgCtO3n2AIjlCEGvAYLqWDO0hICfRUUYBGsHqhmlYAsWNsB14E2ehpq0rUnQyNODIocCsMyohV9MmjUjqTpiLQAuJA6WSNFXBB8TX0yKFZW5xV8SXgQbekt2QBo2hkRiBZAWEaErA4mETLMJaeORr1gX0JNl4NBAKidvhVOWZ+eCQ3ITOAoL/2VmXr59T53J+RNJA3tQghIZigTpkcNKHfuFfBMNx4MAQCb5qbKSVJ4ALlZWoFYwgNCRFZtGnXoyYMx2phq4Ggxtmz+vY/9jK422TgQMdrkC1tBAgYp3GEwNhG2aKwREH6uGLmWskWdEpMo6sNYjNkTJFpa9q4A5XQILxJuNvjf6enTq7SBZWw9aRSN9/jwk3lgInAYNLsJJYAlfgkMovzoKas6TOtg4gMDVsnCPvcimkzCmCCvEcJMIJYlPOAMB0IWXWgqkTygq8hgOMeIG9CXFowY4oAGs1PClw9OSyhBDCnNU50Ief8QRDPh+avHDhABYaEQXKTKRiIX+s0xAmP/SQORDpPIY0cYHcQJyvR27JMVHMMf8S0imdlLyw+uoSnMrKhGTBYE9eAMQON6sxCOtLIlsaEvWyDTtS0A7EXNQQyf581A/zVS0L0EbHaNQSMHccNJF3bE0r0czDZJTTyv99DmrziOAAZ+KMOC8a/r0VNT3Wt0H1lATnVTMMBZ4CcQGDPjMGIrWktVVRIPtlFhFQeXUViNwLQzJOoA5B1hjab2mWmuvxTZbbbfltltvv50WUmQzVdaIrqZxRIDmgJU2XOnchTfeS8skV1giPPIDVwayaWk0efv5N+Bwx7W0XMRKBREBRRpAQAG8tBIY4IgnbpXgWkWNURZMAHgAzX7/KXYOZJHF5TJZe0cuFmWVu9zwW5dfhjnma05emdGab85RUop1XplnnH9ux2eBhR6ZaKCPRsVoeZXeGWmnVWMa3qgjnvppq2O9eoqs9dq665qqnlZmsccmu2yzwfY6bYnVZrttt9t7O2655yYDbbrvxvtmu/Pmu2+q/QY88Lb3Frxwwws+PHHFayZ8cccfr7BxyCenfMLKL8e83sw355xMyRM/O3TRRye9dNNPRz111VdnHdsK5v7cpthHmZ1eqIGsPR25c8+Id0L98p3WyHWEHdbgNQSeveN1l3B5zWcd0/lX08OdeLcnqDYDk7vE/hrtw5K+ie5l+d766MZ3pXyv/yWo1oPtgWT/GvfBhy5+WeY3v/72265g5veB7J8s+BK+JgTQFTwi4BMMmEBAUUAWGIAekBzoCghqKjoTDEAFM8TAJmBQg2qDgCwmEMEfhdAVI7QgdEwYABRuUEIrbKHaIiALCZCQRzN0RQ1TqBocBkCHLmRPD3/INg4E4HU25FERj7hD1SjxRxxsghPfdoEAUKBiZKKiFQe4niw+sUJdfJsGAgCBK45JjGTcYnTO6EUJrfFtFghABMoIJjjKMY3QqSMb2ZPHuF3AeIDyo6PYE0gEYoiQb/wjmSyQvPUsUo979FzrJDlJTkRtkpfMVsjQgElOms1mpehkKLkVKacpzf+SsvpEKnv2ybUtjZRIM6VGUKlJralMPXuBYu9eebRY/i6Rl8qlIDH1roDxLJi3Q54v51jLef1tmKwY2i6B1stKzvJGzYzmM7lWTGmSQUYweZ5kqhmFizQAV+B4gjWaJUxgrlKbtpNaN48gDXQyQRoCsUyuooCMdQ4vmeM8Qjn6VM5zQkGdUujYxphBS0+4k5jQZApFpAFOVFwkQV3gJ81YaRE9VeGbSGTeP+sDFs8AoqDplE+gGDq9om2UodaQqD5TYdGvybMIyJBGghgAlQAsQEZ1SkauyiGf44hDnd2QRT9TQ02REqFjDXNYSc2ZjO4I4CJJNYR8hloHpLrCqoD/CIcrFCrLazKzpe9sZVZj+gBrBEKdOHVFvmSEjQec0xt2TQZ/ZEEAkcjiAchogAIc4NNX1DUZ3iiAXNwqH1WNNa0pKwI99hUAOBTgDUX4aVvzydYA+MEbD5AGbt7qsfzVjaxGkJEAUivVc+6iMBcBhzph2p2/kracT11oWRuKBPE4ArejmK0Y7hmKW75TJ9eoqwIcZtlw1EEaA/gmMAqAK1kUVLOYrQdNw9rZ6GLDumiiR3ZSSgR6sAqeEGpCbOKqXSL8NKPf/CgyHBAbBNAlu2i5bPMA2lRgXKM5BJWFAvaQseqqM76dnWxeCcpTpYplpcMyQm85hhVSBBc1xX0o/xGCO9F8ysgP732Jqlxx0oImFBqycIB2M0qaan3XD/c86FBlet6SMYaoVLWsQDLbWdrO9rNFCO1BiYCMznhpvw5mCibKC2AF4Ha1vZUtj3885J2UswgdIw7tHvwJCT9VCMQRQgOeKp6fbHXCCMjpAq7q1TX39LA9HY5Yw0EA8SRARpfdcWHFCVE+a5jHSMrVmvfAz7NQVka4ITFVEwpbtV4kyys+dC6oOlsY18MaS/hon+0FW7yEdqfV/Wl3FMDhcihDVdSox1wDwFd/IvnI9IAJkZm8hiqLp2E9jfE36qBqvpbzuAig6GnNutsjiJjCE93FAEzsWh+/pGMSGS+jZ/9LXXNQeBcGyKh4DhALXITaz/7iAoY1vWF9SgMTyDiPGgj7jUSDw8RzlYYf5lpbRaw7GS4G9DjqsZ1Rz/ix6IXlkff8P2IPWxA9PXNWA9scE8P0wA4wMT8JPOJpUzWr13BAtnv6bso+gKcXxVqGaWzPoqx4UMYspcBN+0uDQ7gIXaYwANCiBhN7QwDNfkDEU81YXKPppOxtLosXwHE3GCfmNoUHWpsghIuaHFAoD3hTBx7Oglf94L6NOTKy3LHz8KTUddC5VW3d2+24uZ5x9qrGhw7WPOd06v9+8MCQ7tC3z71RqtQtFFZsYoKPHJvEgjovVW73Y235CsrFC9+p7vf/lss95NMc/OP77nKWikzc2/xX4I+QKlcgDAuNKbzUV75Mq1O+aUqPu2EazDKb4oolPsVNNl0t+ickptUtPyYTMb97gEwFAbEvwovu4aPFaFny9xqvn7HBAKYvv6vgSMTzQz976pdFThxhhXnTCW6laD/peTf9xC4PTwT8qsjBP5D3WX98q0DlLgGJwxwoaxn5P8wrCL975EPKFks41vZcaJekMTxbcqm8QwB/+Q0qSYQErAwCmIqQmAo/KATOq4c1kUCsyKtaaL7LOi7ug6waYwJ8Ua8C0AQsQbc6OIZkWL1HGr2megYUiSp1KQQLZAshiIWGmKt62q41S4A1oYYC/6CH+uqOVVMz5KiFogKrAfy7zCvARfGNzsOnBGgO4TOCSygpBugPz1CAASiEicCsQHADLvQFAmAIIXiKBLgIlghAjVK6AUAYjxA7gdCEJAGIYAiKXjEUpqq+jkgSfsmGQsjCMKQDO8ADPVAMcFqLyxCJcdAD81CL6YJDdZkCPAA5JWw8ZxI5uNuGdTkPPGEMRUgDfkEEAyiEAZCGUhFFAiBFKniLO9CEW0gRiCG8TPwFVcOE40qJODkA8FgEXjwUPRw460sXAngAMBuCVFxFT7CF89MweriLtUALroBGA3gLQ+hBGfm9WsiYbLTE0hO/JjQ4bgwQYGAJB7CSYCuGjv+JETB0xTAAiUBsx20oQ1ZEw/lrAA8EuP2zgv9juRbcw8oAkVEjhCGARzFURoNwgtCQRMsosmnMgwU4C3vAkivJMvDDu8hYQ6NYwSjISG9MvUUZquuDCiCsiN9oQKyiwS58BQZISXrUQJf8jQLARxD8wCjgR9KbxWKpjpuKqhmMQLZQxiGsJ/MYj6LrwakIhmkcwvI4LhrJE674vnZCAntjkk0YBg/syE8Ug6wMv4+8xC0AvVS4DH+sSQKkPfZDgrDMmW50EiE0ReDCypmswo00KLkcP00ES7qEBKi4PrLMR8g7S31Ego55mPWTSiO4iMK8uN6oDagcgGj8hQeEhiD/XIBK4IXYoIbR6C/0ULUDGY6UmDlEkEzMlMWo1DS8BLycBBlg9MuLsUhKqMg6BBABwQ/SuECG/IWRaMTQuMrNwzXuI0eEPApMKI0HgL4l2MmE4Mq7NM140byfYU3VfDq2xEOryLLHTBNgEIZjvAbRIK9kXAsDQMrsGI1P44pqFL7NBI5i0E7xxI7lBEeP1Av1G5LbOxmqdCqPqY4ACZboREuSeU0kQDNh6A17FBAPIY2HIMiG/Ik/HIKFtA91lBYpBJE0eMiIHBHSiD32lA0/kFC7jM/KozXmoM/iawKuXAu17BGkQzNHeEtEoDMXxYg1kMvpq7v/zL8APYIDgArB/1pMOCgSN6GHyHzPBk1Go9SJ8JKWARAPejAAfkusDH3MV6gI7UzSpARR1Mu7atwFfApKjpRLrlyH56xDxYQWftnPGv1F/Qs3UeIkttzK2JxOLV2UarQMP0hSIH0NAmmEDlwEAsgGXtjMAFFQrIADByQp4xNM7MyJdUHOalHTPGTTlAM/LdCJLbRR3nssO1UC+JOD+5iPt7iFi2gIYuhLq/hNY/iq2YRR/gsTm6pO8rqGXZxR/rQm6uuaizwrWlwpO22A+bqGFUFQJm3PLCMGRXBPO/mJRIhF7ORQgBS2kxnQgUAAlUAEB0jT/pzUqFtCV6JTg+PSYIC/oIxFB2RH/v+QCEWI0KRMkESAknus0hkVBTK1jh51ADtDlS2s1Ug9uUdAnwBQn6zR1S/thJu8AgcQwi2Yh2BjvK8E1ziJFhEJ0gnrk984QPq40gMwymKgk3iFVmUKN0odA/txBfzZmoElxFAwWKB8ApE4CLSrVieZUTK0Dl9gUsVETYeVTywQU+rBUZQhmgVSG5TN0IL1mQSgiI75hwQgBIE0Bp5wEG48zZwVUYVtMkqRzm98BA8a2i3bU5t1s9cYiNBMBEDNA1urzCEgTQpkBLUVkfqAiV9FAjsrV6gtOcdqzoatWscTTMaBBBjqWousTVHthYcAh+KEvuu70MTCh4TwQjgxF/z/s4ODUMUjMI/keopq6ZOu+Fad3duwyVpMHAMhClxgGlYBwwiwVU87VIQUzUWEGE9TXDXmU9vxnIKDGEtUuQZcoNlfKArO5VWv3FkoWNmvoU+q1dR+ON76RBxIkKK0IdqJNdeUNUcNnUsNWwKRSMZ1rQyQKATuhdv8VASmfdxG6F0H+dTgrdQtjZM+MVGDNdHts8lPGIr41dvkRQhSAdLlDYzF6wIwgt4tQ1CKtYNZGFsq1YfjCoRheAU7XEkGVg6ARNqWIJVYEIjEOt+ikFr8FV4RDVcvpY54sF9m4N/13SjX0xWntIKeNUwycKMANuHWSFkpYGEscFkxuNnOHV4P/+4Mub2Dzayv5tuNlWTAPEVChTJVsDjiYbAss/BJWRgAt8CFofJSemUWNBBbJk0GNZhSS1uC4SjhQoIEPoLhbhUJcBrh/gUFhMVZK1jYEP3cOu0Ml2AVctwP+vPU5GiIPF7I/iWAR82Oi2JiiGRcguQTKf4Dho1j1DuXuQBVLFGGVDEPiVTFU13TTTgkryFarVVfcO1hPzAOnkpGaBhBJQnWbYy9Y/XdBsFG8FzW1xXFO0Bku1BMel2W8svOGQ0GeRUA8VDkOR3jwelg54RjSQjXPbgDCsWVUX6S/LIDlhjXJIhNVdbOliDBB81e3iRIdhTDBqFDQQA+enVDOIDDNv+JC4dRBg37vTRuYU9w03fOJAsZ5njSYcpLQMbUwCZNA+ubExExSVxsytZ41qaEYLAqhMl6LlFbCKJED89N3onDhCDV4tLQYi/eCuADZofWVnnOO+McMnRK3+sFA/VjZ4JdOioo3nruym5FjRqG4/s9PZbeaF3KO31BkstSmLTUy/mEhJSmSeTNvRPl15dG3pjW6FsNmgdTGPNwAAHQlwSEjbToYjUo29hsR3p6QjthDtpliSTxhRwE4kLDhifmsTygTJXGJdkLWW496n4c0wdTrQcQMzHTQQrVB8QVTWhtxzMcESjhT+OE11pASCOwY5TeZi0sxANwRLRWaZASHr//jWHQ5ehLcYOmZmo87cR4nVXQi0eUaJOx3Qb8S+bOMM99NmyZ+wdVVMpOduighpuf3dW2xskVrVTlgoOGeQByjIP8oIjSQD/FMEjPDjQD5RiZ5JPBVmbTllH6Kyk8MFLGZm2kZsPa2wsVrZ7IhgSnQwIro5/JbrzAojJHGEniuApSnI0SUcZXxIV/3ur9OIuq6FEtdtLtuGYiLevnju5F3mG3/suREquPZdkosG76KOk7MjiYq0Qu0O4j4O6DTb7WzC2ZdhfmnGfHdil+4dHpwj6gWMEBV6m8Q/BHWHDETELZoYlNFl0O3iR4ZnFbFkXSYAl4S1uslmRDaI7O/IPP/4Tq2xjDznMEDHyT7l4UBP8ythAzrCAz5dMqQBAsfnoqhgYrKzNPvnqqU9QJBf0qrOrbCJdtY6Hw3WmCF08EdVGItuVrP3xESziQsbJrUCxEiMxp+cAS3RNRY2sOZLuDZbM0Hguvocq4zhq1wlwysLKsBeC2Z+sOA5CurLIHRtvyVEBxtVbxtzGFF2+yBNwJ9Y6IYvTs4uiTXkZgN69GAaiKWBTyA0c43GqrUZuwxZKDaqE3KiMpGXuAcmozrOA4w4qtClQ1yS1LAcTuTfCGzAjqL4+bSleDDLfxh9F088jpxU0/3y1H3iZEaP/sU7e6EJc5qKy5PS+yFeOnIFu1zf+yMsuqjFz/LtXiuTYmapAtPfzk6aIdzKjq7CxwaQgP9tI9gmg0p/aSapeMg6iC0mgfQpIs7x4nwms3cRBP9azjjgnrOiWnLHCvQNump4mScp468kD4pnQvultj98Z296ptUWrNPhoeDZ9e+PzWdzLw8Ize76BrdQClaSf09RpXlyNmwK/+hiLYzBsUYiD9zIlWAyomB3F4VZHP1U0gzNlWD8TLT7z1nBNfKUatDzXIhj7O0IIwRDVuR/5IDuKsA0mWKZf45ZEv6jIGTAnn79e2eWhVAk5H5a1fRibokBIU1lWeXFquC2cM+RvNd7WHzgpvey4vvWl9S2cvjImcksT/Zt7O9uo+OeeHUcjR8O15bfelZ+uYl+63Bj8e/QaKcIAY1BOTRHgdvHtdlFLxCA2Gri8lcP2/x3e21/wxuPd9/ITbR3vX9vya1+iXz1GWF3xPyDLzkFPsRX5QsL0l1Zl7j3S+Tepgb3ovz/yThYdciYXjhxjdl4LlH2riIvzZdvsuT02lt36i+GMkAVT77kFeMGvOHI8vS4a58gMaXJN4pMGzdeIHBUIgCCAWgEZAuBgECgGFMeAACAiAxDFgAGi3XECgq/2Cx+Sy+cydorUEwdqs7orfdPqce6/r9/y+Pm8G6DdIWGjoJ+gloPBQIFBQlABwoMAQ93iwoGAgMASA/yCgNABQQGXw1dAAwKAw0IAQNqBUpMo68Liw4DiLqcnpCSpKavoVp5UAGzgGuPAEddjFSzVmfNZGWB0GzSeYuP0NXue9NXF1lBGerr5elohlJfBIas45HVdgYHWVMAtwPYuPjYGAXmR9IUigHht+xabh03eEIRs30qQoOAJJGRhACDwNSJYu2xaRZK4NEjmOnZdlKlu6TAlAgrkAHlzavDnInQFWC+Q1kDQy2b1fRLT0+4eqVgBXSg3SWrVUDSUDFUkR3XKUYsMDAR4AcJCxHUsuDAIUHXkEAQMvCI5kGcDkyKS2ASQ9YjJECdeIpyJKmaZlL5IiV9xgKcAvbhYCdP8l9a37dyNOOWMnWy4EE0AFc5c7e6a8LIsWeQfoBjjAqu5Qwm6zAphV+kgUBkyYOI39TMAVVVUDOqMqBmlkAhjDkukWzTjUtQmoBHAjT0GUWT8nVeq1qeqWUz0Bc+H6AJM/w6oAbALwQIE/Knq3m0XpGfnn+XbWULiCgb5+nJkvlz2w33GVafEfFwMZBclSAAzEFYAA0TNUVQaYdkA1DBDnVgJAXaOgYEcccE2DE15RoXfadCZfgCrisQYEV0ywYozh9HeTEke4IeMWKW7RkYNqBbBWA86NcqAC0KEC1GgOASdFMgVE8cBp1SADwAJY4KKLYaOYJ9pEk5z2JHpSmrj/EooD5qhfZhFcIQGabhJC45uX7RgYhtJJkdZaCh7YFxNzkRjhF6kloNsSY3IxwEVMGLBAWwo4UhCCGI33ZYUYHQranMvMxGmnnn4KaqiijkpqqXKtwUEAFcjJ6h5xtnoTndgoB6tkZtaKqxYXBEBBrr7a+ut8svJRaCvBZmrZq8d6pkEAECz7q7KGmLTssNAaIi002V57kwUBRMAtrt5EmeQ2bfSDaENK5mhtuIjE5y6aF8QLqzcEEKDAWdBQSwZJK8qqYDjoEuKAJ30cUIBXYt1K74oWNMxqIlzRJpoQbrF1MVwXM+YXa8/BRlcDeu2jhgNXrJXmmZEKDNPAY1AC/+CCcSGwZVsxEwAUV6Mkqi+yk20LcdBCn5FIJ5EpYhHSi3CJnnr3viZlAQCeiwpgVanR1b8qBwyOy30kEIWYohH6mgKgLBRYwAh0CWyyQ29jatxyz0133XaDCicZcX0Y6cg7nzYTiG40qOFEAHV5NRWP1NUzvG2HQZcBOkNtZeSvKTYeAY4UcFFeXzzm2EUff75PFwlr0UDYXCTQwIH+5BywA+Wp3FI55qDzdt65a53TGEoURUAUCoIVKfHnbRFi1LnsUjVWxQjl3fH0AQwdJIUX/lzS56XnDwIAYsm8gWYF77z4+p4mUBeaPKDJKBhesaUBZOpomUzm1LT7u/kHCP90mV2wvh31XKEAoxjgzuICieRlwlHhw43IBHURQhFAE2lpHMNYJAciQSJRDeob4MwhuHW9bhYj+tBHAkAABpCQQniIWXXEVzqcpS1+8zvRZDZzhf3pT4fT090auLYyHtLvcZFyHWPKMzxISI9SkZkKQKCEPtRJJExRipkWTicmHEkwbL+T4Ze2JLuFTeY+R8iPEP9wRmH5EA1ABKIQAaZBLURpSwa83KRMUqgA8KYYlwIRRlTIR0NZsQqqW8QREgKkLTjCi5P7BNt8ZhMXHQFGaaxPJS/IjUuucYhnMIYby+AvQsCMEDwTI07WdIQ2aZKNq3Rb71qZSSKCgRIKC2L/J2tYiIJZ8A0IqyXtXJKqVcFSI8N8ySaLyUpZrrJ/g9hVr5D5S2h+o3/KCqUO23VJZvqhWc+SJiS5YASvWMksQ4vS7NRBTd9NCgzW3B82K6nNPngLXN7EIBnCWaUj7LKeAnolGLwmQk2+M43x7MO8+MnJMeBznBRcy6OsZLYlAGggR1BFlDryo8J8Qo83Is4QIEqczemxShg6XVue4IZmYIR9TQjp4pSiCtGNdJrHNEpwGiMFzg0GQxP0wkCag9M0/NGniGmD5nAThSnoZpCYtGExC8qHhyHUqWBwxhUWYDIHnEIAEF0QCssCCysYIEpp2UJZ1NMWg1gPC13VjSSY/3CAcOoiX2lVgnrCyZUCtBUycC3LOW1DU39GIzjsUV6WsHS2mT6tPQSqxFdUoVjvPcUWj9hSDzdyt8xqdrOekgNnPwva0Ir2VPZUaNYYWpZS5KurYM2jbMwZGKs2Ckhg/cpz9hqFtqSGCG15gG67KlN9NgFPuaXtSE12BV9iq6ZQ81KD4oCzwklBEgFToHsGuDKTIEQh+4EqD7071a2ZYaH6ZI0k9tqA2m4BtoRxw0Vmy4Damoyrw9VNcRkgV87Bt6tG6BJuNxpfPeqGCviEG3Nd81wqTAV8WnJuFFfhWB1tySSpgMotcOnK8CpTw4cAxDjIS06yrgWiF+kpRW/E3v/UIOC9upXvbev7jN9iCAFe+e1wVXqEfMH4vn6dbUSVi5ma2iiBg5PSbthwSCJUt8iDzCN1J4wjpB4tZRz+ZpWXa+UzRGkaXeVwOq+c0CuDF8we5gNxFNZlDX8ZzP4jM5sDW9o3x3KHbn7zmMW8YTn/kLnhvfPu/HzPRA6zzHruw5rPYCPLGgKgeFA079icB/tqobfbMALKtqHbaOW50MQ09BvOxgdGM1rCo/4MoN8W6WdsFMiDsPRTNx0IR78JYdlTo2DNYKxQJ6LUtnx0ndEStt7qRhW6EYDJ6BKFBZTUK41oghAIc6HsESe+71tAtFF4gIu2pQ03gnZZNBqxPJP/aBmydpMDMMwf5hZKLfowjuYOyQQFfO+PCBSM59pSgLWsW09OMYDoQmEoJ8gm3XbugmuPwD4F5ItztnVDWvO7cOPCwtIX5QoVOHdp/Z4iAVv2BxbyCm2zDjfcWY7FccqNpgbg6LJ0FjlzhtSFp51iFI5gxVpk5zLwKCFI6U1kcwoyC/LZlObEIDikDa5qShvBCFGYL2HSQ8626EY9tXU1E8KpXqiYg8YjletwLR1Xc+xTRYRuxyjuMhiLYaFsTciCUrFgsQhv4QmeU4L8piA1ZEPN7sgV9Gjy9BimaurWWnAdXHotnPE8Zgn9uDYW+vEIwyfIKSdMoWt4DY5TDy3V/8HO2rfRN19dAAnimsiXEiaeyEJlBOOKlPd6u94V/o4+e+8leZw3cnap+UJp6jHSgvJV2b2/Lg3AADiOGAOgCttCCTjKWhfK8nImstzTYIB+EWDOhcS3webOIwKVrMSkTyTA+kIC+h1+cnnNlxyhnJ+080+qBZOJLgvKTotX/G0x1I/4IjhyvLXf1wCw5XV3RVudU3tyUnYndzQBoSAjEzOY0g/SdQzmIBFeYhUCgS6LkwBnIXnSZ2sthxZCwG8xpxVe4mSzRUCK8nhXIFn7Zn4etwSA5CWYB2e/hgZpFX+1hgZupT4Kt0ybpiCrkUTmAR3ANw0RWC6dcBboQmFN4f810kN+VMAvpsZnU6V+QdMfp7cFTmcGfddTQqU68CRuHyKEGLEzF3EecYCEXfAbTBhletcPFDQYIagWHkiFhOdlcnaF/JSAnGZJIJiHBeeHhLeHr4aHaqaHg0iIiigOVch+iciIcxZmkWhKkugHUxgjNIhGgkiJjbh+07Jy6lQIjXBp/IFynWaJW4BjqlYGmDgf1aCJnnh0t1QHrlhPfYgIKGeLNjVle4BFyXKKlegqZNARRPAR1hCKMhKLf2iDORgR3VGLyfiIn/gGn2SBZLCMYzAh8RGM/QSIZdEzCKQnP8UxkCFlaGcwozEzdOEVidJ23eMXUsYYTWMJ7LE3fwL/GY7Ih12QHgDCAN7TTiRYZbiYfXHxbq6negwAEbQWg/BojnCoLn0HSPH2BGFISIUnBoVjVHnnF6CTHDfyc/7gAA4UKXQ3dlQ1jP9EK4okPOVBAEqBX7XQCtjBNpjAFW7wc77nb8pWWHElk6OAAA1gLGrge9QhCZRQiqkYiOuVa+qIF0Tggnl0ITgpWdN4e9lHDDQnANwXRm4UJi+5HMrXChXhfMJXCl4Vc6JxCscgCcgXCdZxadzBBb6XNgfQIOUnYUr4CdIIa0QzBgWiihDxZBZ4GKKREKsxEtMQhATQQV4QQg2yXV8SNlPQQQ9yBY+UkrNIfE1QPZmwCdbXHGVh/1ltEJJWmGfaJwCLN3lVIphMVJgYqC4amATBUYLZp5YZ2ZY4sjdYUEIP1pgT4QBvxTZLARH5iIqZ2QU98hprE3WDSSlVpHxRsSRpoJhnRwW+twjKxmTRCZRGYJ1EiCdv2WGQ+JeMMBSS5zpsoHCC500EiTy1uX1y5wX315zPeRrcqR1ckn7/w0WnURq5KUVcQEUPBp5YwXp4GQt6WY3M5UdNMJJ0gRjZpVHnOJ2JaXJq4I7noUDySGzXQQwWg48EqpSImAYbCGEXdkU7kUhCIprIE5xS02enCZ9H4hf6gBsR+j6DA5F/IYeeM4N5sI1IZjYAGqKWIkiI8m+TNg0kqf8gv5FMgEiimmkUpgEd0xmVJ3MNCZBvpkmNcvKL4dA+BnaIMcqJnbigXfompKgOBVODI0qmUmqmTzqJcXqVstiMA0mnZ1qneXpoeFameSqMmcFoxIFu0NSndLCLZZCNb1KI9NKo0uSegzUG6XGSvVgjj6qn1AenePp8EIojJiMa8nBFfLmUc/pPghCQlipQzKV2b4GGi8FVdsJ2GopTvFAAT+kxpCojmBoueUAJQCEAqqAJT5NTiqSrb2qqkiIXuJEAgkEVmKMxz7EP+KeD0fCqf7FUzuAG4uiQkgAyFUVlUJo9S6OT+UI1Z1GuPAk1B2CrnskJrpeovuanQQEG/tb/QaJKCsfKpXsKnkYJl3GwPb23ctBlkWCQrsG3CFMTil/Zk9RRqEanqRm0rlF0GtcgfwLQmBXLZL2RDxuir2RHnqNRLmwQBddwcB+7j1lWmQcBIQoWOA+mhtuWlHUZBiXClhOxAK2pQIcDsoc4hNhpriv3H0CrnZXCsQxWLyFbrN9hDpCAr5CitG1msEciniK0RHTZJGxoF/kyl0UIjTm1PKlZnzvbPPzDqmY4q7BqI5CRobBqtOpiFbO1BCjbXUpLCeURrEZTJeYZFlD7p1LbBX3RFkWqhgjEds8xKCUVJMnYtkcjt45wowDaIN86Ux8YsY02GbqAmWjCq9wCCCck/wSPsHKs87R02559qQ6aUKlgoLnHcqgmZxNX8LBm+7eASkSda2iHVC36eItRa7uQhLtiOKb7eqe/e3vBS1C8e7q1a7woCVXWGA60ZrqHkKp7NrxWWbytOL2WkWjbwGvQm6koSQfZAL6iyAfnpoC95iqKVr1yOqJHsBZrmRN0JGvly7lKWygje40yAmp7IGopsRSL6rxw043QoHLpa7970L5+6bO3ipbz2zDI67rsVEPxOh9NqQf/SzQFfJzjABFvERfxoGCmMQomqQQUOXAkVDrUypeBx4I5K7uXybV6mzYVxBoCdHayO54+uwhii49HGTKicCV5spDEiV0BHHf6pv/DMSLBwQIIcdCq3YqPScVtp+AoSWnCSwF3P9W4GylUIthuBQlvTZB8FVRvL3x6DemCSPx7N3LCTVCRwLsGVIK1aoCXUVF8wnCWazkw3CF02su0XhEwARMQBNEF4CEesdCiC3ycm7gRnCCtb4mUCMp8y1EF2BcwCJMFSOw+45c1jBy7UQvF1eMPMCmWt0BAwudFo5HHtTZT6eqWLnfJiJeV+aqXweCrXbFztACaQxJ0qqPHRXe8cCA6UgOzF1cxA1CcFSgcK0QilTezXuJ4m0y/StIIz/c+HdtorgPK3ni5OsIocTEPl2nI/dCBgzwKrJDMSMjNs/szolydMuOaA2H/mNy1hluwzOjSIRQbQgaSEYfnRqiZz2IwzZCHD/88ebMAzfs5zGQAHl+hRANLYE2hoM1FKQp9EFBkRdWRndlHlfm0yQrjfJrQv8cAC+CXyAURhTssrlnQF1V7feVjyeXnfEthC6SGmyvNxPBscgdyDdBJ0UeIm8S3hHMQMEQ7hSsd0DNa0b9TBSe9gpPmyUHiy+fHzLU5ieNQUhv0b2pAGxZTwpe5n7zQR4pbBMn4DyqYBTZqo1/BtUhqKIuRY5GiDwjgzgzc0lf0Bbjhn0E8By5oo0vxPl/AxlUgCe1217GCv36xJwk0oXqnhkMNTmJt1FvSxdK4xo6Gmh7DKPjm/46LsrYtmCcvqLgMndVvorqFYMGKfb368ULyyqnNe7u5EyWrG8qt7Rkzxp7TN6+y3dCy/bpRmr3NG6l0GtzI2tu+PcDQ0M12UG7dSywgcdtQyr1NbKfJrdzFjQb8QhKXkNiYCwYlbXYlsb1BhttjsNp1UBEmkd7v/Ld9t4HNTZ0B1UrarQfd/d3kNgYYPN6TupLrcNzI+A0D095NVapN448Amd8Gt+C5U9xtizBNNwQmq8OgIxgSNMU5hatbwNc5HINhbJI3DBHXph75FM3opG5D1aqP8awbg3dSRpI8NZt/weJtUH8jx9uxLUdNeeEe+XZgKZIWTjLsca3lqL+bl/9n6Xq3MLp9i2k+3j1ZM6l7S3THA8CVkHV2xZfSDUhOAsrB2lJTV640RKYFAds9yfeTCIpYADccxwdwtj3dd9oJnGmp3BF8egGYXvW1ROkGO7lYIorkKsvPXqUwbdDOC0IhUL5diJmisaCadE2BErgyF6tIX87S3+xVRxxHyQNC2lXPhixdAiARasDebkDp4TrcrBAe09CbNgucjpHo9sCY/Gxd+VPcRLvkCrvSA1oh0DNZ0tnoc9cU3CdhTXIWW+5LBWIlJ54Or0vsPZ1AYbNETWhhaq5XWbLeYUMteX6HcCrqREBZTqLRxuBvxsLresvnFlG0v+ngeQbhkPIKRVv/14rTR4MiFZBdoQSCF0FYOgHjpLKqDx6JHv+N4ofoZEUECX3R4kvARDAeMjA4QRWh8FTTMTl+4KCbPfbeR9VwlngiSPZO5O9Y63+GukNT4FhG3cSL3b5t329Dw3Hupiqv48oNuNZ9TcoLqb4L3CXPiAGOvSu/82ja8zhvqDpP3DyviD7/GS6TwKy9qSyP9IMY3KtYsB3mFOZb7MTS4MJ44Nkd9X4Y3MW4nOugweCtwFvvzWI2WmvP9m0/Kpjl9nEv96EV5l1Oh3piOR3OGkOAjkoWrcZcQUxvOdG61peZORQopjSv+Iuf9gjyfD7nHKT8Cgmq5VNOzTmny3kwrkqU/wXcg8+w4JbyzfWMT/peX30Ees5xRBBGPOSNXtgFrfka5CFSUsxMJPqNX/q5f/RjoJwfodRxxJ0VLYQG4X1QHX7FXiRd8tDEg0fSfem6D/2/KzF2klSj3dirUBtNepnDj4KfHdWYeyB/D4MObBKDkvjRj/58Cg7cjoXp7/7GDQ1rW96a9v71H4k2nyv4b//7P8FAABAOiUXjEZlULplNZzPwlE6pVesVm9VuuV3vFxwWS6NKAWGcVhPLa/cbHpfP6XW7uI08AwiC+18pD3CQsNDwEDExS9BoT3GQ8VFykrLS8hJKL2ATrW+BYFMBYKBg0wAgYTPg1EGV4QBhMwFzKf+S9hY3V3e3K5IhYABgr28gYGFI4fRBdCgBASDgYahh9kCBgXfINpu72/u7MtKgQGjYr1VB4EB180BAYZNcoDRhoVT1lHsbnL/f/1+NrwDYGnTyI+SXtXwA1klzQA6ZAWr89gG0eBFjxiS2UgVAYLCYrFH3yIEKUKDAAngeF8BSdaBbRY0zadaMadOLTJw7efY8pNNnoKBDiRa1A9Qom6RLmTbdgpQpVKdTqSaVarVqVq1VrxrtuhVs2H9fiZIVexbtLrNB16Z1+3YSO7lz6da1exdvXr17+dKF+xdwYMGDCRc2fBhxYsWLGTd2/BhyZMmTKVe2fBlzZs2bOXf2/BkLdGjRo0mXNn36YhAAOw==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ABC: airway, breathing, circulation; IV: intravenous catheter; PE: physical examination; CSF: cerebrospinal fluid; CXR: chest radiograph;&nbsp;HSV: herpes simplex virus; SVT: supraventricular tachycardia; CAH: congenital adrenal hyperplasia.",
"     <br>",
"      * Cultures of blood and urine, CBC, enhanced UA, electrolytes, glucose. Consider lumbar puncture (for patients able to tolerate procedure), CXR, and other studies (such as bilirubin or arterial blood gas) as indicated by history and physical examination.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Patients who cannot tolerate lumber puncture (LP) should have a blood culture and receive antibiotics. LP should be performed once patient's condition is stabilized.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13795=[""].join("\n");
var outline_f13_30_13795=null;
var title_f13_30_13796="EGFR inhibitor paronychia";
var content_f13_30_13796=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F66462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F66462&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    EGFR inhibitor paronychia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 425px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Paronychia of the great toe secondary to cetuximab therapy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Aimee S Payne, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13796=[""].join("\n");
var outline_f13_30_13796=null;
var title_f13_30_13797="Bilateral scleritis";
var content_f13_30_13797=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F81098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F81098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bilateral scleritis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bilateral anterior scleritis in a patient with Cogan's syndrome, manifested by ocular pain and erythema. (The patient also had vertigo and bilateral sensorineural hearing loss as a complication of her Cogan's syndrome.)",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13797=[""].join("\n");
var outline_f13_30_13797=null;
var title_f13_30_13798="Estradiol and levonorgestrel: Patient drug information";
var content_f13_30_13798=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Estradiol and levonorgestrel: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/4/14407?source=see_link\">",
"     see \"Estradiol and levonorgestrel: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F167132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      ClimaraPro&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700311",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Estrogens, when used in women after stopping periods (menopause), may raise the chance of uterine cancer. Progestins may lower this chance. A warning sign for cancer of the uterus is vaginal bleeding. Report any vaginal bleeding to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700259",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take estrogens to stop heart disease or dementia. Using estrogens may raise your chances of having a heart attack, a stroke, breast cancer, or a blood clot.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691539",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to put off soft, brittle bones (osteoporosis) in women after change of life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691649",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or lower the signs of stopping periods (menopause).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to estradiol, levonorgestrel, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Blood clots, breast cancer, stroke, tumor where estrogen makes it grow, or vaginal bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703789",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have surgery and need bed rest.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703881",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you turned yellow during pregnancy or with estrogen-based or hormone contraceptive use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There may be a higher chance of breast cancer.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697169",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any blood flow problems, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697221",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have gallbladder disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697258",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have heart disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698524",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), you will need to watch your blood sugar closely.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697308",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have migraine headaches, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have a bone density test. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698554",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do monthly breast self-exams and have a gynecologic exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have an eye exam every year.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696901",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take St John's wort, dong quai, black cohosh, saw palmetto, red clover, or ginseng with this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid cigarette smoking. People older than 35 years of age and/or smoking more than 15 cigarettes per day have more chance for heart disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697712",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To protect from diseases caused by having sex, use a latex condom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697589",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect patch from the sun.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697997",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698392",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697883",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Back pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697923",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Enlarged breasts.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Gallbladder disease, blood clots, heart attacks, and other blood vessel problems may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699095",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling, warmth, or pain in the leg or arm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698615",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in how contact lenses feel in the eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698598",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A lump in the breast or breast soreness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021922\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694510",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Put patch on clean, dry, healthy skin on the lower belly. Move the site with each new patch.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694737",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not place on breast. Place below waistline.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11533 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-88.81.100.162-2094B74F85-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13798=[""].join("\n");
var outline_f13_30_13798=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F167132\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021918\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021920\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021919\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021924\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021925\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021927\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021922\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021923\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021928\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021929\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?14/4/14407?source=related_link\">",
"      Estradiol and levonorgestrel: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_30_13799="Struma ovarii";
var content_f13_30_13799=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Struma ovarii",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13799/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13799/contributors\">",
"     Douglas S Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13799/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13799/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13799/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13799/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/30/13799/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 17, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Struma ovarii is a specialized or monodermal teratoma predominantly composed of mature thyroid tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/1\">",
"     1",
"    </a>",
"    ]. Thyroid tissue must comprise more than 50 percent of the overall tissue to be classified as a struma ovarii. Struma ovarii accounts for approximately 5 percent of all ovarian teratomas [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Depending on the histologic features, struma ovarii can be classified as benign or malignant [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/5\">",
"     5",
"    </a>",
"    ]. The clinical presentation, diagnosis, and management of struma ovarii will be reviewed here. Ovarian teratomas are reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link&amp;anchor=H9#H9\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\", section on 'Teratomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11205128\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical manifestations of struma ovarii are based upon single case reports and small case series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/2-7\">",
"     2-7",
"    </a>",
"    ]. Struma ovarii is most common between the ages of 40 and 60 years. Women with struma ovarii usually present with pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a pelvic mass and less frequently with ascites. In case series of 20 to 30 patients with histologically confirmed struma ovarii, abdominal pain was present in 20 to 42 percent and a palpable lower abdominal mass in 23 to 58 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/4,8\">",
"     4,8",
"    </a>",
"    ]. In one series, no definite symptoms were present in 14 patients (41.2 percent), in whom the presence of an ovarian tumor was incidentally noted on ultrasonography performed for other reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/4\">",
"     4",
"    </a>",
"    ]. Ascites was present in 12 to 17 percent of patients. CA-125 was elevated in 4 of 13 women in whom it was measured (one of three who were found to have malignant struma ovarii).",
"   </p>",
"   <p>",
"    Clinical and biochemical features of hyperthyroidism are uncommon in women with struma ovarii, occurring in less than 5 to 8 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/3,5,8-10\">",
"     3,5,8-10",
"    </a>",
"    ]. In hyperthyroid patients, the serum TSH is low and free T4",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    T3 are elevated. The thyroid gland typically is not enlarged, but serum thyroglobulin is elevated. Radioiodine uptake is low or absent in the thyroid gland, but present in the pelvis. Rarely, women with struma ovarii and hyperthyroidism also have a goiter [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/10\">",
"     10",
"    </a>",
"    ]. There are at least two possible explanations for this association:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The coexistence of Graves' disease and struma ovarii, which has been reported rarely in the literature [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/11,12\">",
"       11,12",
"      </a>",
"      ]. Serum thyroid-stimulating immunoglobulins (thyrotropin-receptor antibodies) would be expected to stimulate function of thyroid tissue in the ovary as well as in the neck.",
"     </li>",
"     <li>",
"      A toxic nodular goiter with parallel formation of thyroid autonomy in an ovarian teratoma.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These women would have radioiodine accumulation in both locations.",
"   </p>",
"   <p>",
"    On ultrasound, struma ovarii appears as a heterogeneous solid mass [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. There are no distinguishing ultrasound features unique to struma ovarii. Ascites is occasionally present.",
"   </p>",
"   <p>",
"    Most women undergo surgical resection for diagnostic purposes. The histological pattern may show microfollicular, macrofollicular, or oxyphil adenoma, with or without papillary hyperplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/2,15\">",
"     2,15",
"    </a>",
"    ]. As in follicular tumors of the thyroid gland, the thyroid epithelium in the teratoma may be organized in a solid, embryonal or pseudotubular pattern, rather than thyroid follicles [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24452?source=see_link\">",
"     \"Atlas of thyroid cytopathology\"",
"    </a>",
"    .) Immunohistochemical staining for thyroglobulin may be required to identify the cells as being of thyroid origin [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Histologic features of thyroid cancer are found in 5 to 37 percent of struma ovarii [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. One study evaluated 54 patients with ovarian tumors due to struma ovarii [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/6\">",
"     6",
"    </a>",
"    ]. Thirteen (24 percent) were carcinomas: 11 had cytologic features of papillary carcinoma, and two had features of follicular carcinoma. Features indicative of malignancy include nuclear grooves, ground-glass appearance of the nuclei, and vascular invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/17\">",
"     17",
"    </a>",
"    ]. Cancer is more likely in larger tumors (75 percent of tumors greater than 16 cm), and rare in tumors under 5 cm [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/10\">",
"     10",
"    </a>",
"    ]. The tumor can spread to the contralateral ovary and adjacent pelvic structures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/18\">",
"     18",
"    </a>",
"    ]. In one review, distant metastases were reportedly uncommon, occurring in 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/8\">",
"     8",
"    </a>",
"    ]. When present, the predominant sites of metastases are the lung, bone, liver, and brain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rarely, seeding of the peritoneum by a benign tumor, a condition called strumosis, occurs [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11205213\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In women presenting with a pelvic mass, struma ovarii is typically diagnosed postoperatively based upon histologic findings of thyroid follicles in the resected ovary. The diagnostic criteria for malignant struma ovarii are similar to those for differentiated thyroid cancer. A definite diagnosis of carcinoma requires tumor invasion, metastases, or recurrence (for follicular cancer), or the typical cytopathologic features of papillary thyroid cancer. The diagnosis of follicular thyroid cancer in an ovarian teratoma (malignant struma ovarii) may be difficult, and parallels the difficulty in distinguishing benign thyroid microfollicular adenomas from differentiated follicular thyroid cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24452?source=see_link&amp;anchor=H1928059#H1928059\">",
"     \"Atlas of thyroid cytopathology\", section on 'Follicular lesions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24452?source=see_link&amp;anchor=H6#H6\">",
"     \"Atlas of thyroid cytopathology\", section on 'Papillary cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In women presenting with hyperthyroidism (elevated free T4",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    T3, low TSH), the diagnosis of struma ovarii should be considered in a woman with persistent hyperthyroidism (&gt;three to six months), no goiter, absent radioiodine uptake in the neck, and a detectable serum thyroglobulin level. In such women, pelvic ultrasound should be obtained, and if pelvic ultrasound reveals an ovarian mass, pelvic radioimaging (using 123-I or 131-I) is performed to confirm the presence of functional thyroid tissue within the mass [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/19,20\">",
"     19,20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17445884\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17446151\">",
"    <span class=\"h2\">",
"     Pelvic mass",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of a pelvic mass is extensive and is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=see_link\">",
"     \"Differential diagnosis of the adnexal mass\"",
"    </a>",
"    .) Thyroid cancer metastatic to the ovary can be confused with true struma ovarii [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/21\">",
"     21",
"    </a>",
"    ]. Primary thyroid cancer rarely metastasizes to the ovary [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/22\">",
"     22",
"    </a>",
"    ]. In such cases, the ovarian tissue does not have teratomatous features. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=see_link&amp;anchor=H9#H9\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\", section on 'Teratomas'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17446144\">",
"    <span class=\"h2\">",
"     Hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even among women with hyperthyroidism, without goiter, and with minimal or absent thyroid uptake of radioiodine, struma ovarii is rare; the more likely causes of these findings are exogenous thyroid hormone administration and lymphocytic (painless) thyroiditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4103?source=see_link&amp;anchor=H11#H11\">",
"     \"Disorders that cause hyperthyroidism\", section on 'Hyperthyroidism with a near absent radioiodine uptake'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with hyperthyroidism due to struma ovarii or thyroiditis, radioiodine uptake in the neck is low or absent. In most patients with thyroiditis, thyroid function normalizes within several weeks. Patients with persistent hyperthyroidism (&gt;three to six months) are unlikely to have thyroiditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24694?source=see_link\">",
"     \"Painless thyroiditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1399?source=see_link\">",
"     \"Subacute thyroiditis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/15/248?source=see_link\">",
"     \"Postpartum thyroiditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serum thyroglobulin concentrations are low in patients with exogenous hyperthyroidism in the absence of goiter or thyroid cancer. Thyroglobulin should be measured to exclude factitious use of thyroid hormone in patients with persistent hyperthyroidism, without goiter, and with minimal or absent thyroid uptake of radioiodine. In contrast, thyroglobulin is high in hyperthyroid patients with endogenous hyperthyroidism, including functional metastatic thyroid cancer, struma ovarii, and thyroiditis. Whenever serum thyroglobulin is measured, a test for antithyroglobulin antibodies should be performed at the same time (many laboratories do the latter first) because serum thyroglobulin measurements are unreliable if antithyroglobulin antibodies are present. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4165?source=see_link\">",
"     \"Exogenous hyperthyroidism\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43830?source=see_link\">",
"     \"Overview of thyroiditis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with Graves&rsquo; disease typically have a goiter and elevated radioiodine uptake in the neck. The uptake may be lower than expected if iodine-rich drugs (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?22/58/23466?source=see_link\">",
"     amiodarone",
"    </a>",
"    ) or contrast agents used for angiography or CT were recently administered. An exogenous iodine load will dilute the administered radioiodine tracer, and the uptake will be lowered depending upon the amount of the exogenous iodine load, whether the exposure is continuous (eg, amiodarone), and the interval since the iodine exposure. However, a single iodine load (eg, radiocontrast for a CT scan) may transiently reduce the radioiodine uptake in patients with Graves&rsquo; disease to less than 10 percent for up to two to four weeks, but rarely reduces the uptake to less than 1 percent as occurs in patients with painless thyroiditis or struma ovarii. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=see_link&amp;anchor=H25975118#H25975118\">",
"     \"Diagnosis of hyperthyroidism\", section on 'Radioiodine uptake'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20568?source=see_link\">",
"     \"Iodine-induced thyroid dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of benign struma ovarii is surgical resection of the ovarian tumor, typically unilateral oophorectomy. However, some patients undergo total hysterectomy with unilateral or bilateral salpingo-oophorectomy because of the preoperative concern for ovarian cancer. Patients with struma ovarii and hyperthyroidism require special consideration prior to surgery.",
"   </p>",
"   <p>",
"    Patients with malignant struma ovarii may need additional therapy, such as radioactive iodine, particularly in the presence of metastatic disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17446258\">",
"    <span class=\"h2\">",
"     Hyperthyroidism",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no published studies evaluating the risks of nonthyroid surgery in hyperthyroid patients. In patients with untreated or poorly controlled overt hyperthyroidism (low TSH, high free T4",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    T3), an acute event such as surgery can precipitate thyroid storm, a potentially life-threatening condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33655?source=see_link\">",
"     \"Thyroid storm\"",
"    </a>",
"    .) Thus, surgery should be postponed in patients with newly discovered overt hyperthyroidism until the patient has achieved adequate control of their thyroid condition (usually three to eight weeks). Treatment of hyperthyroidism in preparation for nonthyroid surgery is reviewed in detail elsewhere and briefly below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/2/4137?source=see_link&amp;anchor=H10#H10\">",
"     \"Nonthyroid surgery in the patient with thyroid disease\", section on 'Hyperthyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In women with struma ovarii and symptomatic or substantial biochemical hyperthyroidism, we administer a beta blocker (typically",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"     atenolol",
"    </a>",
"    25 to 50 mg daily with the dose increased as needed to maintain the pulse rate below 80) and a thionamide (typically",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/39/19062?source=see_link\">",
"     methimazole",
"    </a>",
"    , 10 mg two to three times daily or 20 to 30 mg once daily) for four to six weeks before surgery. Beta blockers should be continued until the patient's thyroid disease is under control, and then tapered. Thionamides can be discontinued immediately after surgery. If hyperthyroidism is severe and the need for surgery is urgent,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/27/30134?source=see_link\">",
"     potassium iodide",
"    </a>",
"    solution (SSKI, one to five drops three times daily) can be added one hour after thionamide administration. Iodine blocks release of T4 and T3 from the gland (and presumably the ovarian tumor), and thereby shortens the time to achieving a euthyroid state. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12696?source=see_link\">",
"     \"Thionamides in the treatment of Graves' disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/21/41303?source=see_link\">",
"     \"Pharmacology and toxicity of thionamides\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/17/275?source=see_link\">",
"     \"Beta blockers in the treatment of hyperthyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with subclinical hyperthyroidism (low TSH, normal free T4 and T3) can typically proceed with elective surgeries. Unless contraindicated, we administer a beta blocker preoperatively to older patients (&gt;50 years) or younger patients with cardiovascular disease, and taper after recovery. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/2/4137?source=see_link&amp;anchor=H10#H10\">",
"     \"Nonthyroid surgery in the patient with thyroid disease\", section on 'Hyperthyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17446072\">",
"    <span class=\"h2\">",
"     Malignant struma ovarii",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no consensus on the optimal treatment of women with malignant struma ovarii. The optimal ovarian surgical procedure (eg, unilateral or bilateral salpingo-oophorectomy, with or without hysterectomy) and the need for total thyroidectomy and radioactive iodine ablation are unknown. Treatment recommendations are based upon reports of single cases or case series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/5,17,23-25\">",
"     5,17,23-25",
"    </a>",
"    ]. Primary ovarian surgery is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33162?source=see_link&amp;anchor=H3#H3\">",
"     \"Treatment of malignant germ cell tumors of the ovary\", section on 'Primary surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Radioiodine has been used to treat women with functional metastatic struma ovarii [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/3,8,26\">",
"     3,8,26",
"    </a>",
"    ], analogous to its use in the treatment of metastatic differentiated thyroid cancer. After ovariectomy, but before radioiodine scanning is performed, the woman must have a near-total thyroidectomy so that radioiodine uptake by the cancer can be detected and high-dose radioiodine therapy can be given. In a review of 24 cases of malignant struma ovarii, 4 of 24 patients with initial complete response were treated with adjuvant thyroidectomy and radioiodine after ovarian surgery; none of these patients had a recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/8\">",
"     8",
"    </a>",
"    ]. There were eight recurrences (after an initial complete response to surgery), all of which occurred in the 16 patients treated conservatively after initial surgery (ie, followed clinically with or without serum thyroglobulin levels). The median time to recurrence among those patients was 48 months. Seven of eight women with recurrences were treated with radioiodine at the time of recurrence (along with thyroidectomy). Four patients had no evidence of disease at 3, 5, 6, and 324 months following radioiodine. Three patients recurred after radioiodine (at one, three, and six months). One patient did not receive further therapy and died of disease six months after recurrence.",
"   </p>",
"   <p>",
"    In another case series, four patients with malignant struma ovarii confined to the ovary (ie, no extraovarian extension or distant metastases) were reviewed [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/17\">",
"     17",
"    </a>",
"    ]. Surgical procedures included unilateral and bilateral salpingo-oophorectomy (one patient each) and TAH BSO (two patients). Only one patient had a thyroidectomy and treatment with radioactive iodine. This patient was found to have a synchronous papillary thyroid cancer. After a median follow-up of nine years, all patients remain without evidence of disease. In a review of a total of 57 cases of malignant struma ovarii confined to the ovary, 50 of whom did not undergo thyroidectomy-radioactive iodine therapy, the pooled recurrence rate was 7.5 percent at 25 years [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    BRAF and RAS mutations have been reported in tumors of patients with malignant struma ovarii and may prove useful in the diagnosis and management of difficult cases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. BRAF-positive papillary cancer is more aggressive, and presumably this mutation in a malignant struma ovarii also indicates the potential for more aggressive disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/20/43337?source=see_link&amp;anchor=H10#H10\">",
"     \"Oncogenes and tumor suppressor genes in thyroid nodules and nonmedullary thyroid cancer\", section on 'BRAF mutations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, the decision to perform a thyroidectomy and administer radioiodine after oophorectomy should based upon the extent of ovarian disease and the presence of metastatic disease. In patients with a malignant struma ovarii and equivocal indications for radioiodine therapy based upon the ovarian findings, we obtain a thyroid ultrasound to evaluate for synchronous primary thyroid gland abnormalities. Fine needle aspiration of detected thyroid nodules is warranted. Assessment of the ovarian tumor for the presence of a BRAF mutation may also be helpful. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=see_link&amp;anchor=H10#H10\">",
"     \"Diagnostic approach to and treatment of thyroid nodules\", section on 'Fine needle aspiration biopsy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with known distant metastases, gross extraovarian extension of the tumor, large lesions (&gt;4 cm, corresponding to thyroid T3 lesions), the presence of a BRAF mutation, or synchronous primary thyroid cancer, we suggest thyroidectomy followed by radioiodine treatment. These patients also require thyroxine therapy. The goal of thyroxine therapy is to maintain the TSH at levels corresponding to those for conventional thyroid cancer, with TSH values maintained in the 0.1 to 0.5",
"    <span class=\"nowrap\">",
"     mU/L",
"    </span>",
"    range for the first five years and then in the normal range thereafter in patients with no evidence of disease. Patients with persistent disease following initial therapy require maintenance of a serum TSH &lt;0.1",
"    <span class=\"nowrap\">",
"     mU/L.",
"    </span>",
"    Patients with malignant struma ovarii require long-term (at least 10 years) follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13799/abstract/5,13\">",
"     5,13",
"    </a>",
"    ]. Annual monitoring of stimulated serum thyroglobulin is reasonable for the first two years postoperatively and, if negative, unstimulated levels annually thereafter. Patients with biochemical evidence of persistent disease should have pelvic imaging with computed tomography or ultrasound. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/13/34010?source=see_link&amp;anchor=H2#H2\">",
"     \"Radioiodine treatment of differentiated thyroid cancer\", section on 'Indications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link&amp;anchor=H17#H17\">",
"     \"Overview of the management of differentiated thyroid cancer\", section on 'Long-term follow-up'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For women with low risk of recurrence (no extraovarian extension or distant metastases), we suggest thyroxine to suppress TSH to the lower limit or just below normal and monitoring with yearly serum thyroglobulin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8646512\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Struma ovarii is a specialized or monodermal teratoma predominantly composed of mature thyroid tissue. Thyroid tissue must comprise more than 50 percent of the overall tissue to be classified as a struma ovarii (see",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Women with struma ovarii usually present with pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a pelvic mass and less frequently with ascites. Clinical and biochemical features of hyperthyroidism are uncommon in women with struma ovarii, occurring in less than 5 to 8 percent of cases. On ultrasound, struma ovarii appears as a heterogeneous solid mass. The histological pattern may show microfollicular, macrofollicular, or oxyphil adenoma, with or without papillary hyperplasia. Histologic features of thyroid cancer are found in 5 to 37 percent of women with struma ovarii (see",
"      <a class=\"local\" href=\"#H11205128\">",
"       'Clinical manifestations'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      In women presenting with a pelvic mass, struma ovarii is typically diagnosed postoperatively based upon histologic findings of thyroid follicles in the resected ovary. The diagnostic criteria for malignant struma ovarii are similar to those for differentiated thyroid cancer. A definite diagnosis of carcinoma requires tumor invasion, metastases, or recurrence (for follicular cancer), or the typical cytopathologic features of papillary thyroid cancer. In women presenting with hyperthyroidism (elevated free T4",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      T3, low TSH), the diagnosis of struma ovarii should be considered in a woman with persistent hyperthyroidism (&gt;three to six months), no goiter, absent radioiodine uptake in the neck, and a detectable serum thyroglobulin level. In such women, pelvic ultrasound should be obtained, and if pelvic ultrasound reveals an ovarian mass, pelvic radioimaging (using 123-I or 131-I) is performed to confirm the presence of functional thyroid tissue within the mass (see",
"      <a class=\"local\" href=\"#H11205213\">",
"       'Diagnosis'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Even among women with hyperthyroidism, without goiter, and with minimal or absent thyroid uptake of radioiodine, struma ovarii is rare; the more likely causes of these findings are exogenous thyroid hormone administration and lymphocytic (painless) thyroiditis. Thyroid cancer metastatic to the ovary can be confused with true struma ovarii. Primary thyroid cancer rarely metastasizes to the ovary. In such cases, the ovarian tissue does not have teratomatous features. (See",
"      <a class=\"local\" href=\"#H17445884\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=see_link\">",
"       \"Differential diagnosis of the adnexal mass\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The treatment of benign struma ovarii is surgical resection of the ovarian tumor. In patients with untreated or poorly controlled overt hyperthyroidism, an acute event such as surgery can precipitate thyroid storm, a potentially life-threatening condition. Thus, we suggest postponing surgery in patients with newly discovered overt hyperthyroidism until the patient has achieved adequate control of their hyperthyroidism (usually three to eight weeks) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). In women with struma ovarii and symptomatic or substantial biochemical hyperthyroidism, we administer a beta blocker (typically",
"      <a class=\"drug drug_general\" href=\"UTD.htm?29/46/30440?source=see_link\">",
"       atenolol",
"      </a>",
"      25 to 50 mg daily with the dose increased as needed to maintain the pulse rate below 80) and a thionamide (typically",
"      <a class=\"drug drug_general\" href=\"UTD.htm?18/39/19062?source=see_link\">",
"       methimazole",
"      </a>",
"      , 10 mg two to three times daily or 20 to 30 mg once daily) for four to six weeks before surgery. (See",
"      <a class=\"local\" href=\"#H17446258\">",
"       'Hyperthyroidism'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/2/4137?source=see_link&amp;anchor=H10#H10\">",
"       \"Nonthyroid surgery in the patient with thyroid disease\", section on 'Hyperthyroidism'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In our experience, patients with subclinical hyperthyroidism (low TSH, normal free T4 and T3) can typically proceed with elective surgeries. Unless contraindicated, we administer a beta blocker preoperatively to older patients (&gt;50 years) or younger patients with cardiovascular disease, and taper after recovery. (See",
"      <a class=\"local\" href=\"#H17446258\">",
"       'Hyperthyroidism'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/2/4137?source=see_link&amp;anchor=H10#H10\">",
"       \"Nonthyroid surgery in the patient with thyroid disease\", section on 'Hyperthyroidism'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is no consensus on the optimal treatment of women with malignant struma ovarii. The optimal ovarian surgical procedure (eg, unilateral or bilateral salpingo-oophorectomy, with or without hysterectomy) is reviewed elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33162?source=see_link&amp;anchor=H3#H3\">",
"       \"Treatment of malignant germ cell tumors of the ovary\", section on 'Primary surgery'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with known distant metastases, gross extraovarian extension of the tumor, large lesions (&gt;4 cm, corresponding to thyroid T3 lesions), the presence of a BRAF mutation, or a synchronous primary thyroid cancer, we suggest thyroidectomy followed by radioiodine treatment (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). These patients also require thyroxine therapy. The goal of thyroxine therapy is to maintain the TSH at levels corresponding to those for conventional thyroid cancer, with TSH values maintained in the 0.1 to 0.5",
"      <span class=\"nowrap\">",
"       mU/L",
"      </span>",
"      range for the first five years and then in the normal range thereafter in patients with no evidence of disease. Patients with malignant struma ovarii require long-term (at least 10 years) monitoring of serum thyroglobulin and pelvic imaging. (See",
"      <a class=\"local\" href=\"#H17446072\">",
"       'Malignant struma ovarii'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=see_link&amp;anchor=H17#H17\">",
"       \"Overview of the management of differentiated thyroid cancer\", section on 'Long-term follow-up'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For women with low risk of recurrence (no extraovarian extension or distant metastases), we suggest thyroxine to suppress TSH to the lower limit or just below normal (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We measure serum thyroglobulin annually (see",
"      <a class=\"local\" href=\"#H17446072\">",
"       'Malignant struma ovarii'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/1\">",
"      Dunzendorfer T, deLas Morenas A, Kalir T, Levin RM. Struma ovarii and hyperthyroidism. Thyroid 1999; 9:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/2\">",
"      Kondi-Pafiti A, Mavrigiannaki P, Grigoriadis Ch, et al. Monodermal teratomas (struma ovarii). Clinicopathological characteristics of 11 cases and literature review. Eur J Gynaecol Oncol 2011; 32:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/3\">",
"      Yassa L, Sadow P, Marqusee E. Malignant struma ovarii. Nat Clin Pract Endocrinol Metab 2008; 4:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/4\">",
"      Yoo SC, Chang KH, Lyu MO, et al. Clinical characteristics of struma ovarii. J Gynecol Oncol 2008; 19:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/5\">",
"      Kraemer B, Grischke EM, Staebler A, et al. Laparoscopic excision of malignant struma ovarii and 1 year follow-up without further treatment. Fertil Steril 2011; 95:2124.e9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/6\">",
"      Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 1993; 12:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/7\">",
"      Jean S, Tanyi JL, Montone K, et al. Papillary thyroid cancer arising in struma ovarii. J Obstet Gynaecol 2012; 32:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/8\">",
"      DeSimone CP, Lele SM, Modesitt SC. Malignant struma ovarii: a case report and analysis of cases reported in the literature with focus on survival and I131 therapy. Gynecol Oncol 2003; 89:543.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/9\">",
"      Ayhan A, Yanik F, Tuncer R, et al. Struma ovarii. Int J Gynaecol Obstet 1993; 42:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/10\">",
"      Young RH. New and unusual aspects of ovarian germ cell tumors. Am J Surg Pathol 1993; 17:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/11\">",
"      Kung AW, Ma JT, Wang C, Young RT. Hyperthyroidism during pregnancy due to coexistence of struma ovarii and Graves' disease. Postgrad Med J 1990; 66:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/12\">",
"      Teale E, Gouldesbrough DR, Peacey SR. Graves' disease and coexisting struma ovarii: struma expression of thyrotropin receptors and the presence of thyrotropin receptor stimulating antibodies. Thyroid 2006; 16:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/13\">",
"      Makani S, Kim W, Gaba AR. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature. Gynecol Oncol 2004; 94:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/14\">",
"      Zalel Y, Seidman DS, Oren M, et al. Sonographic and clinical characteristics of struma ovarii. J Ultrasound Med 2000; 19:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/15\">",
"      Robboy SJ, Shaco-Levy R, Peng RY, et al. Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread. Int J Gynecol Pathol 2009; 28:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/16\">",
"      Hasleton PS, Kelehan P, Whittaker JS, et al. Benign and malignant struma ovarii. Arch Pathol Lab Med 1978; 102:180.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/17\">",
"      Marti JL, Clark VE, Harper H, et al. Optimal surgical management of well-differentiated thyroid cancer arising in struma ovarii: a series of 4 patients and a review of 53 reported cases. Thyroid 2012; 22:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/18\">",
"      Ryder M, Nikiforov YE, Fagin JA. Follicular variant papillary thyroid carcinoma arising within an ovarian teratoma. Thyroid 2007; 17:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/19\">",
"      Brown WW, Shetty KR, Rosenfeld PS. Hyperthyroidism due to struma ovarii: demonstration by radioiodine scan. Acta Endocrinol (Copenh) 1973; 73:266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/20\">",
"      Yeh EL, Meade RC, Ruetz PP. Radionuclide study of struma ovarii. J Nucl Med 1973; 14:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/21\">",
"      Young RH, Jackson A, Wells M. Ovarian metastasis from thyroid carcinoma 12 years after partial thyroidectomy mimicking struma ovarii: report of a case. Int J Gynecol Pathol 1994; 13:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/22\">",
"      Brogioni S, Viacava P, Tomisti L, et al. A special case of bilateral ovarian metastases in a woman with papillary carcinoma of the thyroid. Exp Clin Endocrinol Diabetes 2007; 115:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/23\">",
"      Gunasekaran S, Kopecka E, Maung KH, England RJ. Struma ovarii and the thyroid surgeon. J Laryngol Otol 2012; 126:858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/24\">",
"      Billan S, Abdah-Bortnyak R, Cohen H, et al. Metastatic malignant struma ovarii. Isr Med Assoc J 2011; 13:247.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/25\">",
"      Michels A, Haugen B. Malignant struma ovarii. J Clin Endocrinol Metab 2010; 95:1505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/26\">",
"      Willemse PH, Oosterhuis JW, Aalders JG, et al. Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131I administration. Cancer 1987; 60:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/27\">",
"      Wolff EF, Hughes M, Merino MJ, et al. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer. Thyroid 2010; 20:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13799/abstract/28\">",
"      Coyne C, Nikiforov YE. RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii. Endocr Pathol 2010; 21:144.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7829 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-2.133.93.82-D9A3241E76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13799=[""].join("\n");
var outline_f13_30_13799=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H8646512\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11205128\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11205213\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17445884\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17446151\">",
"      Pelvic mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17446144\">",
"      Hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17446258\">",
"      Hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17446072\">",
"      Malignant struma ovarii",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8646512\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/56/24452?source=related_link\">",
"      Atlas of thyroid cytopathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/17/275?source=related_link\">",
"      Beta blockers in the treatment of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/57/26520?source=related_link\">",
"      Diagnosis of hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/53/28506?source=related_link\">",
"      Diagnostic approach to and treatment of thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/57/19352?source=related_link\">",
"      Differential diagnosis of the adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/0/4103?source=related_link\">",
"      Disorders that cause hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/4/4165?source=related_link\">",
"      Exogenous hyperthyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/5/20568?source=related_link\">",
"      Iodine-induced thyroid dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/2/4137?source=related_link\">",
"      Nonthyroid surgery in the patient with thyroid disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/20/43337?source=related_link\">",
"      Oncogenes and tumor suppressor genes in thyroid nodules and nonmedullary thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/37/5721?source=related_link\">",
"      Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/17/44313?source=related_link\">",
"      Overview of the management of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/51/43830?source=related_link\">",
"      Overview of thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/7/24694?source=related_link\">",
"      Painless thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/21/41303?source=related_link\">",
"      Pharmacology and toxicity of thionamides",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/15/248?source=related_link\">",
"      Postpartum thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/13/34010?source=related_link\">",
"      Radioiodine treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/23/1399?source=related_link\">",
"      Subacute thyroiditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/25/12696?source=related_link\">",
"      Thionamides in the treatment of Graves' disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/55/33655?source=related_link\">",
"      Thyroid storm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33162?source=related_link\">",
"      Treatment of malignant germ cell tumors of the ovary",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_30_13800="Emerging therapies for COPD: Bronchoscopic treatment of emphysema";
var content_f13_30_13800=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Emerging therapies for COPD: Bronchoscopic treatment of emphysema",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13800/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13800/contributors\">",
"     Michael S Machuzak, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13800/contributors\">",
"     Thomas R Gildea, MD, MS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13800/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13800/contributors\">",
"     James K Stoller, MS, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13800/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13800/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/30/13800/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H12785475\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Emphysema is a form of chronic obstructive pulmonary disease (COPD) that is defined by abnormal and permanent enlargement of the airspaces distal to the terminal bronchioles and is associated with destruction of the alveolar walls. The destruction of alveolar walls causes loss of elastic recoil, early airway closure during exhalation, and air trapping in the distal air spaces. Alveolar wall destruction with formation of emphysematous blebs and bullae leads to loss of gas exchanging surface (also known as increased physiologic dead space). In addition, air trapping and hyperinflation press the diaphragm into a flat configuration, rather than its normal domed shape, and place all the muscles of respiration at a mechanical overstretch disadvantage. In combination, these processes lead to refractory dyspnea.",
"   </p>",
"   <p>",
"    Lung volume reduction surgery (LVRS, also called reduction pneumoplasty or bilateral pneumectomy) is a surgical treatment for patients with advanced emphysema whose dyspnea is poorly controlled with the usual therapies (eg, short and long acting bronchodilators, inhaled glucocorticoids, supplemental oxygen, and pulmonary rehabilitation) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/1\">",
"     1",
"    </a>",
"    ]. LVRS entails reducing the lung volume by wedge excisions of emphysematous tissue. However, surgical morbidity is high and non-pulmonary comorbidities may preclude surgery.",
"   </p>",
"   <p>",
"    Bronchoscopic lung volume reduction (bLVR) refers to techniques developed to treat hyperinflation due to emphysema via a flexible bronchoscope.",
"   </p>",
"   <p>",
"    The devices and techniques for bLVR will be reviewed here. The general management of chronic obstructive pulmonary disease, an overview of flexible bronchoscopy, and the roles of lung volume reduction surgery, bullectomy, and lung transplantation in the management of advanced COPD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"     \"Management of stable chronic obstructive pulmonary disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=see_link\">",
"     \"Flexible bronchoscopy: Equipment, procedure, and complications\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link\">",
"     \"Lung volume reduction surgery in COPD\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=see_link\">",
"     \"Lung transplantation: General guidelines for recipient selection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785482\">",
"    <span class=\"h1\">",
"     RATIONALE FOR LUNG VOLUME REDUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mechanisms by which lung volume reduction might provide benefit in patients with emphysema are not known with certainty. However, it is believed that the removal of diseased, hyperinflated areas of lung would have the following benefits:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As overall hyperinflation decreases, diaphragm and chest wall mechanics would improve and work of breathing would decrease.",
"     </li>",
"     <li>",
"      The remaining lung tissue would have more normal elastic recoil pressure, thereby restoring the outward circumferential pull on the bronchioles and increasing expiratory airflow.",
"     </li>",
"     <li>",
"      With improved expiratory airflow, the amount of hyperinflation associated with exercise (also known as dynamic hyperinflation) would decrease, and thereby reduce exercise related dyspnea. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36454?source=see_link&amp;anchor=H2#H2\">",
"       \"Dynamic hyperinflation in patients with COPD\", section on 'Pathophysiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Reducing the inhomogeneity of regional ventilation and perfusion would improve ventilation-perfusion matching and result in improved alveolar gas exchange and effectiveness of ventilation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"       \"Oxygenation and mechanisms of hypoxemia\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The rationale for lung volume reduction surgery (LVRS) is discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link&amp;anchor=H2#H2\">",
"     \"Lung volume reduction surgery in COPD\", section on 'Rationale of LVRS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among selected patients with advanced upper lobe predominant emphysema, LVRS improved exercise capacity and in some patients, reduced mortality at two years. However, the morbidity of LVRS is substantial. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link&amp;anchor=H5#H5\">",
"     \"Lung volume reduction surgery in COPD\", section on 'Primary endpoints'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link&amp;anchor=H22#H22\">",
"     \"Lung volume reduction surgery in COPD\", section on 'Complications'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link&amp;anchor=H23#H23\">",
"     \"Lung volume reduction surgery in COPD\", section on 'Long-term outcomes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The rationale for bronchoscopic LVR (bLVR) is that the use of endoscopic methods (eg, valves, sealants, thermal ablation) to collapse areas of overinflated emphysematous lung would have a beneficial effect similar to resecting these areas during LVRS, but without the morbidity of surgery. Thus, patients who are not good surgical candidates might be able to undergo bLVR. Several bLVR techniques are reversible, which may contribute to increased safety. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link&amp;anchor=H2#H2\">",
"     \"Lung volume reduction surgery in COPD\", section on 'Rationale of LVRS'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785496\">",
"    <span class=\"h1\">",
"     PROPOSED TECHNIQUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proposed techniques for bLVR include endobronchial placement of one-way valves, plugs and blockers, endobronchial instillation of biologic sealants, thermal airway ablation, and airway stents for decompression of bullae [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. None of these techniques have been approved by the Food and Drug Administration, and none are available for general clinical use. Endobronchial plugs and blockers were the initial method developed to promote resorption atelectasis, but the high rate of post-obstructive pneumonia and migration of the plugs and blockers has led to abandonment of these devices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785503\">",
"    <span class=\"h2\">",
"     Valves",
"    </span>",
"    &nbsp;&mdash;&nbsp;One-way valves have been designed for bronchoscopic placement based on the hypothesis that they will allow air and mucus to exit the treated area, but not allow air to reenter. The goal of this treatment is to facilitate atelectasis of the emphysematous, hyperinflated lung distal to the valve.",
"   </p>",
"   <p>",
"    Two valve designs, called endobronchial and intrabronchial, are under investigation for the endoscopic treatment of emphysema. They differ in the design by which the one-way valve is created; the endobronchial valve uses a duckbill shape (",
"    <a class=\"graphic graphic_picture graphicRef76276 graphicRef64484 \" href=\"UTD.htm?16/43/17078\">",
"     picture 1A-B",
"    </a>",
"    ) and the intrabronchial valve uses an umbrella shape (",
"    <a class=\"graphic graphic_picture graphicRef55269 \" href=\"UTD.htm?31/5/31825\">",
"     picture 2",
"    </a>",
"    ). Both valves are deployed within the bronchus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785510\">",
"    <span class=\"h3\">",
"     Endobronchial valves",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial design of the endobronchial valve (EBV) system (Emphasys Medical, now Pulmonx) was that of a nitinol skeleton and a silicone body with a \"duckbill\" valve on the proximal end. The first two designs were deployed in an over-the-wire technique, meaning that the guidewire was placed in the target airway under bronchoscopic guidance, the bronchoscope was removed leaving the guidewire in place, and the delivery catheter passed over the guidewire to insert the valve. The third and most recent version of the EBV, known as the Zephyr valve, maintains the \"duckbill\" mechanism, but its deployment catheter can be inserted through the working channel of a bronchoscope under direct vision (",
"    <a class=\"graphic graphic_picture graphicRef76276 graphicRef64484 \" href=\"UTD.htm?16/43/17078\">",
"     picture 1A-B",
"    </a>",
"    ). The deployment catheter also acts as a sizing mechanism, enabling the bronchoscopist to select the size valve that will best fit that bronchus. Two sizes of valve are available.",
"   </p>",
"   <p>",
"    Several individual case series, a multicenter registry, and a randomized trial have reported a modest improvement in symptoms and lung function after bLVR with placement of Zephyr valves [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. Inclusion and exclusion criteria have been similar to the National Emphysema Treatment Trial (NETT) protocol (",
"    <a class=\"graphic graphic_table graphicRef69501 \" href=\"UTD.htm?2/9/2205\">",
"     table 1",
"    </a>",
"    ); patients with a forced expiratory volume in one second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ) less than 20 percent of predicted, hypercapnia, pulmonary hypertension, or a low diffusing capacity (DLCO) (less than 25 percent of predicted) were excluded [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/1,7,8\">",
"     1,7,8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=see_link&amp;anchor=H3#H3\">",
"     \"Lung volume reduction surgery in COPD\", section on 'National Emphysema Treatment Trial'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Endobronchial Valve for Emphysema Palliation Trial (VENT) was performed to evaluate unilateral treatment with endobronchial valves [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/9,10\">",
"       9,10",
"      </a>",
"      ]. The trial randomly assigned 321 patients with severe heterogeneous emphysema (forced expiratory volume in one second [FEV",
"      <sub>",
"       1",
"      </sub>",
"      ] 15 to 45 percent of predicted value) to bronchoscopic placement of Zephyr endobronchial valves or standard medical care in a 2:1 ratio. High resolution computed tomography was used to target the areas of greatest heterogeneity (ie, the difference in the proportion of pixels of less than -910 Hounsfield units between the targeted lobe and ipsilateral adjacent nontargeted lobe) for valve placement. The valves were placed under moderate or general anesthesia in lobar, segmental, and subsegmental bronchi to completely isolate the targeted lobe. At six months, the mean between group difference for FEV",
"      <sub>",
"       1",
"      </sub>",
"      was 6.8 percent (95% CI, 2.1 to 11.5) and for distance walked in six minutes 5.8 percent (95% CI, 0.5 to 11.2). Modest improvements in dyspnea and quality of life were also noted. The frequency of adverse events was higher in the endobronchial valve group and included pneumonia, hemoptysis, pneumothorax, and exacerbations of COPD requiring hospitalization. Among patients with a radiographically complete lobar fissure, a clinically important improvement in FEV",
"      <sub>",
"       1",
"      </sub>",
"      was more likely. Similar findings were noted in the European VENT study cohort [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/11\">",
"       11",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A retrospective analysis from a prospective multicenter registry reported the experience of the first 98 patients in nine centers in seven countries with unilateral lobar placement of endobronchial valves [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/8\">",
"       8",
"      </a>",
"      ]. In this registry study, patients had severe COPD with an FEV",
"      <sub>",
"       1",
"      </sub>",
"      of 20 to 40 percent of predicted and a residual volume (RV) of approximately 244 percent of predicted. At 90 days after valve placement, modest, but statistically significant improvements were noted in FEV",
"      <sub>",
"       1",
"      </sub>",
"      , forced expiratory volume (FVC), RV, and 6-minute walk distance. The greatest improvement was seen in patients with the lowest FEV",
"      <sub>",
"       1",
"      </sub>",
"      (less than 30 percent) and the most hyperinflation (RV greater than 225 percent of predicted). Additionally, there was a trend towards improvement in patients treated unilaterally. A similar trend was seen when one entire lobe was treated as opposed to one or two segments. No statistically significant improvement occurred in DLCO. Eight patients (8.2 percent) had a serious complication in the first 90 days and one died. The majority of the serious complications were pneumothoraces; three required surgical intervention and four lasted greater than seven days. None of the patients developed a post-obstructive pneumonia in a treated lobe, although five developed pneumonia in an untreated lobe.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A proposed explanation for the limited improvement after endobronchial valve placement relative to LVRS is that collateral ventilation, particularly through incomplete lobar fissures, prevents resorption atelectasis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/12-15\">",
"     12-15",
"    </a>",
"    ]. Without atelectasis of the emphysematous areas, hyperinflation is unlikely to improve. Thus, investigators are exploring ways to determine the amount of collateral ventilation in a given subsegment or segment at the time of bronchoscopy. A specialized catheter has been developed to assess collateral ventilation, known as the Chartis System [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. In an observational study, 80 patients were evaluated for collateral ventilation prior to placement of endobronchial valves [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/18\">",
"     18",
"    </a>",
"    ]. Of those without evidence of collateral ventilation, 70 percent had a significant improvement in target lobe volume reduction (TLVR) and improvement in FEV",
"    <sub>",
"     1",
"    </sub>",
"    . In contrast, only 17 percent of those with collateral ventilation met the threshold for reduction in TLVR. Further study is needed to determine the optimal method for patient selection for endobronchial valve placement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785517\">",
"    <span class=\"h3\">",
"     Intrabronchial valves",
"    </span>",
"    &nbsp;&mdash;&nbsp;The second valve design to undergo investigation in the United States was the Spiration implantable Intrabronchial Valve (IBV valve; Spiration). This device is an umbrella-shaped nitinol framed prosthesis with a synthetic polymer cover. The flexible nitinol frame allows for the valve to maintain contact with the airway wall and prevent air from passing inwards while allowing for mucus and air to escape. This creates a one-way valve effect with the intent of redirecting airflow to more normal areas",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    inducing atelectasis of the emphysematous area blocked by the valve.",
"   </p>",
"   <p>",
"    The valve can be deployed through the working channel of a flexible bronchoscope under direct vision. Valve sizes range from 5 to 7 mm. After the appropriate airways are selected, a calibrated balloon is used to determine the valve with the best fit for the airway. Then, under direct vision, the valve deployment device is passed through the working channel of the bronchoscope and the valve is deployed. If the valve needs to be repositioned or removed, a standard biopsy forceps is used to grab the central rod; when the rod is pulled, the umbrella collapses and can be removed. Several small modifications have been made on this valve, but the basic design has changed little (",
"    <a class=\"graphic graphic_picture graphicRef55269 \" href=\"UTD.htm?31/5/31825\">",
"     picture 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In a multicenter trial, 73 patients with severe emphysema were randomly assigned to Spiration IBV placement or sham bronchoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/19\">",
"     19",
"    </a>",
"    ]. At three months, eight patients in the IBV group had a significant improvement on a quality of life questionnaire and a lobar volume shift (decrease in upper lobes and compensatory increase in the nontreated lobes &ge;7.5 percent) by computed tomography, while none of the sham-treated patients improved. The procedure was well-tolerated, but not effective in the majority of patients.",
"   </p>",
"   <p>",
"    The Spiration IBV was also evaluated in a multicenter, prospective, open-enrollment cohort study which enrolled 30 patients in five centers [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/20\">",
"     20",
"    </a>",
"    ]. Patients enrolled met criteria for LVRS (",
"    <a class=\"graphic graphic_table graphicRef69501 \" href=\"UTD.htm?2/9/2205\">",
"     table 1",
"    </a>",
"    ). Criteria for exclusion were prior listing for LVRS or transplant, high risk according to the NETT protocol, significant bronchospasm, or copious respiratory secretions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/1\">",
"     1",
"    </a>",
"    ]. No significant improvements were seen in physiological testing, including exercise capacity, pulmonary function testing, or gas exchange. However, a clinically and statistically significant improvement was noted in quality of life as measured by the St. George's Respiratory Questionnaire (SGRQ) (an improvement of 6.8",
"    <span class=\"nowrap\">",
"     (+/-",
"    </span>",
"    14.3) units at six months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/21\">",
"     21",
"    </a>",
"    ]). This study showed that this procedure is feasible and can be performed without significant adverse events.",
"   </p>",
"   <p>",
"    A multicenter trial that randomly assigned 277 subjects to IBV treatment versus sham bronchoscopy has been completed, but the results are not yet available. The primary outcome measures were improvement in the St. George Respiratory Questionnaire (SGRQ) and regional lung volume changes on computed tomography at six months.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4992606\">",
"    <span class=\"h2\">",
"     Coils",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nitinol coils behave like springs. They are passed through the working channel of a flexible bronchoscope in a straightened configuration into subsegmental airways and out into the lung parenchyma. As they are deployed, they resume their coiled shape and thereby collect and collapse the lung tissue in that area.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a pilot study of 16 patients with severe heterogeneous emphysema, bilateral coil implants were placed in 12 patients in two successive procedures and unilateral coils were placed in four for a total of 260 coils [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/22\">",
"       22",
"      </a>",
"      ]. After six months, FEV",
"      <sub>",
"       1",
"      </sub>",
"      , FVC, exercise capacity, and quality of life were improved. Adverse effects included hemoptysis, transient chest pain, and pneumothorax, which occurred in 12, 4, and 1 patient, respectively.",
"     </li>",
"     <li>",
"      In a separate study of 11 patients with severe emphysema, coils were placed in 11 patients under general anesthesia [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/23\">",
"       23",
"      </a>",
"      ]. Most patients underwent two procedures with approximately five coils being placed per procedure. Efficacy seemed better in those with heterogeneous than homogenous emphysema. Adverse effects were considered mild.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785524\">",
"    <span class=\"h2\">",
"     Biologic lung volume reduction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biologic lung volume reduction uses direct application of a",
"    <span class=\"nowrap\">",
"     sealant/remodeling",
"    </span>",
"    system to collapse areas of emphysema. The initial method applied fibrin-thrombin mixtures to selected endobronchial locations to collapse hyperinflated areas of emphysematous lung through resorptive atelectasis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/24,25\">",
"     24,25",
"    </a>",
"    ]. Although this method was partially successful, a revised technique, called BioLVR, was developed, adding chondroitin sulfate and poly-L-lysine to the fibrin mixture. A hydrogel is created when the fibrin and thrombin solutions mix, theoretically providing a scaffold for fibroblast attachment and collagen synthesis that promotes scarring and prevents future recanalization and ventilation of the treated area. It is thought that the hydrogel sealant will block the interalveolar and bronchiolar-alveolar pores and channels, eradicating collateral ventilation, and thus promoting resorptive atelectasis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The procedure is performed under conscious sedation via flexible bronchoscopy. The bronchoscope is introduced into an airway leading to emphysematous alveoli and moved into wedged position, completely occluding the segment or subsegment to be treated. Suction is applied through the bronchoscope to collapse the distal airways in that segment [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. An enzymatic primer solution (eg, porcine trypsin) is instilled to promote detachment of epithelial cells from the target region. After two minutes, the primer is removed by suction and 10 mL of cell culture media is used to wash out residual primer. Next, a dual lumen catheter with the thrombin mixture in one lumen and the fibrin mixture in the other is placed through the wedged bronchoscope. The contents of the two lumens are instilled, followed by 60 mL of air to push the solutions distally. The solutions mix as they are simultaneously delivered to the distal airway and alveoli. The liquid component is thought to fill the alveoli prior to complete polymerization, thus blocking collateral ventilation. Each subsegmental application takes approximately 10 minutes and four to eight subsegments are treated during a single procedure.",
"   </p>",
"   <p>",
"    The technique has been used in a sheep model of papain induced emphysema [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. After BioLVR, a 16 percent reduction in total lung capacity and a 55 percent reduction in residual volume were noted. At autopsy, no evidence was found of the abscess formation, infection, or granulomas. Scar formation was seen in 91 percent of treated segments [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a preliminary human study of biologic lung volume reduction, 22 patients with upper lobe predominant emphysema were treated with 20 mL of",
"    <span class=\"nowrap\">",
"     hydrogel/subsegment",
"    </span>",
"    and 28 with 10",
"    <span class=\"nowrap\">",
"     mL/subsegment",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/30\">",
"     30",
"    </a>",
"    ]. The six month follow-up revealed a greater improvement in forced vital capacity (FVC), forced expiratory volume in one second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ), and residual volume (RV) in the higher dose group compared with the low dose. No significant change in the six-minute walk test was seen in either group, compared with baseline. Chest computed tomography at six months revealed scarring and atelectasis in the previously hyperinflated area in the high-dose, but not the low dose group (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef57927 \" href=\"UTD.htm?31/8/31882\">",
"     image 1",
"    </a>",
"    ). Similar findings were reported in a study of 25 patients with bilateral homogeneous emphysema in whom high or low dose hydrogel was administered to eight subsegments [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A separate observational study compared the effect of contiguous single lobe versus scattered double lobe BioLVR for upper lobe predominant emphysema [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/32\">",
"     32",
"    </a>",
"    ]. Targeting a single lobe led to a greater improvement in forced expiratory volume in one second at 12 weeks after the procedure, than treating scattered subsegments in both upper lobes. It is hypothesized that full treatment of one lobe prevented collateral ventilation leading to sustained lobar collapse and a better functional result [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/27\">",
"     27",
"    </a>",
"    ]. Phase III studies of BioLVR are not planned.",
"   </p>",
"   <p>",
"    Initial tests of a synthetic polymeric foam sealant called emphysematous lung sealant (ELS; AeriSeal) were performed in 25 patients with heterogeneous emphysema [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/33\">",
"     33",
"    </a>",
"    ]. The number of subsegment sites treated at one time varied from two to four. Modest improvements in air trapping and gas transfer were noted among patients with GOLD stage III, but not among those with GOLD stage IV (",
"    <a class=\"graphic graphic_table graphicRef56868 \" href=\"UTD.htm?2/48/2828\">",
"     table 2",
"    </a>",
"    ). Five patients underwent a second instillation of ELS and additional clinical benefit was noted in two.",
"   </p>",
"   <p>",
"    Over 90 percent of patients treated with biologic lung volume reduction experience flu-like symptoms, such as fever, dyspnea, pleuritic chest pain, nausea, headache, malaise, and leukocytosis within 24 hours of the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/27,33\">",
"     27,33",
"    </a>",
"    ]. These symptoms resolved in 24 to 48 hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H472953628\">",
"    <span class=\"h2\">",
"     Thermal airway ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technique of thermal airway ablation involves using a specialized catheter via a flexible bronchoscope to administer steam vapor directly to segmental airways [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/34\">",
"     34",
"    </a>",
"    ]. The procedure utilizes a reusable vapor generator with a disposable bronchoscopic catheter that delivers heated water vapor to the targeted airways. During the procedure, a vapor occlusion balloon is inflated to protect other airways from the heated vapor. The goal is to induce an inflammatory response that will result in occlusion and atelectasis of that segment. It is hoped that the complication rate will be lower than with bronchial valve techniques, as no foreign body is left in place. The procedure is typically performed under general anesthesia.",
"   </p>",
"   <p>",
"    In a multicenter observational study, 44 patients with upper lobe predominant emphysema underwent unilateral bronchoscopic thermal airway ablation or sham bronchoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/35\">",
"     35",
"    </a>",
"    ]. At six months, FEV",
"    <sub>",
"     1",
"    </sub>",
"    was improved by 141",
"    <span class=\"nowrap\">",
"     +/-",
"    </span>",
"    26 mL over baseline; exercise tolerance and quality of life also improved. Adverse events included exacerbations of COPD, pneumonia, lower respiratory tract infection, and hemoptysis. One patient died during an exacerbation of COPD, two months after the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785531\">",
"    <span class=\"h2\">",
"     Airway bypass procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Airway bypass or extra anatomic bronchial fenestration is a technique used to decompress areas of emphysema by placing a drug eluting stent through a bronchial wall into an area with severe emphysematous disease (",
"    <a class=\"graphic graphic_picture graphicRef68661 \" href=\"UTD.htm?40/49/41759\">",
"     picture 3",
"    </a>",
"    ). Because of collateral ventilation, emphysematous alveoli receive ventilation through interalveolar pores, accessory respiratory bronchioles, and interlobar pathways across fissures, despite airways obstruction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/26\">",
"     26",
"    </a>",
"    ]. The degree of collateral ventilation is thought to increase as homogeneity of emphysema increases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/36\">",
"     36",
"    </a>",
"    ]. The airway bypass technique was developed with the idea that decompression of emphysematous areas would lead to decreased trapped gas and hyperinflation, and allow the chest to resume normal shape and muscle capacity, resulting in better lung function and decreased dyspnea.",
"   </p>",
"   <p>",
"    A preclinical study using explanted emphysematous lungs found that expiratory airflow almost doubled with placement of five stents and was approximately 50 percent greater than control with three stents [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/37\">",
"     37",
"    </a>",
"    ]. In an animal model, most airway bypass stents became occluded within one week, so drug eluting stents were developed, first",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/16/38144?source=see_link\">",
"     mitomycin",
"    </a>",
"    and then",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/38,39\">",
"     38,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The airway bypass procedure is performed under general anesthesia using a flexible bronchoscope. First, the bronchoscope is passed to an area of known emphysema and a Doppler probe is used to identify a segmental bronchus that is free of blood vessels [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/26\">",
"     26",
"    </a>",
"    ]. Next, a special transbronchial balloon dilation needle is passed through the wall of the bronchus into the adjacent alveolus, creating a fenestration. Finally, a delivery catheter carrying a drug-eluting stent is passed through the fenestration, and the stent is deployed to maintain patency of the fenestration.",
"   </p>",
"   <p>",
"    A preliminary study of airway bypass stenting in 35 patients demonstrated significant improvement in residual volume, total lung capacity, forced vital capacity, forced expiratory volume, modified Medical Research Council scale, 6-minute walk, and St. George's Respiratory Questionnaire at one month, but only improvements in dyspnea and residual volume at six months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/40\">",
"     40",
"    </a>",
"    ]. However, the multicenter trial Exhale Airway Stents for Emphysema (EASE trial) randomly assigned 208 subjects with severe homogeneous emphysema to receive drug-eluting stents or a sham bronchoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/41\">",
"     41",
"    </a>",
"    ]. After six months, no difference was noted in the co-primary endpoint of a 12 percent or greater improvement in forced vital capacity (FVC) and 1 point or greater decrease in the modified Medical Research Council dyspnea score from baseline.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23609954\">",
"    <span class=\"h1\">",
"     OUTCOME MEASURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ideal outcome measures for assessing efficacy of lung volume reduction procedures are not known. As the main goal is to reduce dyspnea and improve quality of life, measures of dyspnea, performance of activities of daily living, and quality of life are key. Radiographic, static and dynamic lung volume measures should also be assessed, as these are objective end-points and as most devices aim to improve lung function by reducing hyperinflation. Functional measures such as the 6-minute walk distance may also be helpful.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785538\">",
"    <span class=\"h1\">",
"     CLINICAL TRIAL SITES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A listing of active clinical trials in this area may be found at",
"    <a class=\"external\" href=\"file://www.clinicaltrials.gov/\">",
"     www.clinicaltrials.gov",
"    </a>",
"    using the search terms &ldquo;bronchoscopy&rdquo; and &ldquo;emphysema.&rdquo;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12785545\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The rationale for lung volume reduction surgery (LVRS) is that removing emphysematous, hyperinflated areas of lung will decrease hyperinflation, improve diaphragm and chest wall mechanics, and decrease work of breathing. Bronchoscopic lung volume reduction (bLVR) was developed to collapse areas of emphysematous lung in hopes of having the same effect on respiratory function as LVRS, but without the morbidity and mortality of surgery. (See",
"      <a class=\"local\" href=\"#H12785482\">",
"       'Rationale for lung volume reduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients who might be considered for bLVR in the future would likely have to meet inclusion and exclusion criteria similar to those of the National Emphysema Treatment Trial (NETT) (",
"      <a class=\"graphic graphic_table graphicRef69501 \" href=\"UTD.htm?2/9/2205\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Proposed techniques for bLVR include endobronchial placement of one-way valves, plugs, and coils; biologic sealants; thermal ablation; and airway stents for decompression [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13800/abstract/3\">",
"       3",
"      </a>",
"      ]. None of these have been approved by the Food and Drug Administration for treatment of emphysema. The use of plugs and blockers has been abandoned due to adverse effects. (See",
"      <a class=\"local\" href=\"#H12785496\">",
"       'Proposed techniques'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      One-way valves have been designed for bronchoscopic placement with the idea that they will allow air and mucus to exit the treated area, but not allow air to reenter. The endobronchial valve, known as the Zephyr valve, uses a \"duckbill\" mechanism that allows air and secretions to pass through a central orifice that opens during exhalation and closes on inhalation. The IntraBronchial Valve (IBV) is umbrella-shaped and expands on inhalation and contracts on exhalation to prevent air from entering the bronchus during inhalation, but allow air and secretions to pass around the device during exhalation. (See",
"      <a class=\"local\" href=\"#H12785503\">",
"       'Valves'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Biologic lung volume reduction uses bronchoscopic instillation of a sealant (eg, a fibrin-thrombin-polymer mixture) to collapse areas of emphysema. (See",
"      <a class=\"local\" href=\"#H12785524\">",
"       'Biologic lung volume reduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The technique of thermal airway ablation involves administering steam vapor directly to segmental airways via a flexible bronchoscope. The goal is to induce an inflammatory response that will result in occlusion and atelectasis of that segment. (See",
"      <a class=\"local\" href=\"#H472953628\">",
"       'Thermal airway ablation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Based on available evidence, endobronchial placement of a drug-eluting stent through the bronchial wall to decompress over-inflated areas of emphysema does not appear to improve physiology or dyspnea in patients with severe homogeneous emphysema. (See",
"      <a class=\"local\" href=\"#H12785531\">",
"       'Airway bypass procedure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A listing of active clinical trials for bLVR may be found at",
"      <a class=\"external\" href=\"file://www.clinicaltrials.gov/\">",
"       www.clinicaltrials.gov",
"      </a>",
"      using the search terms &ldquo;bronchoscopy&rdquo; and &ldquo;emphysema.&rdquo;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/1\">",
"      Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003; 348:2059.",
"     </a>",
"    </li>",
"    <li>",
"     West, JB. Pulmonary Pathophysiology; the essentials, 5th, Lippincott, Williams &amp; Williams, Baltimore 1998. p.49.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/3\">",
"      Ingenito EP, Wood DE, Utz JP. Bronchoscopic lung volume reduction in severe emphysema. Proc Am Thorac Soc 2008; 5:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/4\">",
"      Herth FJ, Gompelmann D, Ernst A, Eberhardt R. Endoscopic lung volume reduction. Respiration 2010; 79:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/5\">",
"      Snell GI, Holsworth L, Borrill ZL, et al. The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest 2003; 124:1073.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/6\">",
"      Toma TP, Hopkinson NS, Hillier J, et al. Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/7\">",
"      Yim AP, Hwong TM, Lee TW, et al. Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg 2004; 127:1564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/8\">",
"      Wan IY, Toma TP, Geddes DM, et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest 2006; 129:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/9\">",
"      Strange C, Herth FJ, Kovitz KL, et al. Design of the Endobronchial Valve for Emphysema Palliation Trial (VENT): a non-surgical method of lung volume reduction. BMC Pulm Med 2007; 7:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/10\">",
"      Sciurba FC, Ernst A, Herth FJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/11\">",
"      Herth FJ, Noppen M, Valipour A, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39:1334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/12\">",
"      Coxson HO, Nasute Fauerbach PV, Storness-Bliss C, et al. Computed tomography assessment of lung volume changes after bronchial valve treatment. Eur Respir J 2008; 32:1443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/13\">",
"      Terry PB, Traystman RJ, Newball HH, et al. Collateral ventilation in man. N Engl J Med 1978; 298:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/14\">",
"      Macklem PT. Collateral ventilation. N Engl J Med 1978; 298:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/15\">",
"      Fessler HE. Collateral ventilation, the bane of bronchoscopic volume reduction. Am J Respir Crit Care Med 2005; 171:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/16\">",
"      Aljuri N, Freitag L. Validation and pilot clinical study of a new bronchoscopic method to measure collateral ventilation before endobronchial lung volume reduction. J Appl Physiol 2009; 106:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/17\">",
"      Gompelmann D, Eberhardt R, Michaud G, et al. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration 2010; 80:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/18\">",
"      Herth FJ, Eberhardt R, Gompelmann D, et al. Radiological and clinical outcomes of using Chartis&trade; to plan endobronchial valve treatment. Eur Respir J 2013; 41:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/19\">",
"      Ninane V, Geltner C, Bezzi M, et al. Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J 2012; 39:1319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/20\">",
"      Wood DE, McKenna RJ Jr, Yusen RD, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg 2007; 133:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/21\">",
"      Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19:398.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/22\">",
"      Slebos DJ, Klooster K, Ernst A, et al. Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012; 142:574.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/23\">",
"      Herth FJ, Eberhard R, Gompelmann D, et al. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 2010; 4:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/24\">",
"      Hillerdal G, Gustafsson G, Wegenius G, et al. Large emphysematous bullae. Successful treatment with thoracoscopic technique using fibrin glue in poor-risk patients. Chest 1995; 107:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/25\">",
"      Reilly J, Washko G, Pinto-Plata V, et al. Biological lung volume reduction: a new bronchoscopic therapy for advanced emphysema. Chest 2007; 131:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/26\">",
"      Ernst A, Anantham D. Endoscopic management of emphysema. Clin Chest Med 2010; 31:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/27\">",
"      Berger RL, Decamp MM, Criner GJ, Celli BR. Lung volume reduction therapies for advanced emphysema: an update. Chest 2010; 138:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/28\">",
"      Ingenito EP, Reilly JJ, Mentzer SJ, et al. Bronchoscopic volume reduction: a safe and effective alternative to surgical therapy for emphysema. Am J Respir Crit Care Med 2001; 164:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/29\">",
"      Ingenito EP, Berger RL, Henderson AC, et al. Bronchoscopic lung volume reduction using tissue engineering principles. Am J Respir Crit Care Med 2003; 167:771.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/30\">",
"      Criner GJ, Pinto-Plata V, Strange C, et al. Biologic lung volume reduction in advanced upper lobe emphysema: phase 2 results. Am J Respir Crit Care Med 2009; 179:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/31\">",
"      Refaely Y, Dransfield M, Kramer MR, et al. Biologic lung volume reduction therapy for advanced homogeneous emphysema. Eur Respir J 2010; 36:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/32\">",
"      Strange, C, Criner, G, Leeds, W, et al. Improved Efficacy of Biological Lung Volume Reduction (BLVR) Therapy with Lobar Targeting. Am J Respir Crit Care Med 2009; 179:A4391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/33\">",
"      Herth FJ, Gompelmann D, Stanzel F, et al. Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal&reg;). Respiration 2011; 82:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/34\">",
"      Snell GI, Hopkins P, Westall G, et al. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg 2009; 88:1993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/35\">",
"      Snell G, Herth FJ, Hopkins P, et al. Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012; 39:1326.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/36\">",
"      Higuchi T, Reed A, Oto T, et al. Relation of interlobar collaterals to radiological heterogeneity in severe emphysema. Thorax 2006; 61:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/37\">",
"      Lausberg HF, Chino K, Patterson GA, et al. Bronchial fenestration improves expiratory flow in emphysematous human lungs. Ann Thorac Surg 2003; 75:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/38\">",
"      Choong CK, Phan L, Massetti P, et al. Prolongation of patency of airway bypass stents with use of drug-eluting stents. J Thorac Cardiovasc Surg 2006; 131:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/39\">",
"      Choong CK, Haddad FJ, Gee EY, Cooper JD. Feasibility and safety of airway bypass stent placement and influence of topical mitomycin C on stent patency. J Thorac Cardiovasc Surg 2005; 129:632.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/40\">",
"      Cardoso PF, Snell GI, Hopkins P, et al. Clinical application of airway bypass with paclitaxel-eluting stents: early results. J Thorac Cardiovasc Surg 2007; 134:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13800/abstract/41\">",
"      Shah PL, Slebos DJ, Cardoso PF, et al. Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial. Lancet 2011; 378:997.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14862 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.76.133-3453397B85-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13800=[""].join("\n");
var outline_f13_30_13800=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12785545\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12785475\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12785482\">",
"      RATIONALE FOR LUNG VOLUME REDUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12785496\">",
"      PROPOSED TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12785503\">",
"      Valves",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12785510\">",
"      - Endobronchial valves",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12785517\">",
"      - Intrabronchial valves",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4992606\">",
"      Coils",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12785524\">",
"      Biologic lung volume reduction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H472953628\">",
"      Thermal airway ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12785531\">",
"      Airway bypass procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23609954\">",
"      OUTCOME MEASURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12785538\">",
"      CLINICAL TRIAL SITES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12785545\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PULM/14862\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/14862|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/8/31882\" title=\"diagnostic image 1\">",
"      Biologic lung volume reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/14862|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/61/32720\" title=\"picture 1A\">",
"      Zephyr Endobronchial Valve end view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/48/23297\" title=\"picture 1B\">",
"      Zephyr Endobronchial Valve side view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/5/31825\" title=\"picture 2\">",
"      Spiration intrabronchial valve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?40/49/41759\" title=\"picture 3\">",
"      Bronchoscopic image of stent through bronchial wall",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PULM/14862|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/9/2205\" title=\"table 1\">",
"      Indication contraind LVRS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/48/2828\" title=\"table 2\">",
"      GOLD COPD Table 2",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/38/36454?source=related_link\">",
"      Dynamic hyperinflation in patients with COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43816?source=related_link\">",
"      Flexible bronchoscopy: Equipment, procedure, and complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/20/26953?source=related_link\">",
"      Lung transplantation: General guidelines for recipient selection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33257?source=related_link\">",
"      Lung volume reduction surgery in COPD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=related_link\">",
"      Management of stable chronic obstructive pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_30_13801="Anatomy and etiology of taste and smell disorders";
var content_f13_30_13801=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anatomy and etiology of taste and smell disorders",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13801/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13801/contributors\">",
"     Norman M Mann, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13801/contributors\">",
"     Denis Lafreniere, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13801/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13801/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13801/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13801/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/30/13801/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 2.7 million adults in the United States have olfactory impairment [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/1\">",
"     1",
"    </a>",
"    ]. The prevalence of impaired olfaction increases with age; it has been estimated that 50 percent of adults over age 60 have a decreased sense of smell [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/1-5\">",
"     1-5",
"    </a>",
"    ]. Nevertheless, there has been much less research in these problem areas as compared with disorders of vision and hearing. Patients often do not report the problem and, when they do, frequently get little attention since the complaint is not considered important and life threatening. Often patients, after having seen many physicians, are told to live with their problem or that there is no help for them. Yet these individuals are not neurotic and their smell and taste disorders are significantly disabling.",
"   </p>",
"   <p>",
"    The anatomy of taste and olfaction and the etiology of taste and smell disorders are reviewed here. The evaluation of patients with taste and smell complaints and their management is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18455?source=see_link\">",
"     \"Evaluation and treatment of taste and smell disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY OF OLFACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The receptors of smell consist of a small area of neuroepithelial cells (the olfactory mucosa) that are located along the superior and middle turbinates and upper part of the nasal septum [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/6\">",
"     6",
"    </a>",
"    ]. The surface of the epithelium has a mucous layer secreted by submucosal Bowman's glands [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/7\">",
"     7",
"    </a>",
"    ]. Within its secretions are immunoglobulins A and M, secretory component, lactoferrin, and Iysozyme; these help prevent pathogens from gaining intracranial entry [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/8\">",
"     8",
"    </a>",
"    ]. Also present are odorant binding proteins that facilitate the transport of odorants to receptors and are thought to remove odorants from the receptor area once activation has occurred [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Olfactory chemoreceptor cells are primary neurons that project directly to the brain. New olfactory receptors are formed repeatedly during adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/10\">",
"     10",
"    </a>",
"    ]. The receptor neurons number approximately 6 to 10 million in each nasal cavity and are flask shaped with a dendritic pole terminating in a dilated knob from which cilia extend into the overlying mucus [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/8\">",
"     8",
"    </a>",
"    ]. The receptors on the cilia bind odorants. The axons of the receptor neurons travel through the cribriform plate of the ethmoid bone and terminate in the glomeruli of the olfactory bulb. These axons constitute the olfactory nerve. Neural pathways subsequently project to the olfactory cortex, orbital frontal cerebral cortex, thalamus, and hypothalamus.",
"   </p>",
"   <p>",
"    Mammalian olfactory epithelium maintains the ability to replace olfactory neurons lost via injury [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/11\">",
"     11",
"    </a>",
"    ]. Olfactory receptor cells are directly exposed to the external environment and its dangers, including injury from infection, inflammation, and noxious chemical agents. This exposure results in regular turnover of receptor cells via apoptosis, a programmed process in which activation of intrinsic enzymes leads to cell death. Increased levels of Capase3, the dominant enzyme in the apoptotic pathway, have been identified in olfactory epithelial cells in patients with nasal sinus disease and in mouse models of traumatic smell loss, suggesting an increase in apoptosis in these conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ANATOMY OF TASTE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The taste buds are derived from epithelial cells. They are located in the dorsal and lateral surfaces of the tongue and on the soft palate, uvula, larynx, pharynx, epiglottis, and esophagus [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/13\">",
"     13",
"    </a>",
"    ]. There are approximately 50 to 150 cells within each taste bud. Taste receptor cells have an average life span of 10 days [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Taste receptor cells are innervated by afferent neurons (see below). The initial site of signal transduction is at the taste pore. Protein stimulus interaction induces a change in the cell membrane, opening ion channels and allowing stimulus ions to enter directly through the channels [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lingual taste buds are located on structures called papillae. There are three types of papillae:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The fungiform papillae are distributed in the anterior two-thirds of the tongue and vary in number from two hundred to several hundred. Approximately 80 percent of fungiform taste buds are located within the first two centimeters of the tip of the tongue [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The foliate papillae are located on the posterior lateral sides of the tongue.",
"     </li>",
"     <li>",
"      The circumvallate papillae are located in the rear of the tongue.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The fungiform papillae may contain as many as 20 taste buds each. The circumvallate and foliate papillae can have hundreds of taste buds [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The afferent nerves innervating taste buds are contained in three different nerves. The anterior two-thirds of the tongue are supplied by the chorda tympani branch of the facial nerve (VII). The palate is innervated by another branch of the facial nerve, the superficial petrosal nerve. The posterior tongue is innervated by the glossopharyngeal nerve (IX). The pharynx and larynx are innervated by the vagus nerve (X).",
"   </p>",
"   <p>",
"    The primary taste afferent nerves synapse in the nucleus of the solitary tract in the medulla. Taste information is then transmitted to the thalamus and primary gustatory cortex [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/17\">",
"     17",
"    </a>",
"    ]. Ageusia (absent taste function) is uncommon due to the interaction between the cranial nerves VII, IX, and X.",
"   </p>",
"   <p>",
"    Branches of the trigeminal nerve innervate the interior of the mouth and nasal cavity; they account for the burning and irritating sensation afforded by hot pepper and the fumes of ammonia. Innervation of the respiratory and sinus areas of the nasal cavity is by two branches of the trigeminal nerve: the ethmoid and nasopalatine nerves. In the oral cavity, the lingual nerve innervates the tongue and floor of the mouth, the nasopalatine nerve innervates the hard palate, the posterior palatine innervates the soft palate, and the buccal nerve innervates the cheek mucosa. Seventy-five percent of the innervation of the fungiform papillae on the tongue is carried out by trigeminal fibers; the remainder is accounted for by the chorda tympani nerve. The glossopharyngeal nerve carries out the sensory function of the trigeminal nerve in the posterior portion of the mouth [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/18\">",
"     18",
"    </a>",
"    ]. The epiglottis and uvula are innervated by the vagus nerve.",
"   </p>",
"   <p>",
"    Four taste qualities have generally been described: sweet, sour, salty, and bitter. More recently, a fifth taste \"umami,\" the taste of glutamate, has been added [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/19\">",
"     19",
"    </a>",
"    ]. It is an unusual taste, and because the taste system is complex it has generally been more practical to deal with only the original four taste qualities. However, in the future it is possible that taste testing may include umami.",
"   </p>",
"   <p>",
"    The tastants travel through salivary secretion and mucus surrounding taste buds to interact with taste cells. Saliva plays an essential role in transporting the tastants to the buds. Taste stimuli that are water soluble are carried readily to the receptors. Others need soluble carrier proteins to arrive at the receptor.",
"   </p>",
"   <p>",
"    Changes in taste occur when the inorganic ingredients of saliva are altered [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/20\">",
"     20",
"    </a>",
"    ], when there are changes in the structure of taste pore mucus or the taste cell environment [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/21\">",
"     21",
"    </a>",
"    ], and when there are changes in receptor proteins, transport proteins, and cation channels [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/22\">",
"     22",
"    </a>",
"    ]. In Sj&ouml;gren's syndrome, as an example, decreased salivary function is common; the lack of saliva greatly impedes the sensation of taste (see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normosmia is used to describe normal smell function. The following terms are used to describe olfactory dysfunction:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hyposmia &mdash; Diminished smell function",
"     </li>",
"     <li>",
"      Anosmia &mdash; Absent smell function",
"     </li>",
"     <li>",
"      Parosmia &mdash; Abhorrent odor perception either without an odorant stimulus (phantosmia) or with an odorant stimulus (distortion or troposmia)",
"     </li>",
"     <li>",
"      Dysosmia &mdash; A general term describing distortion of smell sensations",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Normogeusia is used to describe normal taste function. Taste disorders are reported in the following terms:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypogeusia &mdash; Diminished taste function to one or more specific tastants",
"     </li>",
"     <li>",
"      Ageusia &mdash; Absent taste function",
"     </li>",
"     <li>",
"      Dysgeusia &mdash; Persistent sweet, sour, salty, bitter, or metallic taste",
"     </li>",
"     <li>",
"      Aliageusia &mdash; Unpleasant taste of food or drink that is usually pleasant",
"     </li>",
"     <li>",
"      Phantogeusia &mdash; Unpleasant taste produced indigenously due to a gustatory hallucination",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     DISORDERS OF OLFACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a study of 202 cases of dysosmia, nasal and paranasal sinus diseases occurred in 39 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/23\">",
"     23",
"    </a>",
"    ]. Head trauma was second in frequency (30 percent); other common causes included upper respiratory infection and exposures or medications (",
"    <a class=\"graphic graphic_table graphicRef56441 \" href=\"UTD.htm?10/15/10493\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anosmia occasionally presents as a congenital problem but in such cases is more often noted in conjunction with another organ system disease such as Kallmann syndrome (a disorder characterized by hypogonadotropic hypogonadism and one or more nongonadal congenital abnormalities, including anosmia, red-green color blindness, midline facial abnormalities such as cleft palate, urogenital tract abnormalities, and neurosensory hearing loss) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Parosmia and hyposmia are more frequently seen with the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obstructive phenomena",
"     </li>",
"     <li>",
"      Upper respiratory infection",
"     </li>",
"     <li>",
"      Head trauma",
"     </li>",
"     <li>",
"      Facial trauma",
"     </li>",
"     <li>",
"      Central olfactory damage",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Inflammatory and obstructive disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal and paranasal sinus disease, including rhinosinusitis, rhinitis (allergic and nonallergic), and nasal polyps, are the most common causes of olfactory dysfunction",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    anosmia. These conditions can interfere with olfaction through inflammation of the mucosa as well as overt obstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=see_link\">",
"     \"Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Upper respiratory infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral upper respiratory infections can damage peripheral olfactory receptors and probably central olfactory pathways [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/26\">",
"     26",
"    </a>",
"    ]. Virulent strains also may cause destruction of neural elements and result in anosmia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/27\">",
"     27",
"    </a>",
"    ]. Less virulent elements may cause hyposmia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Aging and neurodegenerative processes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sense of smell can decrease with aging [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/5\">",
"     5",
"    </a>",
"    ] and several processes may be involved. With aging there is a loss of olfactory epithelium surface area and a decrease in the density of adrenergic innervation within the lamina propria [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/28\">",
"     28",
"    </a>",
"    ]. The calcium binding protein-D 28K-immunoreactive elements are also decreased in the older olfactory epithelium. Additionally, the olfactory bulb undergoes significant degenerative changes in older adults that result in losses in the number of cell bodies and neurons [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/29\">",
"     29",
"    </a>",
"    ]. While it has been estimated that the adult olfactory bulb contains approximately 60,000 mitral cells at age 25, there are often only 14,500 at the age of 95 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Specific neurodegenerative disorders such as Alzheimer disease, Parkinson disease, and dementia with Lewy bodies are associated with changes in olfaction. However, neurofibrillary tangles and amyloid deposits are common in the olfactory bulbs even in healthy older adults [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In Alzheimer disease, odor identification, discrimination, and threshold are impaired. In the early onset of difficulty, odor identification is disturbed, but in the later stage, odor detection is markedly impaired [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/31\">",
"       31",
"      </a>",
"      ]. The olfactory pathways in patients with Alzheimer disease exhibit significant neuritic plaques that often lead to elevated olfactory perceptual thresholds [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/32\">",
"       32",
"      </a>",
"      ]. Unexplained olfactory dysfunction may be a marker for future cognitive decline, particularly among individuals with one or two apolipoprotein E (APOE)-epsilon 4 alleles [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Parkinson disease (PD) and dementia with Lewy bodies are also associated with olfactory impairment [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/34-36\">",
"       34-36",
"      </a>",
"      ]. In PD, identification, discrimination, and threshold are disturbed and it is likely that these features are seen in the early stages. Impaired olfaction (lower quartile of smell discrimination, compared to upper third and fourth quartiles) was associated with a fivefold increased incidence of PD over 4 years in a study of Hawaiian subjects aged 71 to 95 years [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/37\">",
"       37",
"      </a>",
"      ]. The olfactory bulb in patients with PD typically reveals the presence of Lewy bodies in the neurons of the anterior olfactory nucleus and in mitral cells, with subsequent neuronal cell loss. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=see_link\">",
"       \"Pharmacologic treatment of Parkinson disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Olfaction is also significantly impaired in pure autonomic failure according to one case series of 12 patients [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/38\">",
"       38",
"      </a>",
"      ]. In the same study, 10 patients with multiple system atrophy had relatively intact olfaction. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=see_link\">",
"       \"Multiple system atrophy: Clinical features and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The olfactory system can also be involved in other neurodegenerative diseases such as prion disease. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/28/31176?source=see_link\">",
"       \"Diseases of the central nervous system caused by prions\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Head trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Head trauma can cause significant smell impairment. The prevalence of anosmia and hyposmia increases with increasing severity of the injury. The following are possible mechanisms by which head trauma alters olfactory ability [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/39\">",
"     39",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Damage to the nose, sinuses, or both with a mechanical obstruction to odorants",
"     </li>",
"     <li>",
"      Shearing of the primary olfactory axons as they course through the cribriform plate",
"     </li>",
"     <li>",
"      Contusion to the bulb",
"     </li>",
"     <li>",
"      Contusion or destruction of the olfactory areas of the cerebral cortex",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The injury may be caused by mild or severe jolting of the brain within the skull. This type of damage is likely the most common explanation of head trauma-related anosmia. Olfactory neurons have regenerative capabilities and olfactory function may return [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/40\">",
"     40",
"    </a>",
"    ]. However, only 10 percent of 99 patients with olfactory loss due to head trauma showed improvement over one year in a series from a university outpatient smell and taste clinic [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/41\">",
"     41",
"    </a>",
"    ]. One small study (n = 25) found a correlation between the degree of retronasal parosmia, loss of volume of the olfactory bulb, and presence of frontal and temporal cerebral damage on MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Facial trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal or sinus deformity due to scarring may cause olfactory impairment in patients who suffer facial trauma. In addition, disruption of nerve fibers can occur as they course through the tiny holes in the bony cribriform plate to synapse with the olfactory bulb. Damage or tearing of nerve filaments may lead to deterioration of receptor cells.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Nasal surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who undergo surgery for sinus or septal disease may have variable results in relationship to olfaction. Although a transient postoperative decrease in smell may occur, affecting one third of patients in one series of 93 patients, permanent anosmia occurred in only one patient in this series [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Central olfactory damage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cortical lesions such as edema, brain compression, and hemorrhage can cause temporary or permanent injury of olfactory brain sensors. Such difficulties may lead to olfactory identification problems and impair detection ability [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are other problems that are involved with smell difficulties. Many of these factors also impact taste.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sj&ouml;gren's syndrome is a chronic, slowly progressive inflammatory autoimmune disease that causes inflammation, dysfunction, and destruction of the exocrine glands, resulting in lacrimal dysfunction and complaints of dry eyes [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/45,46\">",
"       45,46",
"      </a>",
"      ]. Patients with Sj&ouml;gren's syndrome also may exhibit xerostomia and accompanying taste complaints [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/47\">",
"       47",
"      </a>",
"      ]. Lymphocytic infiltration in the nasal mucosa often produces olfactory impairment [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/48\">",
"       48",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=see_link\">",
"       \"Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Less common disorders involved with smell difficulties include Kallmann syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/25\">",
"       25",
"      </a>",
"      ], Turner's syndrome, hypothyroidism [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/49\">",
"       49",
"      </a>",
"      ], and diabetes mellitus.",
"     </li>",
"     <li>",
"      Nutritional abnormalities may also lead to olfactory complaints. Conditions such as malnutrition, pellagra, pernicious anemia, and vitamin deficiency have been prominent etiologic factors in taste and smell abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/50\">",
"       50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Exposure to toxic agents, tobacco, and drugs may cause olfactory dysfunction: methacrylate vapors, ammonia, benzene, cadmium dust, chromate, formaldehyde, hydrogen sulfide, nickel dust, solvents, and sulfuric acid are some of the agents implicated in occupational exposure situations [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/51\">",
"       51",
"      </a>",
"      ]. Welders working in confined spaces have been found to have decreased olfactory sensation, though the cause for this is unknown and not related to any change in neurologic or neuropsychological test performance [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Medications such as beta blockers, antithyroid drugs, dihydropyridine (calcium channel blocker) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/53\">",
"       53",
"      </a>",
"      ], and angiotensin converting enzyme (ACE) inhibitors can lead to olfactory abnormalities. Intranasal zinc, used as an over-the-counter remedy for the common cold, can cause hyposmia and anosmia [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Neoplasms within the nasal cavity or the brain such as meningioma or temporal lobe growths rarely present with anosmia [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/55\">",
"       55",
"      </a>",
"      ]. Neurodegenerative diseases such as Alzheimer disease and Parkinsonism are frequently associated with olfactory impairment [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/56\">",
"       56",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Persistent anosmia can complicate subarachnoid hemorrhage (SAH). Anosmia occurs more commonly after aneurysmal SAH (15 to 30 percent) than after nonaneurysmal SAH (about 5 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/57,58\">",
"       57,58",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     DISORDERS OF TASTE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sense of taste is an oropharyngeal chemical sense that is activated when substances are placed within the mouth. The taste system either accepts or rejects food or drink. An intact taste system can protect the body against poisonous or injurious material. The taste system also is an important feature in salivation and swallowing, contributes to reflexes of ingestion and egestion, and is associated with conscious taste sensations [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/59\">",
"     59",
"    </a>",
"    ]. It has a primary role in sensory recognition as a gatekeeper to the intake of food and drink.",
"   </p>",
"   <p>",
"    The term flavor involves the combined features of smell, taste, irritation, texture, and temperature. The smell or aroma of food and beverages is the most important contributor to flavor; derangement of the smell system is often described by patients as a problem with taste [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/60\">",
"     60",
"    </a>",
"    ]. Olfactory disorders are reported more frequently than taste impairment since patients recognize smell loss more readily due to the dramatic decrease in the ability to perceive the flavor of food and beverages.",
"   </p>",
"   <p>",
"    As previously mentioned, total loss of taste is rarely seen because of the anatomy and redundancy of the taste system. Complaints of taste distortion or phantom tastes (dysgeusia) are much more common. Losses in taste perception do occur with aging, although they are not as marked as losses in olfaction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/61\">",
"     61",
"    </a>",
"    ]. Detection and recognition thresholds are higher in older individuals, and sensitivity to sweet, sour, salty, and bitter qualities is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/62\">",
"     62",
"    </a>",
"    ]. Some investigators believe that loss of taste buds is of primary importance in the pathogenesis of taste impairment with aging, while others have concluded that changes in taste cell membranes are the important factor [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/63\">",
"     63",
"    </a>",
"    ]. Complications due to the loss of taste can occur if sugar and salt are consumed in greater amounts (eg, in patients with diabetes, congestive heart failure, or renal insufficiency) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition to the effects of aging, the taste buds are subject to direct attack from viral infections, chemicals, and drugs due to their superficial location. A large number of medical disorders also can be associated with gustatory dysfunction (",
"    <a class=\"graphic graphic_table graphicRef68168 \" href=\"UTD.htm?37/12/38092\">",
"     table 2",
"    </a>",
"    ). In one study of 196 cases of taste complaints, the most common complaint was hypogeusia (54 percent); upper respiratory infection was a prominent cause (15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/23\">",
"     23",
"    </a>",
"    ]. Dysgeusia was also common (38 percent). In 94 patients with complaints of hypogeusia, 61 percent had normal test results; 2 of 7 patients with complaints of ageusia also had normal studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Infections",
"    </span>",
"    &nbsp;&mdash;&nbsp;Taste impairment can result from inflammatory conditions in the mouth. A dry mouth (xerostomia) makes proper chewing of food difficult and can give rise to mucosal infections. Reduction in saliva output may cause injury to taste buds and their activity. Closure of taste pores, which provide access to taste buds, can occur [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/65\">",
"     65",
"    </a>",
"    ]. Bacterial and fungal infections in the mouth can cause significant disturbances and affect taste via reduced blood flow to the tongue. Swelling and blockage in the salivary ducts can impair salivary flow. Gastritis associated with gastric reflux can cause dysgeusia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of drugs can significantly affect taste (and smell) (",
"    <a class=\"graphic graphic_table graphicRef81856 \" href=\"UTD.htm?15/34/15916\">",
"     table 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef59575 \" href=\"UTD.htm?25/35/26174\">",
"     table 4",
"    </a>",
"    ). The site of action of pharmaceutical compounds is unclear; drugs can have effects at different levels such as the peripheral receptors, chemosensory neural pathways, and the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The drug can be tasted when taken in the mouth, and may be excreted in the saliva causing adverse taste effects.",
"     </li>",
"     <li>",
"      Some medications such as anticholinergics and antidepressants cause dryness in the mouth and disturb taste because of inadequate saliva used to carry the tastants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Drugs can pass from the blood and affect taste receptor cells [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Drugs can disturb taste cell turnover by interfering with protein formation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Some drugs can inhibit calcium channel activity, interfere with receptor membrane function and, in some cases, there may be an effect upon impulse transmission through the taste nerves [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/68\">",
"       68",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/11/23736?source=see_link\">",
"     Lithium",
"    </a>",
"    can cause dysgeusia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/69\">",
"     69",
"    </a>",
"    ], presumably due to effects upon sodium channels and an inhibitory effect upon norepinephrine [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/70\">",
"     70",
"    </a>",
"    ]. Dihydropyridine occasionally causes phantogeusia; this is attributed to inhibition of receptor coupled events [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/71\">",
"     71",
"    </a>",
"    ]. The taste abnormalities seen with antithyroid drugs and ACE inhibitors (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/59/9145?source=see_link\">",
"     Captopril",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/19/8505?source=see_link\">",
"     Enalapril",
"    </a>",
"    ) are most likely due to the presence of a sulfhydryl (-SH) group [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/72\">",
"     72",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     Metronidazole",
"    </a>",
"    can induce a metallic type of phantogeusia, which may be related to its ability to cause glossitis and inhibit receptor turnover [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/73\">",
"     73",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/57/10138?source=see_link\">",
"     Clarithromycin",
"    </a>",
"    is reported to occasionally cause taste perversion (personal communication).",
"   </p>",
"   <p>",
"    Many chemotherapeutic agents used in cancer treatment can also affect taste and olfaction and may contribute to cachexia in cancer patients. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/22/38250?source=see_link&amp;anchor=H20051867#H20051867\">",
"     \"Oral toxicity associated with chemotherapy\", section on 'Alterations in taste and smell'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17960?source=see_link\">",
"     \"Clinical features and pathogenesis of cancer cachexia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Chemical exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe taste loss is rare with chemical exposure; distorted taste sensations and phantom tastes (dysgeusias) are more frequently encountered. Chemicals, drugs, and exposure to certain metals (mercury, copper, zinc, chromium, lead, etc) may lead to taste alterations. Solvents often cause injury to chemosensory receptors. A sweet metallic taste has been described with lead poisoning [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/74\">",
"     74",
"    </a>",
"    ]. In one report, silver jewelry workers with elevated lead levels complained of taste disturbance after being exposed to lead fumes in their work places. Brass foundry workers and steel welders have complained of a metallic type of dysgeusia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/75\">",
"     75",
"    </a>",
"    ]. Metallic tastes have been reported in dental patients with dentures, appliances, and fillings [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pesticides can reach taste receptors by air, water, and food, and are absorbed in the epithelium. Binding to the tongue by insecticides may cause damage to neurotransmitters that are responsible for referral of taste information to the brain; changes in taste bud morphology have also been reported [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/77\">",
"     77",
"    </a>",
"    ]. In addition, toxic material can have a direct adverse effect upon the brain itself.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Head trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;The neural pathways for taste run in varied areas. Thus, complete taste loss in head trauma is rarely seen unless severe central neurologic damage has occurred. Only 0.5 percent of patients with head injuries complain of taste loss; dysgeusia is a much more frequent problem.",
"   </p>",
"   <p>",
"    Peripheral nerve injury may cause localized taste impairment. As an example, injury to the chorda tympani branch of the facial nerve can lead to loss of taste in the anterior two-thirds of the tongue on that side.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Radiation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiation therapy can cause taste impairment via direct taste cell injury. The taste nerves may also be affected. Salivary gland impairment and infections within the mouth are other complicating factors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/78\">",
"     78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Iatrogenic causes of taste impairment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alterations in taste function may arise following problems associated with surgical procedures or radiation therapy. Surgical procedures in the head and neck area may injure the cranial nerves innervating the taste structure; the chorda tympani nerves that innervate taste buds on the anterior two-thirds of the tongue are particularly vulnerable. Injury to the chorda tympani nerve is occasionally associated with surgery that has to do with the middle ear. Stretching or sectioning the nerve may cause taste loss or dysgeusia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/79\">",
"     79",
"    </a>",
"    ]. The chorda tympani and lingual nerves also can be damaged during third molar extractions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. Bronchoscopy, laryngoscopy, or tonsillectomy can cause taste dysfunction due to injury of the lingual branch of the glossopharyngeal nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Other causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital disorders, metabolic problems, liver disorders, neoplasm, neurologic disease, psychiatric difficulties, and kidney abnormalities rarely can present with taste alterations [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13801/abstract/83\">",
"     83",
"    </a>",
"    ]. At our Taste and Smell Clinic there have been several cases of dysgeusia seen in patients who underwent general anesthesia for non-head and neck related surgery. No other etiologic factors were found in these cases and it is thought that general anesthesia may have contributed to the problem. Further studies are necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Approximately 2.7 million adults in the United States have olfactory impairment. The prevalence of impaired olfaction increases with age. Olfactory disorders are reported more frequently than taste impairment since patients recognize smell loss more readily due to the dramatic decrease in the ability to perceive the flavor of food and beverages. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Normosmia and normogeusia are used to describe normal smell and taste function, respectively. The following terms are used to describe olfactory and taste dysfunction (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Definitions'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hyposmia &mdash; Diminished smell function",
"     </li>",
"     <li>",
"      Anosmia &mdash; Absent smell function",
"     </li>",
"     <li>",
"      Dysosmia &mdash; A general term describing distortion of smell",
"     </li>",
"     <li>",
"      Hypogeusia &mdash; Diminished taste function",
"     </li>",
"     <li>",
"      Ageusia &mdash; Absent taste function",
"     </li>",
"     <li>",
"      Dysgeusia &mdash; Persistent sweet, sour, salty, bitter, or metallic taste",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Common causes of olfactory dysfunction include inflammatory disorders (eg, allergies), obstruction, infections, neurodegenerative processes (eg, Alzheimer disease, Parkinson disease), and trauma (",
"      <a class=\"graphic graphic_table graphicRef56441 \" href=\"UTD.htm?10/15/10493\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Disorders of olfaction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common causes of taste dysfunction are infections, drugs, and trauma (",
"      <a class=\"graphic graphic_table graphicRef68168 \" href=\"UTD.htm?37/12/38092\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Disorders of taste'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/1\">",
"      Murphy C, Schubert CR, Cruickshanks KJ, et al. Prevalence of olfactory impairment in older adults. JAMA 2002; 288:2307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/2\">",
"      Doty RL. Olfactory capacities in aging and Alzheimer's disease. Psychophysical and anatomic considerations. Ann N Y Acad Sci 1991; 640:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/3\">",
"      Stevens JC, Cruz LA, Hoffman JM, Patterson MQ. Taste sensitivity and aging: high incidence of decline revealed by repeated threshold measures. Chem Senses 1995; 20:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/4\">",
"      Cain WS, Stevens JC. Uniformity of olfactory loss in aging. Ann N Y Acad Sci 1989; 561:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/5\">",
"      Cain WS, Gent J, Catalanotto FA, Goodspeed RB. Clinical evaluation of olfaction. Am J Otolaryngol 1983; 4:252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/6\">",
"      Moran DT, Rowley JC 3rd, Jafek BW. Electron microscopy of human olfactory epithelium reveals a new cell type: the microvillar cell. Brain Res 1982; 253:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/7\">",
"      Moran DT, Rowley JC 3rd, Jafek BW, Lovell MA. The fine structure of the olfactory mucosa in man. J Neurocytol 1982; 11:721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/8\">",
"      Mellert TK, Getchell ML, Sparks L, Getchell TV. Characterization of the immune barrier in human olfactory mucosa. Otolaryngol Head Neck Surg 1992; 106:181.",
"     </a>",
"    </li>",
"    <li>",
"     Kinammon S, Getchell TV. Sensory transduction in olfactor receptor neurons and gustatory receptor cells. In: Smell and Taste in Health and Disease, Getchell TV, Bartoshuk LM, Doty RL, et al (Eds), Raven Press, New York 1991. p.145.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/10\">",
"      Morrison EE, Costanzo RM. Morphology of the human olfactory epithelium. J Comp Neurol 1990; 297:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/11\">",
"      Robinson AM, Conley DB, Shinners MJ, Kern RC. Apoptosis in the aging olfactory epithelium. Laryngoscope 2002; 112:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/12\">",
"      Kern RC, Conley DB, Haines GK 3rd, Robinson AM. Pathology of the olfactory mucosa: implications for the treatment of olfactory dysfunction. Laryngoscope 2004; 114:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/13\">",
"      Mistretta CM. Anatomy and neurophysiology of the taste system in aged animals. Ann N Y Acad Sci 1989; 561:277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/14\">",
"      Beidler LM, Smallman RL. Renewal of cells within taste buds. J Cell Biol 1965; 27:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/15\">",
"      Miller IJ Jr. Variation in human fungiform taste bud densities among regions and subjects. Anat Rec 1986; 216:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/16\">",
"      Mistretta CM, Baum BJ. Quantitative study of taste buds in fungiform and circumvallate papillae of young and aged rats. J Anat 1984; 138 ( Pt 2):323.",
"     </a>",
"    </li>",
"    <li>",
"     Mistretta CM. Developmental neurobiology of the taste system. In: Smell and Taste in Health and Disease, Getchell TV, Bartoshuk LM, Doty RL, et al (Eds), Raven Press, New York 1991. p.35.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/18\">",
"      Farbman AI, Hellekant G. Quantitative analyses of the fiber population in rat chorda tympani nerves and fungiform papillae. Am J Anat 1978; 153:509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/19\">",
"      Heckmann JG, Heckmann SM, Lang CJ, Hummel T. Neurological aspects of taste disorders. Arch Neurol 2003; 60:667.",
"     </a>",
"    </li>",
"    <li>",
"     Christensen CM. Role of saliva in human taste perception. In: Clinical Measurement of Taste and Smell, Neiselman HL, Rivlin RS (Eds), Macmillan Publishing Co, New York 1986. p.414.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/21\">",
"      Bartoshuk LM. The psychophysics of taste. Am J Clin Nutr 1978; 31:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/22\">",
"      Plata-Salaman CR, Scott TR, Smith-Swintosky VL. Gustatory neural coding in the monkey cortex: L-amino acids. J Neurophysiol 1992; 67:1552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/23\">",
"      Mott AE, Leopold DA. Disorders in taste and smell. Med Clin North Am 1991; 75:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/24\">",
"      Doty RL, Bromley SM. Effects of drugs on olfaction and taste. Otolaryngol Clin North Am 2004; 37:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/25\">",
"      Kallman FJ, Schoenfield WA, Barrera SE. The Genetic Aspects of Primary Eunuchordism. Am J Mental Deficiency 1944; 47:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/26\">",
"      Doty RL. A review of olfactory dysfunctions in man. Am J Otolaryngol 1979; 1:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/27\">",
"      Jafek BW, Hartman D, Eller PM, et al. Postviral olfactory dysfunction. Am J Rhino 1990; 4:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/28\">",
"      Chen Y, Getchell TV, Sparks DL, Getchell ML. Patterns of adrenergic and peptidergic innervation in human olfactory mucosa: age-related trends. J Comp Neurol 1993; 334:104.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/29\">",
"      Nakashima T, Kimmelman CP, Snow JB Jr. Structure of human fetal and adult olfactory neuroepithelium. Arch Otolaryngol 1984; 110:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/30\">",
"      Bhatnagar KP, Kennedy RC, Baron G, Greenberg RA. Number of mitral cells and the bulb volume in the aging human olfactory bulb: a quantitative morphological study. Anat Rec 1987; 218:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/31\">",
"      Kov&aacute;cs T, Cairns NJ, Lantos PL. beta-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer's disease. Neuropathol Appl Neurobiol 1999; 25:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/32\">",
"      Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull 1987; 18:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/33\">",
"      Graves AB, Bowen JD, Rajaram L, et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 1999; 53:1480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/34\">",
"      Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988; 38:1237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/35\">",
"      Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson's disease by olfactory bulb pathology. Lancet 1992; 340:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/36\">",
"      Williams SS, Williams J, Combrinck M, et al. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J Neurol Neurosurg Psychiatry 2009; 80:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/37\">",
"      Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk for future Parkinson's disease. Ann Neurol 2008; 63:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/38\">",
"      Garland EM, Raj SR, Peltier AC, et al. A cross-sectional study contrasting olfactory function in autonomic disorders. Neurology 2011; 76:456.",
"     </a>",
"    </li>",
"    <li>",
"     Costanzo RM, Becker DP. Smell and taste disorders in head injury and neurosurgery patients. In: Clinical Measurement of Taste and Smell, Meiselman HL, Rivlin RS (Eds), Macmillan, New York 1986. p.565.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/40\">",
"      Graziadei PP, Monti Graziadei AG. Regeneration in the olfactory system of vertebrates. Am J Otolaryngol 1983; 4:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/41\">",
"      Reden J, Mueller A, Mueller C, et al. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Arch Otolaryngol Head Neck Surg 2006; 132:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/42\">",
"      Rombaux P, Mouraux A, Bertrand B, et al. Retronasal and orthonasal olfactory function in relation to olfactory bulb volume in patients with posttraumatic loss of smell. Laryngoscope 2006; 116:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/43\">",
"      Kimmelman CP. The risk to olfaction from nasal surgery. Laryngoscope 1994; 104:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/44\">",
"      Nakashima T, Kimmelman CP, Snow JB. Progressive olfactory degeneration due to ischemia. Surg Forum 1983; 34:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/45\">",
"      BLOCH KJ, BUCHANAN WW, WOHL MJ, BUNIM JJ. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES. Medicine (Baltimore) 1965; 44:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/46\">",
"      Talal N. Sj&ouml;gren's syndrome. Bull Rheum Dis 1966; 16:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/47\">",
"      Baum BJ. Salivary gland fluid secretion during aging. J Am Geriatr Soc 1989; 37:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/48\">",
"      Henkin RI, Talal N, Larson AL, Mattern CF. Abnormalities of taste and smell in Sjogren's syndrome. Ann Intern Med 1972; 76:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/49\">",
"      McConnell RJ, Menendez CE, Smith FR, et al. Defects of taste and smell in patients with hypothyroidism. Am J Med 1975; 59:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/50\">",
"      Green RF. Subclinical pellagra and idiopathic hypogeusia. JAMA 1971; 218:1303.",
"     </a>",
"    </li>",
"    <li>",
"     Amoore JE. Effects of chemical exposure in olfaction in humans. In: Toxicology of Nasal Passages, Barrow CS (Ed), Hemisphere Publishing Co, Washington, DC 1986. p.155.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/52\">",
"      Antunes MB, Bowler R, Doty RL. San Francisco/Oakland Bay Bridge Welder Study: olfactory function. Neurology 2007; 69:1278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/53\">",
"      Nguyen-Khoa BA, Goehring EL Jr, Vendiola RM, et al. Epidemiologic study of smell disturbance in 2 medical insurance claims populations. Arch Otolaryngol Head Neck Surg 2007; 133:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/54\">",
"      Davidson TM, Smith WM. The Bradford Hill criteria and zinc-induced anosmia: a causality analysis. Arch Otolaryngol Head Neck Surg 2010; 136:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/55\">",
"      Bakay L. Olfactory meningiomas. The missed diagnosis. JAMA 1984; 251:53.",
"     </a>",
"    </li>",
"    <li>",
"     Doty RI. Olfactory dysfunction in neurodegenerate disorders. In: Smell and Taste in Health and Disease, Getchell TV, Doty RL, Bartoshuk LM, Snow JB Jr (Eds), Raven Press, New York 1991. p.735.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/57\">",
"      Greebe P, Rinkel GJ, Algra A. Anosmia after perimesencephalic nonaneurysmal hemorrhage. Stroke 2009; 40:2885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/58\">",
"      Wermer MJ, Donswijk M, Greebe P, et al. Anosmia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2007; 61:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/59\">",
"      Frank ME, Hettinger TP, Mott AE. The sense of taste: neurobiology, aging, and medication effects. Crit Rev Oral Biol Med 1992; 3:371.",
"     </a>",
"    </li>",
"    <li>",
"     Mott AE, Mann NM. Taste. In: Encyclopedia of Occupational Health and Safety, 4th ed, Stellman JM (Ed), 1998. p.1:11.22.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/61\">",
"      Weiffenbach JM, Baum BJ, Burghauser R. Taste thresholds: quality specific variation with human aging. J Gerontol 1982; 37:372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/62\">",
"      Stevens JC, Cain WS. Changes in taste and flavor in aging. Crit Rev Food Sci Nutr 1993; 33:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/63\">",
"      Mistretta CM. Aging effects on anatomy and neurophysiology of taste and smell. Gerodontology 1984; 3:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/64\">",
"      Breslin PA, Beauchamp GK. Suppression of bitterness by sodium: variation among bitter taste stimuli. Chem Senses 1995; 20:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/65\">",
"      Schiffman SS. Taste and smell losses in normal aging and disease. JAMA 1997; 278:1357.",
"     </a>",
"    </li>",
"    <li>",
"     Kinnamon S, Getchell TV. Sensory Transduction in Olfactor Receptor Neurons and Gustatory Receptor Cells. In: Smell and Taste in Health and Disease, Getchell TV, Bartoshuk LM, Doty RL, et al (Eds), Raven, New York 1991. p.145.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/67\">",
"      Lancet D, Striem BJ, Pace U, et al. Adenylate cyclase and GTP binding protein in rat sweet taste transduction. Soc Neurosci Abstr 1987; 13:361.",
"     </a>",
"    </li>",
"    <li>",
"     Oakley B. Trophic competence in mammalian gestation. In: Taste, Olfaction and the Central Nervous System, Pfaff DW (Ed), Rockefeller University Press, 1985. p.95.",
"    </li>",
"    <li>",
"     Henkin RI. Drug effects in taste and smell. In: Pharmacology in Medicine: Principles and Practice, Pradham SN, Maickel RP, Dietta SN (Eds), SP Press Int, Bethesda 1986. p.748.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/70\">",
"      Duffield JE. Side effects of lithium carbonate. Br Med J 1973; 1:491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/71\">",
"      Henkin RI, Graziadei PP, Bradley BF. NIH clinical staff conference. The molecular basis of taste and its disorders. Ann Intern Med 1969; 71:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/72\">",
"      Henkin RI. Drug-induced taste and smell disorders. Incidence, mechanisms and management related primarily to treatment of sensory receptor dysfunction. Drug Saf 1994; 11:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/73\">",
"      Koch-Weser J, Goldman P. Drug therapy: metronidazole. N Engl J Med 1980; 303:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/74\">",
"      Kachru DN, Tandon SK, Misra UK, Nag D. Occupational lead poisoning among silver jewellery workers. Indian J Med Sci 1989; 43:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/75\">",
"      Gordon T, Fine JM. Metal fume fever. Occup Med 1993; 8:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/76\">",
"      Siblerud RL. The relationship between mercury from dental amalgam and oral cavity health. Ann Dent 1990; 49:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/77\">",
"      Vij S, Kanagasuntheram R. Effect of tri-O-cresyl phosphate (TOCP) poisoning on sensory nerve terminations of slow loris (Nycticebus coucang coucang). Acta Neuropathol 1972; 20:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/78\">",
"      Mossman K, Shatzman A, Chencharick J. Long-term effects of radiotherapy on taste and salivary function in man. Int J Radiat Oncol Biol Phys 1982; 8:991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/79\">",
"      Jeppsson PH, Hall&eacute;n O. The taste after operation for otosclerosis. Pract Otorhinolaryngol (Basel) 1971; 33:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/80\">",
"      Blackburn CW, Bramley PA. Lingual nerve damage associated with the removal of lower third molars. Br Dent J 1989; 167:103.",
"     </a>",
"    </li>",
"    <li>",
"     Mott, A, Shafer, D, Miller, D, et al. Gustatory function after oral maxillofacial surgery: Submitted.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/82\">",
"      Boenninghaus HG, Denecke U. [Paralysis of the hypoglossal nerve after tonsillectomy? (author's transl)]. Laryngol Rhinol Otol (Stuttg) 1982; 61:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13801/abstract/83\">",
"      Deems DA, Doty RL, Settle RG, et al. Smell and taste disorders, a study of 750 patients from the University of Pennsylvania Smell and Taste Center. Arch Otolaryngol Head Neck Surg 1991; 117:519.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6842 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-58.240.98.179-5450C57513-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13801=[""].join("\n");
var outline_f13_30_13801=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY OF OLFACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ANATOMY OF TASTE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      DISORDERS OF OLFACTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Inflammatory and obstructive disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Upper respiratory infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Aging and neurodegenerative processes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Head trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Facial trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Nasal surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Central olfactory damage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      DISORDERS OF TASTE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Infections",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Drugs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Chemical exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Head trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Radiation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Iatrogenic causes of taste impairment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Other causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/6842\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/6842|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?10/15/10493\" title=\"table 1\">",
"      Diseases with impaired smell",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?37/12/38092\" title=\"table 2\">",
"      Diseases with impaired taste",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/34/15916\" title=\"table 3\">",
"      Drugs chemicals affecting smell",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/35/26174\" title=\"table 4\">",
"      Drugs chemicals impair taste",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17960?source=related_link\">",
"      Clinical features and pathogenesis of cancer cachexia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/1/11287?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Exocrine gland disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/34/35370?source=related_link\">",
"      Clinical manifestations, pathophysiology, and diagnosis of chronic rhinosinusitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/28/31176?source=related_link\">",
"      Diseases of the central nervous system caused by prions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/1/18455?source=related_link\">",
"      Evaluation and treatment of taste and smell disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=related_link\">",
"      Multiple system atrophy: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/22/38250?source=related_link\">",
"      Oral toxicity associated with chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32762?source=related_link\">",
"      Pharmacologic treatment of Parkinson disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_30_13802="Orthopedic aspects of child abuse";
var content_f13_30_13802=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Orthopedic aspects of child abuse",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13802/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13802/contributors\">",
"     Susan A Scherl, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13802/contributors\">",
"     Erin E Endom, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13802/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13802/contributors\">",
"     William Phillips, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13802/contributors\">",
"     Daniel M Lindberg, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/30/13802/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/30/13802/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/30/13802/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Child abuse accounts for approximately 1200 deaths per year in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Nearly one-half of these deaths occur among children younger than 12 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/2\">",
"     2",
"    </a>",
"    ], and nearly one-half occur among children who had prior or current contact with local child protective service agencies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prevention of these deaths requires appropriate recognition of and early intervention in cases of inflicted injury. An early report of child abuse, based on extrapolation from a series of 50 patients, and often quoted, estimated that an abused child who is returned to an unsafe home environment is at 50 percent risk for further injury and 10 percent risk of death over the next five years [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/3\">",
"     3",
"    </a>",
"    ]. Early identification of, and intervention in, households where children have been abused can lower the recurrence rate to less than 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/4\">",
"     4",
"    </a>",
"    ]. This requires that medical personnel have an understanding of childhood injury patterns; for orthopedic trauma this includes an understanding of childhood fracture patterns, mechanisms of injury, and stages of healing [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An overview of the orthopedic aspects of child abuse will be presented here. The differential diagnosis of the orthopedic manifestations of child abuse is presented separately. The clinical manifestations, differential diagnosis, diagnostic evaluation, and management of suspected child abuse also are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/23/11641?source=see_link\">",
"     \"Differential diagnosis of the orthopedic manifestations of child abuse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23990?source=see_link\">",
"     \"Differential diagnosis of suspected child abuse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The epidemiology of the orthopedic aspects of child abuse will be discussed below. The epidemiology of child abuse, including risk factors in the perpetrators, victims, and environment, is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Soft-tissue injuries are the most common injuries identified in physical abuse and are present in as many as 92 percent of victims [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/6\">",
"     6",
"    </a>",
"    ]. Fractures are the second most common injury and are present in as many as 55 percent of physically abused children, depending upon the type of abuse and the method of fracture detection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7-9\">",
"     7-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most inflicted fractures occur during infancy and early childhood [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8\">",
"     8",
"    </a>",
"    ], with as many as 85 percent occurring in children younger than three years, and 69 percent in children younger than one year [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7,10,11\">",
"     7,10,11",
"    </a>",
"    ]. The estimated annual incidence of fractures attributable to abuse is 36 cases per 100,000 children younger than 12 months, and 5 cases per 100,000 children between 12 and 35 months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Data from the Kids' Inpatient Database (discharge data on 80 percent of acute pediatric hospitalizations in the United States) for 1997, 2000, and 2003 indicate that child abuse accounts for approximately 12 percent of fracture-related hospitalizations in children younger than 36 months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/12\">",
"     12",
"    </a>",
"    ]. The proportion of fracture hospitalizations attributed to abuse decreased with increasing age (25 percent for children &lt;12 months of age, 7 percent for children 12 to 23 months of age, and 3 percent for children 24 to 35 months of age) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/12\">",
"     12",
"    </a>",
"    ]. In a retrospective review of 258 patient visits with abusive fractures, 20 percent had at least one previous physician encounter for the fracture at which the possibility of abuse was not raised [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the largest study of inflicted fractures (429 fractures in 189 children), the median age was seven months (range &lt;1 month to 13 years); 69 percent of the patients were younger than one year of age, 17 percent were between one and two years of age, and 14 percent were older than two years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7\">",
"     7",
"    </a>",
"    ]. This study also provided a description of some of the characteristic features of the fractures associated with child abuse, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      50 percent of the patients had only a single fracture; 21 percent had two fractures, 12 percent had three, and 17 percent had more than three.",
"     </li>",
"     <li>",
"      Among the patients with a single fracture, the femur was the most common location (35 percent), followed by the humerus (29 percent), and the skull (16 percent); all of the single long-bone fractures occurred in the middle one-third of the bone.",
"     </li>",
"     <li>",
"      Among long-bone fractures, transverse fractures were most common (48 percent), followed by spiral fractures (26 percent), avulsion fractures (16 percent), and oblique fractures (10 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MEDICAL EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of the medical evaluation of children with suspected child abuse is to determine whether the level of suspicion is sufficiently high to warrant making a report to Child Protective Services (CPS). Suspicion is raised when there are inconsistencies between the mechanism of injury described by the parent or caregiver and the child's injuries. Mandated reporting of child abuse is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link&amp;anchor=H21#H21\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\", section on 'Mandated reporting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although there are musculoskeletal injuries or patterns of injury that are highly suggestive of child abuse, there are no pathognomonic musculoskeletal injuries. The diagnosis of abusive fractures may be facilitated by including a detailed review of the fracture mechanism and having a low threshold for performing a skeletal survey, consultation with a pediatric radiologist or pediatric orthopedist who has experience in the imaging of child abuse, and consultation with child protective services [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The risks to the family and to the child must be weighed carefully in the decision to make a report to CPS. Serious consequences may occur for the family and child if the report is unsubstantiated. However, the potential consequences for the child of unreported child abuse include life-threatening injury and death [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/3,14,15\">",
"     3,14,15",
"    </a>",
"    ]. In a retrospective review of 258 patients with abusive fractures, approximately 20 percent had at least one previous physician encounter for the fracture at which the possibility of abuse was not raised [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The medical evaluation of suspected child abuse includes a complete history, physical examination, observation of the interactions between the parents and child, radiographs and laboratory tests as indicated, and information from the child's primary care provider about past history, injuries, medical problems, immunization status, and frequency of health maintenance visits. These aspects of the evaluation are discussed in detail separately. Information pertinent to musculoskeletal injuries is discussed below. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Children who have pathologic bone disease (eg, children with chronic renal disease, osteogenesis imperfecta, rickets) may sustain fractures from seemingly trivial incidents. These children also may be more likely to be abused or neglected than children without chronic medical problems [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/16-18\">",
"     16-18",
"    </a>",
"    ]. The following discussion presumes that the child has a normal skeletal system. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/23/11641?source=see_link\">",
"     \"Differential diagnosis of the orthopedic manifestations of child abuse\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is essential to obtain a detailed account of the mechanism of injury from the parents or caregivers. It may be necessary to ask specific questions as the interview progresses (eg, if the mechanism of injury is a fall down the stairs, it is important to know how many steps, what the steps are made of, and whether or not they are carpeted). It is also important to ask about the initial position of the child, the dynamics of the fall, and the final position and location of the child relative to the steps [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Aspects of the history that increase the level of suspicion for inflicted injuries include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/11,20\">",
"     11,20",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inconsistencies",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      discrepancies in caretakers' accounts of the circumstances surrounding the injury",
"     </li>",
"     <li>",
"      Unwitnessed injuries",
"     </li>",
"     <li>",
"      Injuries attributed to the patient's siblings",
"     </li>",
"     <li>",
"      Injuries inconsistent with the child's developmental stage",
"     </li>",
"     <li>",
"      Injuries inconsistent with the mechanism of injury offered",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For example, children who have inflicted musculoskeletal injuries are often said to have fallen from a piece of furniture. However, when young children fall from furniture, the risk of fracture is low (&lt;2 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/21-23\">",
"     21-23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12106?source=see_link&amp;anchor=H10#H10\">",
"     \"Prevention of falls in children\", section on 'Furniture'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination of the child with suspected inflicted injury should include evaluation for characteristic skin lesions, swelling or deformity, bone tenderness, reluctance to use an extremity, retinal hemorrhages, trauma to the genitals, and signs of neglect (eg, malnourishment, poor hygiene). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"     \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=see_link\">",
"     \"Child neglect and emotional abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A systematic, thorough examination of the musculoskeletal system should be performed. Areas that are obviously injured should be examined last in order to minimize the child's anxiety and discomfort.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The entire surface area of the skin should be examined. The location, size, and approximate ages of any skin lesions (bruises, welts, burns) should be documented. Sketches",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      high-quality photographs are helpful in documenting extensive injuries. However, in some states, parental permission must be obtained before photographs may be taken. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=see_link\">",
"       \"Physical abuse in children: Epidemiology and clinical manifestations\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link&amp;anchor=H22#H22\">",
"       \"Physical abuse in children: Diagnostic evaluation and management\", section on 'Documentation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There may or may not be bruising at the site of fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/24-26\">",
"       24-26",
"      </a>",
"      ]. Associated bruising is more common with skull fractures than with fractures of the extremities or ribs [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/24\">",
"       24",
"      </a>",
"      ]. The absence of bruising does not help to distinguish inflicted trauma from an underlying bone disorder [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/27-29\">",
"       27-29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The axial and appendicular skeleton should be examined for deformity, decreased range of motion, tenderness, crepitus, and swelling. Fracture callus, which indicates healing fracture, is sometimes palpable.",
"     </li>",
"     <li>",
"      A detailed neurologic examination of the extremities should also be performed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14618?source=see_link&amp;anchor=H10928992#H10928992\">",
"       \"Detailed neurologic assessment of infants and children\", section on 'Neurologic examination'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Findings that raise the suspicion of child abuse include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/30\">",
"     30",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Injuries that are not consistent with the history or child's developmental stage. This point cannot be overemphasized.",
"     </li>",
"     <li>",
"      Multiple injuries in various stages of healing, or different types of injuries coexisting (bruises, burns, fractures).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The radiographic evaluation for suspected child abuse depends upon the age of the child, the presenting complaints, and the physical examination findings. When the injuries are unintentional, the radiologic evaluation may provide an alternative explanation (eg, osteopenia, skeletal dysplasia). On the other hand, when the injuries have been inflicted, the radiologic evaluation may identify the extent of injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/31-33\">",
"     31-33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Plain radiographs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Orthogonal radiographs (anteroposterior (AP) and lateral) should be obtained of all areas of bone tenderness, swelling, deformity, or limited range of motion, and all areas that have a history or evidence of previous trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32\">",
"     32",
"    </a>",
"    ]. All radiographs should be reviewed by a pediatric radiologist who has experience in the imaging of child abuse.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Skeletal survey",
"    </span>",
"    &nbsp;&mdash;&nbsp;According to the American Academy of Pediatrics (AAP) Section on Radiology [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32,34\">",
"     32,34",
"    </a>",
"    ] and the American College of Radiology [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/35\">",
"     35",
"    </a>",
"    ], the skeletal survey is \"the method of choice for global skeletal imaging in cases of suspected child abuse\" and is mandatory for all children younger than two years of age in whom child abuse is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32\">",
"     32",
"    </a>",
"    ]. All radiographs should be reviewed by a pediatric radiologist who has experience in the imaging of child abuse.",
"   </p>",
"   <p>",
"    The standard skeletal survey in the United States includes AP and lateral views of the skull and chest; lateral views of the spine; AP views of the pelvis, long bones of the extremities, and feet; and posteroanterior oblique views of the hands (",
"    <a class=\"graphic graphic_table graphicRef82510 \" href=\"UTD.htm?15/14/15595\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32\">",
"     32",
"    </a>",
"    ]. This includes children with burns concerning for abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/36\">",
"     36",
"    </a>",
"    ]. The British Society of Paediatric Radiology recommends the same set of radiographs with the addition of oblique radiographs of the ribs [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    All of these views are necessary if occult fractures of abuse are to be detected. Proper positioning of the child and radiographic penetration are essential [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/39\">",
"     39",
"    </a>",
"    ]. Abbreviated skeletal surveys, or studies that image the entire infant or young child with one or two radiographic exposures (eg, \"babygrams\"), have no role in the evaluation of suspected child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32,39\">",
"     32,39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The skeletal survey should be followed by additional detailed views in at least two projections of any site where abnormalities are detected. Oblique views of the ribs increase the likelihood of detection of rib fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32,40\">",
"     32,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A repeat skeletal survey taken two weeks after the initial evaluation may increase the diagnostic yield and is recommended in cases in which the suspicion of child abuse is high [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32,41\">",
"     32,41",
"    </a>",
"    ]. The second study may demonstrate fractures that were not apparent initially and permit more precise determination of the age of individual injuries (",
"    <a class=\"graphic graphic_table graphicRef50629 \" href=\"UTD.htm?33/0/33803\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32,42\">",
"     32,42",
"    </a>",
"    ]. On the other hand, a repeat study that is unchanged from the initial evaluation may suggest an explanation other than fracture for the original abnormalities (eg, normal anatomic variant, bone dysplasia), and may lower the suspicion of abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The skeletal survey is more helpful in detecting fresh or healing fractures not suspected on the basis of clinical examination in younger children than in older children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/11,44\">",
"     11,44",
"    </a>",
"    ]. For this reason, a skeletal survey should be obtained in all young children in whom child abuse is suspected. The AAP Section on Radiology considers it mandatory in all such children who are younger than two years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Skeletal survey usually is not necessary in children older than five years of age, but it may be recommended in children with intellectual disability (mental retardation) or who are otherwise unable to give a history or indicate areas of trauma or pain. Children between the ages of two and five years must be evaluated on an individual basis, and localized radiographs or skeletal survey must be obtained based upon clinical indications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Fracture age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinicians may be asked to determine the age of fractures diagnosed by skeletal survey. There is a general timetable of the stages of fracture healing by which practitioners can estimate the approximate age of individual injuries (",
"    <a class=\"graphic graphic_table graphicRef50629 \" href=\"UTD.htm?33/0/33803\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Soft-tissue changes (obliteration of the normal fat planes and muscle boundaries), secondary to hemorrhage or inflammation, are the first radiographically apparent signs of musculoskeletal injury [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/45\">",
"       45",
"      </a>",
"      ]. These changes usually persist for several days [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/46,47\">",
"       46,47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Periosteal new bone formation, which is detectable on plain radiographs only after it becomes calcified, may occur as early as four days after injury, but usually occurs between 7 and 14 days [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/45\">",
"       45",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      As necrotic bone is resorbed, the margins of the fracture lines become blurred, and the fracture gap widens [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/45\">",
"       45",
"      </a>",
"      ]. This process peaks between two and three weeks after injury and may be the only means of dating metaphyseal fractures [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/46,47\">",
"       46,47",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Soft callus, from the production and calcification of osteoid, is visible as an increase in density soon after the appearance of periosteal new bone.",
"     </li>",
"     <li>",
"      Hard callus (the lamellar bone that bridges the fracture site, filling in the fracture line) appears approximately one week after soft callus. This phase of healing is usually complete between three and six weeks after injury [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/47,48\">",
"       47,48",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Radionuclide scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radionuclide bone scanning, or bone scintigraphy, has been recommended by some authorities as an alternative to skeletal survey for the initial evaluation of possible fractures and as a complementary study by others [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/49-53\">",
"     49-53",
"    </a>",
"    ]. The use of this study as the initial evaluation has both advantages and disadvantages. Bone scintigraphy is more sensitive than is plain radiography, especially in the detection of rib and costovertebral fractures, recent nondisplaced fractures that are not yet visible on plain films, and early periosteal elevation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32,50,54\">",
"     32,50,54",
"    </a>",
"    ]. In one study of child abuse cases in which the child underwent both skeletal survey and scintigraphy, 124 bony injuries were detected in 30 children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/51\">",
"     51",
"    </a>",
"    ]. Injuries were detected by both modalities in 70 percent of cases; by scintigraphy alone in 20 percent; and by skeletal survey alone in 10 percent.",
"   </p>",
"   <p>",
"    The disadvantages to the use of nuclear scintigraphy as the first line of evaluation include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/31,55\">",
"     31,55",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Scintigraphy is less specific than plain films, with more false positive findings that must then be evaluated with radiographs.",
"     </li>",
"     <li>",
"      Scintigraphy does not detect skull fractures, requiring supplemental plain skull radiographs.",
"     </li>",
"     <li>",
"      Symmetrically located bilateral fractures may be overlooked.",
"     </li>",
"     <li>",
"      The age of fractures cannot be estimated.",
"     </li>",
"     <li>",
"      Evaluation of injuries in or near the physis is difficult because uptake in this location normally is increased in children (because of active bone growth).",
"     </li>",
"     <li>",
"      Nuclear scans are difficult to obtain on an emergency basis and are not available in all hospitals.",
"     </li>",
"     <li>",
"      Sedation, with its inherent risks, often is required to obtain an adequate scintigraphic study.",
"     </li>",
"     <li>",
"      Nuclear scanning delivers a substantially greater exposure to radiation than does skeletal survey with modern imaging systems [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A nuclear scan usually is more expensive than a skeletal survey [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/9,32,54\">",
"       9,32,54",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For these reasons, skeletal survey remains the first line of screening for abuse-related fractures. Bone scan serves as a follow-up modality in the setting of a strong suspicion of fracture and negative plain films [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/56,57\">",
"     56,57",
"    </a>",
"    ], or as a screening tool in children who are too young to localize pain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. A repeat skeletal survey performed two weeks after the first evaluation serves a similar purpose without the disadvantages of the bone scan [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/32,37\">",
"     32,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasonography is particularly useful in the diagnosis of costochondral injuries and can sometimes be used to detect subperiosteal hemorrhage, indicative of fracture, before the appearance of the fracture on a plain radiograph [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/48,58,59\">",
"     48,58,59",
"    </a>",
"    ]. Ultrasonography also is appealing because it is noninvasive, can be performed in a relatively short time period, and does not expose the child to radiation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     DEXA scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone mineral density scanning may have a role in differentiating between child abuse and osteogenesis imperfecta (OI) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/60\">",
"     60",
"    </a>",
"    ]. Most OI patients have osteoporosis, whereas most victims of child abuse have normal bone density. Osteogenesis imperfecta is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/23/11641?source=see_link&amp;anchor=H13#H13\">",
"     \"Differential diagnosis of the orthopedic manifestations of child abuse\", section on 'Osteogenesis imperfecta'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38040?source=see_link\">",
"     \"Osteogenesis imperfecta: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     FRACTURE PATTERNS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there are fracture patterns that are suggestive of inflicted injury [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/4,10,11,14,31,45,48,56,61-64\">",
"     4,10,11,14,31,45,48,56,61-64",
"    </a>",
"    ], there is no particular fracture pattern, location, or morphology that is absolutely pathognomonic of child abuse. Many physically abused children present with a single fracture, and fractures that are common in abuse (skull fractures, diaphyseal fractures of the long bones) are also common in nonaccidental trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7,8,12,65\">",
"     7,8,12,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With every fracture, the possibility of inflicted injury must be considered, based upon the age of the child, overall injury pattern, stated mechanism of injury, and pertinent psychosocial factors [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,65\">",
"     8,65",
"    </a>",
"    ]. Any fracture in an infant or young child should raise concern for child abuse. Fractures suspicious for child abuse include any fracture of the femur in a child who is too young to walk, any fracture that is inconsistent with the age of the child or the history provided by the caretakers, any fracture that occurs in combination with extraskeletal injuries, and any healing fracture for which there was a delay in seeking medical attention [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,11,45,65-68\">",
"     8,11,45,65-68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fractures that are highly suggestive of intentional injury include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,10,14,57,65,66\">",
"     8,10,14,57,65,66",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Metaphyseal corner fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79186 \" href=\"UTD.htm?8/12/8399\">",
"       image 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_diagnosticimage graphicRef82390 \" href=\"UTD.htm?13/37/13906\">",
"       image 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef50274 \" href=\"UTD.htm?28/62/29667\">",
"       figure 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Rib fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73993 \" href=\"UTD.htm?24/16/24847\">",
"       image 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fractures of the sternum, scapula, or spinous processes",
"     </li>",
"     <li>",
"      Multiple fractures in various stages of healing (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73313 \" href=\"UTD.htm?15/23/15742\">",
"       image 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Bilateral acute long-bone fractures",
"     </li>",
"     <li>",
"      Skull fractures in children younger than 18 months of age, particularly without a corresponding history",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fractures less frequently associated with abuse include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8\">",
"     8",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated long-bone fractures",
"     </li>",
"     <li>",
"      Skull fractures in children older than 18 months of age",
"     </li>",
"     <li>",
"      Clavicle fractures",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Long-bone fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The long bones most commonly injured in child abuse are the femur, humerus, and tibia [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7,62\">",
"     7,62",
"    </a>",
"    ]. Isolated fractures of the tibia and femur are common in toddlers and may result from low-energy falls [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/69\">",
"     69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Femur fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The peak age of incidence for femur fractures is between two and three years; boys outnumber girls by approximately 3:1 [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/70\">",
"     70",
"    </a>",
"    ]. Among children younger than one year of age, child abuse accounts for 60 to 80 percent of femoral shaft fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/62,71,72\">",
"     62,71,72",
"    </a>",
"    ]. Among children older than one year of age who have femoral shaft fractures, there are no clinical features (eg, fracture type) that absolutely differentiate intentional from unintentional injury [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/73,74\">",
"     73,74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Whether or not the child is ambulatory is the single most important predictor of inflicted injury in isolated femur fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/65,75\">",
"     65,75",
"    </a>",
"    ]. In one review of 139 children younger than four years with isolated fractures of the shaft of one or both femurs, a greater proportion of nonambulatory than ambulatory children had fractures that were caused by abuse (42 versus 2.6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a meta-analysis of 13 studies (including the one described above [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/75\">",
"     75",
"    </a>",
"    ]), the probability of confirmed or suspected abuse in children with a femur fracture was 43 percent (95% CI, 32-54 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/65\">",
"     65",
"    </a>",
"    ]. Children with an overt history of significant trauma (eg, motor vehicle crash) or predisposition to pathologic fracture were excluded from the analysis. Midshaft fractures were most frequent in both abused and nonabused children. Likewise, the distribution of transverse, spiral, and oblique fractures was similar between the groups.",
"   </p>",
"   <p>",
"    The American Academy of Orthopaedic Surgeons recommends that children younger than 36 months with a diaphyseal femur fracture be evaluated for child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Humeral fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a meta-analysis of four cross-sectional studies, the probability of confirmed or suspected abuse in children younger than three years with a humeral fracture was 54 percent (95% CI 20-88 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/65\">",
"     65",
"    </a>",
"    ]. In two of the included studies, the prevalence of abuse was increased among children younger than 15 months [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Midshaft humeral fractures of the humerus were more common in abuse than nonabuse, whereas supracondylar fractures were more common in nonabuse than abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/65\">",
"     65",
"    </a>",
"    ].",
"    <span class=\"nowrap\">",
"     Spiral/oblique",
"    </span>",
"    fractures were the most common type of humeral fracture related to abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Location and type of fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The components of a long bone are depicted in figure 2 (",
"    <a class=\"graphic graphic_figure graphicRef76662 \" href=\"UTD.htm?22/53/23391\">",
"     figure 2",
"    </a>",
"    ). Transverse and spiral diaphyseal fractures and metaphyseal corner fractures comprise the most common type of long bone fracture seen in abused children.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H190271\">",
"    <span class=\"h4\">",
"     Diaphyseal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single, fresh fractures of the diaphysis (shaft) of long bones are the most common fracture pattern in child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7,11,78,79\">",
"     7,11,78,79",
"    </a>",
"    ]. Diaphyseal fractures are of two basic types: spiral and transverse.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Spiral fractures of the long bones result from a torsional force on the limb [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/80\">",
"       80",
"      </a>",
"      ]. Like all long-bone fractures, they are suspicious (but not pathognomonic) in a child who is too young to walk or who lacks a consistent history (ie, of having had a twisting or rotational injury). However, in the presence of such a twisting force, these fractures often occur accidentally, as in the noninflicted \"toddler's fracture\" (childhood accidental spiral tibial [CAST] fracture), a spiral fracture of the tibia that usually is nondisplaced [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Transverse fractures result from a direct blow with the line of force perpendicular to the shaft of the bone. Transverse fractures are the most common type of long-bone fracture associated with abuse, comprising 48 to 71 percent of abuse-related fractures in various studies [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/4,7,8,76,78,82,83\">",
"       4,7,8,76,78,82,83",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H190279\">",
"    <span class=\"h4\">",
"     Metaphyseal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Certain types of metaphyseal fractures are considered highly suggestive of child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,9,37,84\">",
"     8,9,37,84",
"    </a>",
"    ], particularly when present in more than one bone. These metaphyseal fractures account for between 11 and 28 percent of nonaccidental long-bone injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7,61,78\">",
"     7,61,78",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    The classic metaphyseal lesion (CML) is also called a \"corner\" or \"bucket-handle\" fracture. CMLs occur when the extremity is pulled or twisted forcibly, or the child is shaken [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/85-87\">",
"     85-87",
"    </a>",
"    ]. CML fractures that occur in infants who are not yet walking are highly associated with child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/88\">",
"     88",
"    </a>",
"    ]. The resultant shearing force undercuts an isolated peripheral fragment of the metaphysis that includes the subperiosteal bone collar, resulting in a disk-shaped bone fragment that is wider at the edges than at the center (",
"    <a class=\"graphic graphic_figure graphicRef60912 \" href=\"UTD.htm?39/2/39983\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82390 \" href=\"UTD.htm?13/37/13906\">",
"     image 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/52,66,89,90\">",
"     52,66,89,90",
"    </a>",
"    ]. Rarely, CMLs can occur from unintentional mechanisms which result in significant twisting motion at the knee [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/91\">",
"     91",
"    </a>",
"    ]. Iatrogenic CML has occurred in one infant who was subject to cephalic version and subsequent delivery by Caesarean section and in eight young infants receiving treatment for club foot [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/92,93\">",
"     92,93",
"    </a>",
"    ].",
"    <br/>",
"    <br/>",
"    CMLs are typically asymptomatic, causing pain only when severe or accompanied by epiphyseal displacement [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/66\">",
"     66",
"    </a>",
"    ]. Plain radiographs reveal a disruption of the metaphysis with lucency [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/9\">",
"     9",
"    </a>",
"    ]. The radiographic projection influences the appearance of the lesion. When viewed tangentially, the lesion appears as a triangular fragment of the metaphysis (ie, the \"corner\" fracture) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79186 \" href=\"UTD.htm?8/12/8399\">",
"     image 1",
"    </a>",
"    ); if an angulated view is obtained, the fragment appears as a curvilinear density adjacent to the metaphysis (ie, the \"bucket handle\"). Repeated injury results in widening of the radiolucent zone and traumatic cupping of the metaphysis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Rib fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rib fractures are produced by direct blows to the chest or compression of the chest (eg, as the torso is grasped during squeezing or shaking) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8\">",
"     8",
"    </a>",
"    ]. Children's ribs are flexible and difficult to fracture, so a rib fracture in the absence of a history of severe trauma such as a motor vehicle crash or fall from a significant height is strongly suggestive of child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,37,94\">",
"     8,37,94",
"    </a>",
"    ], particularly if the fractures are of the first rib [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/95\">",
"     95",
"    </a>",
"    ]. The force used for chest compressions in cardiopulmonary resuscitation of infants is not great enough to cause rib fractures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/96-98\">",
"     96-98",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The predictive value of rib fractures as an indicator of child abuse was evaluated in a meta-analysis of seven cross-sectional studies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/65\">",
"     65",
"    </a>",
"    ]. When children with significant trauma (eg, motor vehicle crash) and postoperative children were excluded, the probability of abuse in children with a rib fracture was 71 percent (95% CI 42-91 percent). Six of the seven studies indicated that the number of rib fractures was greater in abused than nonabused children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/65\">",
"     65",
"    </a>",
"    ]. Inflicted rib fractures usually are nondisplaced and involve multiple sequential ribs (corresponding to the positioning of the abuser's fingers) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73993 \" href=\"UTD.htm?24/16/24847\">",
"     image 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,9,97\">",
"     8,9,97",
"    </a>",
"    ]. Two studies in the meta-analysis confirmed that anterior rib fractures were more common in abuse and that lateral fractures were more common in nonabuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/99,100\">",
"     99,100",
"    </a>",
"    ]. Information regarding the predictive value of posterior rib fractures for abuse was inconsistent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/99-101\">",
"     99-101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Inflicted rib fractures are associated with a high risk of mortality from related injuries because of the degree of force that is required to produce them [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8\">",
"     8",
"    </a>",
"    ]. Nonetheless, external signs of injury may be absent. In addition, rib fractures may be difficult to detect on radiographs because of overlapping structures [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/66\">",
"     66",
"    </a>",
"    ]. In one study of 31 infants who died as a result of abuse, 51 percent (84 of 165) of fractures involved the ribs [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/102\">",
"     102",
"    </a>",
"    ]. Only 36 percent of the rib fractures were visible on skeletal survey; the remainder required specialized imaging or pathologic analysis.",
"   </p>",
"   <p>",
"    Rib fractures are most apparent during the stage of callus formation, 10 to 14 days after the injury (",
"    <a class=\"graphic graphic_table graphicRef50629 \" href=\"UTD.htm?33/0/33803\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/9\">",
"     9",
"    </a>",
"    ]. Asymmetry of the rib necks from side to side or between upper and lower ribs is a radiographic sign of healing rib fractures. The asymmetry is due to widening of the neck of the rib from apposition of subperiosteal bone [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/66\">",
"     66",
"    </a>",
"    ]. The addition of oblique views",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    radionuclide imaging (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef73993 \" href=\"UTD.htm?24/16/24847\">",
"     image 3",
"    </a>",
"    ) increases ability to detect rib fractures in children suspected to be victims of nonaccidental trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,32,40,50,54\">",
"     8,32,40,50,54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Spinal fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Spinal fractures are uncommon in children, comprising only 2 to 3 percent of all pediatric injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,103,104\">",
"     8,103,104",
"    </a>",
"    ]. They are caused either by direct trauma to the spinal column or by forceful",
"    <span class=\"nowrap\">",
"     acceleration/deceleration",
"    </span>",
"    forces, and are most common in the lower thoracic and upper lumbar spine [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/9,103,104\">",
"     9,103,104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The pediatric spine, especially the cervical spine, is more prone to injury than is the adult spine for several reasons (",
"    <a class=\"graphic graphic_table graphicRef55343 \" href=\"UTD.htm?2/31/2555\">",
"     table 3",
"    </a>",
"    ). Nonaccidental spinal injuries constitute only 0 to 3 percent of all inflicted injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,104\">",
"     8,104",
"    </a>",
"    ]. However, these numbers may significantly underestimate the actual frequency of spinal injuries, because most inflicted spinal fractures are asymptomatic [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/105\">",
"     105",
"    </a>",
"    ] and may elude detection on skeletal surveys that do not include high-quality lateral spine images [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/104\">",
"     104",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most common type of inflicted fracture of the spine is an asymptomatic compression fracture of the vertebral body that is detected on skeletal survey; multiple vertebrae may be involved, most commonly in the lower thoracic and upper lumbar spine [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/9,103,106\">",
"     9,103,106",
"    </a>",
"    ]. Compression or burst fractures of the thoracic, lumbar, or sacral spine may result from forceful \"sitting\" (ie, the child is thrown down into the sitting position from a height). A burst fracture with formation of a hematoma or retropulsion of a bone fragment may lead to immediate paraplegia or delayed symptoms of spinal cord compression [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/106,107\">",
"     106,107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High-velocity hyperflexion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hyperextension, as in violent shaking of an infant or small child, may produce a variety of fracture-dislocations of the posterior elements of the spinal column. They usually involve the cervical spine, cervico-thoracic, or thoraco-lumbar junctions [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/103,105,106\">",
"     103,105,106",
"    </a>",
"    ]. The hangman's fracture (fracture-dislocation of C2) is a classic example of a hyperextension injury [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/108\">",
"     108",
"    </a>",
"    ]. Compression fractures and notching of the anterior surfaces of the vertebral bodies (caused by disruption of the vertebral end plates and resulting bone loss) also can be produced by this mechanism [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/106\">",
"     106",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Fracture/avulsions",
"    </span>",
"    of the cartilaginous processes of the posterior spinous processes result from traction and shearing forces on the interspinous ligament during shaking; they usually are not seen acutely because of the lack of visualization of cartilage on plain radiographs. These injuries become visible as ossification of the avulsed cartilage progresses during the healing process [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/9,105\">",
"     9,105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Presenting signs and symptoms of spinal injury may be entirely absent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/106\">",
"     106",
"    </a>",
"    ] or may include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated irritability [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/109\">",
"       109",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Slight abnormality of tone or posture [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/106\">",
"       106",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Tender spinal mass [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/103,104,106,110\">",
"       103,104,106,110",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Acute or subacute onset of paraplegia or quadriplegia with urinary retention, loss of anal tone, and loss of bulbocavernosus reflex [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/110\">",
"       110",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Multiple other fractures that may be visualized on skeletal survey [",
"      <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/106,108,109\">",
"       106,108,109",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Skull fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Skull fractures are frequently seen in abused children. Linear, parietal skull fractures are the most common type of skull injury following both unintentional and inflicted trauma. Complicated skull fractures (ie, complex [eg, stellate, branching], multiple, bilateral, crossing suture lines, depressed, or diastatic) are suggestive of abusive head trauma, but also occur following unintentional injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link&amp;anchor=H12#H12\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\", section on 'Skull fractures'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given the potentially similar features of accidental and inflicted skull fractures, these injuries should be evaluated in the context of the history that is provided by the child's caregiver(s). Abusive injury should be suspected if the history is inconsistent with the physical examination findings. If the mechanism of injury is a fall, it is important to determine the height of the fall and the type of surface of impact (eg, concrete, wood, carpet). In general, falls from two feet or less are unlikely to produce head injuries more serious than linear skull fractures. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=see_link&amp;anchor=H12#H12\">",
"     \"Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children\", section on 'Skull fractures'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link&amp;anchor=H2#H2\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\", section on 'Medical evaluation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12106?source=see_link\">",
"     \"Prevention of falls in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Other fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the sternum, scapula, and pelvis are suspicious for child abuse if they occur in the absence of a plausible history of high-energy injury, such as a motor vehicle accident [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,10,14,31,111,112\">",
"     8,10,14,31,111,112",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, fractures of the hands and feet, particularly in nonambulatory children, should raise the suspicion of child abuse [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/52,113\">",
"     52,113",
"    </a>",
"    ]. It may be necessary to obtain oblique or high-detail, coned-down radiographs to detect these subtle lesions, which typically include torus fractures of the metacarpals and metatarsals, and buckle fractures of the proximal phalanges (from forced hyperextension) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/113\">",
"     113",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Multiple fractures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple fractures (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef79186 \" href=\"UTD.htm?8/12/8399\">",
"     image 1",
"    </a>",
"    ), old or in various stages of healing (",
"    <a class=\"graphic graphic_table graphicRef50629 \" href=\"UTD.htm?33/0/33803\">",
"     table 2",
"    </a>",
"    ), are highly suggestive of child abuse in the absence of a metabolic disorder [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/9,12,65,114\">",
"     9,12,65,114",
"    </a>",
"    ]. The likelihood of abuse increases four- to sixfold for children with &ge;3 fractures compared to those with only one [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/23/11641?source=see_link\">",
"     \"Differential diagnosis of the orthopedic manifestations of child abuse\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Multiple fractures are found in approximately 80 percent of abused children younger than one year of age, and more than 50 percent of all abused children [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/8,84,115\">",
"     8,84,115",
"    </a>",
"    ]. Nevertheless, many abused children present with only one fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7,78\">",
"     7,78",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Periosteal reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although periosteal new bone formation is a common finding in cases of child abuse, it is nonspecific. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/23/11641?source=see_link\">",
"     \"Differential diagnosis of the orthopedic manifestations of child abuse\"",
"    </a>",
"    .) It usually occurs in association with fracture, but may be seen in the absence of fracture if there is subperiosteal hemorrhage (eg, after the application of a gripping, twisting, or shaking force) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/48,61,66,116\">",
"     48,61,66,116",
"    </a>",
"    ]. In one study of 429 fractures in 189 abused children, eight patients (4 percent) had traumatic periosteal reaction without fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Periosteal reaction may not be apparent clinically. It is only apparent on radiographs as the new bone is calcified (eg, 10 to 14 days after the injury) (",
"    <a class=\"graphic graphic_table graphicRef50629 \" href=\"UTD.htm?33/0/33803\">",
"     table 2",
"    </a>",
"    ). Nuclear bone scan or repeat radiographs may be indicated if suspicion of fracture is high and no fracture is seen on initial films [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/116,117\">",
"     116,117",
"    </a>",
"    ]. In addition, a bone scan may show areas of increased radionuclide uptake at sites of subperiosteal hemorrhage even when the radiographs are normal [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/118\">",
"     118",
"    </a>",
"    ]. Ultrasonography is also particularly useful in demonstrating subclinical periosteal reaction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/48\">",
"     48",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Radiographic evaluation'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;As a general rule, fractures resulting from child abuse can be managed nonoperatively, usually with splinting or casting. The rare exceptions are some physeal and intraarticular fractures, which require operative reduction and fixation. Since child abuse victims are usually young, healing is rapid, the potential for remodeling is great, and the prognosis is good.",
"   </p>",
"   <p>",
"    Soft-tissue injuries (bruises, lacerations, burns) that are to be covered by a cast or splint should be photographed before treatment begins [",
"    <a class=\"abstract\" href=\"UTD.htm?13/30/13802/abstract/66\">",
"     66",
"    </a>",
"    ]. In some states, parental permission must be obtained before photographs may be taken. The management of child abuse is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=see_link\">",
"     \"Physical abuse in children: Diagnostic evaluation and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Early identification and intervention in cases of inflicted orthopedic trauma require that medical personnel have an understanding of childhood fracture patterns, mechanisms of injury, and stages of healing.",
"   </p>",
"   <p>",
"    Features of the history that are suspicious for inflicted injury include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inconsistencies",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      discrepancies in caretakers' accounts of the circumstances surrounding the injury",
"     </li>",
"     <li>",
"      Unwitnessed injuries",
"     </li>",
"     <li>",
"      Injuries attributed to the patient's siblings",
"     </li>",
"     <li>",
"      Injuries inconsistent with the child's developmental stage",
"     </li>",
"     <li>",
"      Injuries inconsistent with the mechanism of injury offered",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Biplanar radiographs (AP and lateral) of the injured area and the joint above and below it should be obtained in all patients. A skeletal survey (",
"    <a class=\"graphic graphic_table graphicRef82510 \" href=\"UTD.htm?15/14/15595\">",
"     table 1",
"    </a>",
"    ) should be obtained in all children younger than two years who have any evidence of physical abuse, children younger than five years with a suspicious fracture, and older children who are unable to give a history or indicate areas of trauma or pain (ie, intellectually disabled children). A radionuclide bone scan or repeat skeletal survey can be helpful when the suspicion for inflicted injury is strong but the skeletal survey is negative.",
"   </p>",
"   <p>",
"    Although there are no absolutely pathognomonic fracture patterns, fracture patterns that are highly suggestive of inflicted trauma include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Metaphyseal corner fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef79186 \" href=\"UTD.htm?8/12/8399\">",
"       image 1",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Rib fractures (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73993 \" href=\"UTD.htm?24/16/24847\">",
"       image 3",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Fractures of the sternum, scapula, or spinous processes",
"     </li>",
"     <li>",
"      Multiple fractures in various stages of healing (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef73313 \" href=\"UTD.htm?15/23/15742\">",
"       image 4",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Bilateral acute long-bone fractures",
"     </li>",
"     <li>",
"      Skull fractures in children younger than 18 months of age, particularly without a corresponding history",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Fractures less frequently associated with abuse include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Isolated long-bone fractures",
"     </li>",
"     <li>",
"      Skull fractures in children older than 18 months of age",
"     </li>",
"     <li>",
"      Clavicle fractures",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Current trends in child abuse reporting and fatalities: The results of the 1995 annual fifty state survey. Lung, CT, Daro, D (Eds), National Committee to Prevent Child Abuse, Chicago 1996. p.1.",
"    </li>",
"    <li>",
"     Children's Bureau Administration on Children, Youth and Families. National Child Abuse and Neglect Data System Summary of Key Findings from Calendar Year 2000. Washington, DC 2002.",
"    </li>",
"    <li>",
"     Green M, Haggerty RJ. Physically abused children. In: Ambulatory Pediatrics, WB Saunders, Philadelphia 1968. p.285.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/4\">",
"      Galleno H, Oppenheim WL. The battered child syndrome revisited. Clin Orthop Relat Res 1982; :11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/5\">",
"      Green FC. Child abuse and neglect. A priority problem for the private physician. Pediatr Clin North Am 1975; 22:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/6\">",
"      McMahon P, Grossman W, Gaffney M, Stanitski C. Soft-tissue injury as an indication of child abuse. J Bone Joint Surg Am 1995; 77:1179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/7\">",
"      King J, Diefendorf D, Apthorp J, et al. Analysis of 429 fractures in 189 battered children. J Pediatr Orthop 1988; 8:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/8\">",
"      Kocher MS, Kasser JR. Orthopaedic aspects of child abuse. J Am Acad Orthop Surg 2000; 8:10.",
"     </a>",
"    </li>",
"    <li>",
"     Albert, MJ, Drvaric, DM. Injuries resulting from pathologic forces: child abuse. In: Pediatric Fractures: A Practical Approach to Assessment and Treatment, MacEwen, GD, Kasser, JR, Heinrich, SD (Eds), Williams and Wilkins, Baltimore 1993. p.388.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/10\">",
"      Akbarnia B, Torg JS, Kirkpatrick J, Sussman S. Manifestations of the battered-child syndrome. J Bone Joint Surg Am 1974; 56:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/11\">",
"      Leventhal JM, Thomas SA, Rosenfield NS, Markowitz RI. Fractures in young children. Distinguishing child abuse from unintentional injuries. Am J Dis Child 1993; 147:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/12\">",
"      Leventhal JM, Martin KD, Asnes AG. Incidence of fractures attributable to abuse in young hospitalized children: results from analysis of a United States database. Pediatrics 2008; 122:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/13\">",
"      Ravichandiran N, Schuh S, Bejuk M, et al. Delayed identification of pediatric abuse-related fractures. Pediatrics 2010; 125:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/14\">",
"      Kogutt MS, Swischuk LE, Fagan CJ. Patterns of injury and significance of uncommon fractures in the battered child syndrome. Am J Roentgenol Radium Ther Nucl Med 1974; 121:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/15\">",
"      Saade, DN, Simon, HK, Greenwald, M. Abused children. Missed opportunities for recognition in the ED. Acad Emerg Med 2002; 9:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/16\">",
"      Smith SM, Hanson R. 134 battered children: a medical and psychological study. Br Med J 1974; 3:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/17\">",
"      Jaudes PK, Diamond LJ. The handicapped child and child abuse. Child Abuse Negl 1985; 9:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/18\">",
"      Soeffing M. Abused children are exceptional children. Except Child 1975; 42:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/19\">",
"      Pierce MC, Bertocci GE, Janosky JE, et al. Femur fractures resulting from stair falls among children: an injury plausibility model. Pediatrics 2005; 115:1712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/20\">",
"      Hettler J, Greenes DS. Can the initial history predict whether a child with a head injury has been abused? Pediatrics 2003; 111:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/21\">",
"      Helfer RE, Slovis TL, Black M. Injuries resulting when small children fall out of bed. Pediatrics 1977; 60:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/22\">",
"      Nimityongskul P, Anderson LD. The likelihood of injuries when children fall out of bed. J Pediatr Orthop 1987; 7:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/23\">",
"      Lyons TJ, Oates RK. Falling out of bed: a relatively benign occurrence. Pediatrics 1993; 92:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/24\">",
"      Peters ML, Starling SP, Barnes-Eley ML, Heisler KW. The presence of bruising associated with fractures. Arch Pediatr Adolesc Med 2008; 162:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/25\">",
"      Mathew MO, Ramamohan N, Bennet GC. Importance of bruising associated with paediatric fractures: prospective observational study. BMJ 1998; 317:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/26\">",
"      Eastwood D. Breaks without bruises. Are common and can't be said to rule out non-accidental injury. BMJ 1998; 317:1095.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/27\">",
"      Paterson C. Bruising associated with paediatric fractures. Each case should be treated individually. BMJ 1999; 318:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/28\">",
"      Paterson CR. Child abuse or copper deficiency? Br Med J (Clin Res Ed) 1987; 295:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/29\">",
"      Taitz LS. Child abuse and metabolic bone disease: are they often confused? BMJ 1991; 302:1244.",
"     </a>",
"    </li>",
"    <li>",
"     Ludwig, S. Child abuse. In: Textbook of Pediatric Emergency Medicine, 5th ed, Fleisher, GR, Ludwig, S, Henretig, FM (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia 2006. p.1761.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/31\">",
"      Merten DF, Radkowski MA, Leonidas JC. The abused child: a radiological reappraisal. Radiology 1983; 146:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/32\">",
"      Section on Radiology, American Academy of Pediatrics. Diagnostic imaging of child abuse. Pediatrics 2009; 123:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/33\">",
"      Ablin DS, Sane SM. Non-accidental injury: confusion with temporary brittle bone disease and mild osteogenesis imperfecta. Pediatr Radiol 1997; 27:111.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Radiology. ACR appropriateness criteria. Suspected physical abuse--child. Available at: file://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/SuspectedPhysicalAbuseChild.pdf(Accessed on August 6, 2012).",
"    </li>",
"    <li>",
"     American College of Radiology. ACR Standards for Skeletal Surveys in Children. Resolution 22. American College of Radiology, Reston, VA 1997. p.23.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/36\">",
"      Degraw M, Hicks RA, Lindberg D, Using Liver Transaminases to Recognize Abuse (ULTRA) Study Investigators. Incidence of fractures among children with burns with concern regarding abuse. Pediatrics 2010; 125:e295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/37\">",
"      Offiah A, van Rijn RR, Perez-Rossello JM, Kleinman PK. Skeletal imaging of child abuse (non-accidental injury). Pediatr Radiol 2009; 39:461.",
"     </a>",
"    </li>",
"    <li>",
"     British Society of Paediatric Radiology. Standard for skeletal surveys in suspected non-accidental injury (NAI) in children. Available at: www.bspr.org.uk/nai.htm. (Accessed on May 26, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/39\">",
"      Radkowski, MA, Merten, DF, Leonidas, JC. The abused child: Criteria for the radiologic diagnosis. Radiographics 1983; 3:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/40\">",
"      Hansen KK, Prince JS, Nixon GW. Oblique chest views as a routine part of skeletal surveys performed for possible physical abuse--is this practice worthwhile? Child Abuse Negl 2008; 32:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/41\">",
"      American Academy of Pediatrics Committee on Child Abuse and Neglect: Shaken baby syndrome: inflicted cerebral trauma. Pediatrics 1993; 92:872.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/42\">",
"      Kleinman PK, Nimkin K, Spevak MR, et al. Follow-up skeletal surveys in suspected child abuse. AJR Am J Roentgenol 1996; 167:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/43\">",
"      Zimmerman S, Makoroff K, Care M, et al. Utility of follow-up skeletal surveys in suspected child physical abuse evaluations. Child Abuse Negl 2005; 29:1075.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/44\">",
"      Belfer RA, Klein BL, Orr L. Use of the skeletal survey in the evaluation of child maltreatment. Am J Emerg Med 2001; 19:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/45\">",
"      Cramer KE. Orthopedic aspects of child abuse. Pediatr Clin North Am 1996; 43:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/46\">",
"      Chapman S. The radiological dating of injuries. Arch Dis Child 1992; 67:1063.",
"     </a>",
"    </li>",
"    <li>",
"     O'Connor, JF, Cohen, J. Dating fractures. In: Diagnostic Imaging of Child Abuse, Kleinman, PK (Ed), Williams &amp; Wilkins, Baltimore 1987. p.103.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/48\">",
"      Chapman S. Radiological aspects of non-accidental injury. J R Soc Med 1990; 83:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/49\">",
"      Howard JL, Barron BJ, Smith GG. Bone scintigraphy in the evaluation of extraskeletal injuries from child abuse. Radiographics 1990; 10:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/50\">",
"      Smith FW, Gilday DL, Ash JM, Green MD. Unsuspected costo-vertebral fractures demonstrated by bone scanning in the child abuse syndrome. Pediatr Radiol 1980; 10:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/51\">",
"      Mandelstam SA, Cook D, Fitzgerald M, Ditchfield MR. Complementary use of radiological skeletal survey and bone scintigraphy in detection of bony injuries in suspected child abuse. Arch Dis Child 2003; 88:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/52\">",
"      Nimkin K, Kleinman PK. Imaging of child abuse. Radiol Clin North Am 2001; 39:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/53\">",
"      Drubach LA, Sapp MV, Laffin S, Kleinman PK. Fluorine-18 NaF PET imaging of child abuse. Pediatr Radiol 2008; 38:776.",
"     </a>",
"    </li>",
"    <li>",
"     Kleinman, PK. Skeletal imaging strategies. In: Diagnostic Imaging of Child Abuse, Kleinman, PK (Ed), Mosby, St. Louis 1998. p.237.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/55\">",
"      Merten DF, Kirks DR, Ruderman RJ. Occult humeral epiphyseal fracture in battered infants. Pediatr Radiol 1981; 10:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/56\">",
"      Merten DF, Carpenter BL. Radiologic imaging of inflicted injury in the child abuse syndrome. Pediatr Clin North Am 1990; 37:815.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/57\">",
"      Rao P, Carty H. Non-accidental injury: review of the radiology. Clin Radiol 1999; 54:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/58\">",
"      Smeets AJ, Robben SG, Meradji M. Sonographically detected costo-chondral dislocation in an abused child. A new sonographic sign to the radiological spectrum of child abuse. Pediatr Radiol 1990; 20:566.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/59\">",
"      Kelloff J, Hulett R, Spivey M. Acute rib fracture diagnosis in an infant by US: a matter of child protection. Pediatr Radiol 2009; 39:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/60\">",
"      Miller ME, Hangartner TN. Bone density measurements by computed tomography in osteogenesis imperfecta type I. Osteoporos Int 1999; 9:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/61\">",
"      Worlock P, Stower M, Barbor P. Patterns of fractures in accidental and non-accidental injury in children: a comparative study. Br Med J (Clin Res Ed) 1986; 293:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/62\">",
"      Beals RK, Tufts E. Fractured femur in infancy: the role of child abuse. J Pediatr Orthop 1983; 3:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/63\">",
"      O'Neill JA Jr, Meacham WF, Griffin JP, Sawyers JL. Patterns of injury in the battered child syndrome. J Trauma 1973; 13:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/64\">",
"      Thomas SA, Rosenfield NS, Leventhal JM, Markowitz RI. Long-bone fractures in young children: distinguishing accidental injuries from child abuse. Pediatrics 1991; 88:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/65\">",
"      Kemp AM, Dunstan F, Harrison S, et al. Patterns of skeletal fractures in child abuse: systematic review. BMJ 2008; 337:a1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/66\">",
"      Carty HM. Fractures caused by child abuse. J Bone Joint Surg Br 1993; 75:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/67\">",
"      Rivara FP, Bergman AB, LoGerfo JP, Weiss NS. Epidemiology of childhood injuries. II. Sex differences in injury rates. Am J Dis Child 1982; 136:502.",
"     </a>",
"    </li>",
"    <li>",
"     American Academy of Orthopaedic Surgeons. Treatment of pediatric diaphyseal femur fractures. Guideline and evidence report. American Academy of Orthopaedic Surgeons, Rosemont, IL, 2009. Available at: www.aaos.org/Research/guidelines/PDFFguideline.asp. (Accessed on September 30, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/69\">",
"      Tarantino CA, Dowd MD, Murdock TC. Short vertical falls in infants. Pediatr Emerg Care 1999; 15:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/70\">",
"      Hedlund R, Lindgren U. The incidence of femoral shaft fractures in children and adolescents. J Pediatr Orthop 1986; 6:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/71\">",
"      Gross RH, Stranger M. Causative factors responsible for femoral fractures in infants and young children. J Pediatr Orthop 1983; 3:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/72\">",
"      McClelland CQ, Heiple KG. Fractures in the first year of life. A diagnostic dilemma. Am J Dis Child 1982; 136:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/73\">",
"      Blakemore LC, Loder RT, Hensinger RN. Role of intentional abuse in children 1 to 5 years old with isolated femoral shaft fractures. J Pediatr Orthop 1996; 16:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/74\">",
"      Rex C, Kay PR. Features of femoral fractures in nonaccidental injury. J Pediatr Orthop 2000; 20:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/75\">",
"      Schwend RM, Werth C, Johnston A. Femur shaft fractures in toddlers and young children: rarely from child abuse. J Pediatr Orthop 2000; 20:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/76\">",
"      Shaw BA, Murphy KM, Shaw A, et al. Humerus shaft fractures in young children: accident or abuse? J Pediatr Orthop 1997; 17:293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/77\">",
"      Strait RT, Siegel RM, Shapiro RA. Humeral fractures without obvious etiologies in children less than 3 years of age: when is it abuse? Pediatrics 1995; 96:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/78\">",
"      Loder RT, Bookout C. Fracture patterns in battered children. J Orthop Trauma 1991; 5:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/79\">",
"      Leonidas JC. Skeletal trauma in the child abuse syndrome. Pediatr Ann 1983; 12:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/80\">",
"      Pierce MC, Bertocci GE, Vogeley E, Moreland MS. Evaluating long bone fractures in children: a biomechanical approach with illustrative cases. Child Abuse Negl 2004; 28:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/81\">",
"      Mellick LB, Milker L, Egsieker E. Childhood accidental spiral tibial (CAST) fractures. Pediatr Emerg Care 1999; 15:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/82\">",
"      Scherl SA, Miller L, Lively N, et al. Accidental and nonaccidental femur fractures in children. Clin Orthop Relat Res 2000; :96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/83\">",
"      Radkowski, MA, Merten, DF, Leonidas, JC. Abused child: Criteria for the radiologic diagnosis. Radiographics 1983; 3:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/84\">",
"      Stewart GM, Rosenberg NM. Conditions mistaken for child abuse: Part I. Pediatr Emerg Care 1996; 12:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/85\">",
"      Lazoritz S, Baldwin S, Kini N. The Whiplash Shaken Infant Syndrome: has Caffey's syndrome changed or have we changed his syndrome? Child Abuse Negl 1997; 21:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/86\">",
"      Caffey J. The whiplash shaken infant syndrome: manual shaking by the extremities with whiplash-induced intracranial and intraocular bleedings, linked with residual permanent brain damage and mental retardation. Pediatrics 1974; 54:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/87\">",
"      Caffey J. On the theory and practice of shaking infants. Its potential residual effects of permanent brain damage and mental retardation. Am J Dis Child 1972; 124:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/88\">",
"      Arkader A, Friedman JE, Warner WC Jr, Wells L. Complete distal femoral metaphyseal fractures: a harbinger of child abuse before walking age. J Pediatr Orthop 2007; 27:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/89\">",
"      Kleinman PK, Marks SC Jr. Relationship of the subperiosteal bone collar to metaphyseal lesions in abused infants. J Bone Joint Surg Am 1995; 77:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/90\">",
"      Kleinman PK, Marks SC, Blackbourne B. The metaphyseal lesion in abused infants: a radiologic-histopathologic study. AJR Am J Roentgenol 1986; 146:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/91\">",
"      Grant P, Mata MB, Tidwell M. Femur fracture in infants: a possible accidental etiology. Pediatrics 2001; 108:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/92\">",
"      Lysack JT, Soboleski D. Classic metaphyseal lesion following external cephalic version and cesarean section. Pediatr Radiol 2003; 33:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/93\">",
"      Grayev AM, Boal DK, Wallach DM, Segal LS. Metaphyseal fractures mimicking abuse during treatment for clubfoot. Pediatr Radiol 2001; 31:559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/94\">",
"      Garcia VF, Gotschall CS, Eichelberger MR, Bowman LM. Rib fractures in children: a marker of severe trauma. J Trauma 1990; 30:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/95\">",
"      Strouse PJ, Owings CL. Fractures of the first rib in child abuse. Radiology 1995; 197:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/96\">",
"      Spevak MR, Kleinman PK, Belanger PL, et al. Cardiopulmonary resuscitation and rib fractures in infants. A postmortem radiologic-pathologic study. JAMA 1994; 272:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/97\">",
"      Betz P, Liebhardt E. Rib fractures in children--resuscitation or child abuse? Int J Legal Med 1994; 106:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/98\">",
"      Feldman KW, Brewer DK. Child abuse, cardiopulmonary resuscitation, and rib fractures. Pediatrics 1984; 73:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/99\">",
"      Barsness KA, Cha ES, Bensard DD, et al. The positive predictive value of rib fractures as an indicator of nonaccidental trauma in children. J Trauma 2003; 54:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/100\">",
"      Cadzow SP, Armstrong KL. Rib fractures in infants: red alert! The clinical features, investigations and child protection outcomes. J Paediatr Child Health 2000; 36:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/101\">",
"      Bulloch B, Schubert CJ, Brophy PD, et al. Cause and clinical characteristics of rib fractures in infants. Pediatrics 2000; 105:E48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/102\">",
"      Kleinman PK, Marks SC Jr, Nimkin K, et al. Rib fractures in 31 abused infants: postmortem radiologic-histopathologic study. Radiology 1996; 200:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/103\">",
"      Gabos PG, Tuten HR, Leet A, Stanton RP. Fracture-dislocation of the lumbar spine in an abused child. Pediatrics 1998; 101:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/104\">",
"      Akbarnia BA. Pediatric spine fractures. Orthop Clin North Am 1999; 30:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/105\">",
"      Kleinman PK, Zito JL. Avulsion of the spinous processes caused by infant abuse. Radiology 1984; 151:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/106\">",
"      Diamond P, Hansen CM, Christofersen MR. Child abuse presenting as a thoracolumbar spinal fracture dislocation: a case report. Pediatr Emerg Care 1994; 10:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/107\">",
"      Thomas NH, Robinson L, Evans A, Bullock P. The floppy infant: a new manifestation of nonaccidental injury. Pediatr Neurosurg 1995; 23:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/108\">",
"      Kleinman PK, Shelton YA. Hangman's fracture in an abused infant: imaging features. Pediatr Radiol 1997; 27:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/109\">",
"      Rooks VJ, Sisler C, Burton B. Cervical spine injury in child abuse: report of two cases. Pediatr Radiol 1998; 28:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/110\">",
"      Carrion WV, Dormans JP, Drummond DS, Christofersen MR. Circumferential growth plate fracture of the thoracolumbar spine from child abuse. J Pediatr Orthop 1996; 16:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/111\">",
"      Starling SP, Heller RM, Jenny C. Pelvic fractures in infants as a sign of physical abuse. Child Abuse Negl 2002; 26:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/112\">",
"      Ablin DS, Greenspan A, Reinhart MA. Pelvic injuries in child abuse. Pediatr Radiol 1992; 22:454.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/113\">",
"      Nimkin K, Spevak MR, Kleinman PK. Fractures of the hands and feet in child abuse: imaging and pathologic features. Radiology 1997; 203:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/114\">",
"      McGraw EP, Pless JE, Pennington DJ, White SJ. Postmortem radiography after unexpected death in neonates, infants, and children: should imaging be routine? AJR Am J Roentgenol 2002; 178:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/115\">",
"      Krishnan J, Barbour PJ, Foster BK. Patterns of osseous injuries and psychosocial factors affecting victims of child abuse. Aust N Z J Surg 1990; 60:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/116\">",
"      Morzaria S, Walton JM, MacMillan A. Inflicted esophageal perforation. J Pediatr Surg 1998; 33:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/117\">",
"      Conway JJ, Collins M, Tanz RR, et al. The role of bone scintigraphy in detecting child abuse. Semin Nucl Med 1993; 23:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/30/13802/abstract/118\">",
"      Sty JR, Starshak RJ. The role of bone scintigraphy in the evaluation of the suspected abused child. Radiology 1983; 146:369.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6613 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-115.66.252.144-FC8D04C3D0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13802=[""].join("\n");
var outline_f13_30_13802=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MEDICAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RADIOGRAPHIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Plain radiographs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Skeletal survey",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Fracture age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Radionuclide scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      DEXA scan",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      FRACTURE PATTERNS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Long-bone fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Femur fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Humeral fractures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Location and type of fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H190271\">",
"      Diaphyseal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H190279\">",
"      Metaphyseal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Rib fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Spinal fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Skull fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Other fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Multiple fractures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Periosteal reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6613\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6613|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?8/12/8399\" title=\"diagnostic image 1\">",
"      Metaphyseal corner fx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/37/13906\" title=\"diagnostic image 2\">",
"      Bucket handle fx distal tib",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?24/16/24847\" title=\"diagnostic image 3\">",
"      Multiple posterior rib fx",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?15/23/15742\" title=\"diagnostic image 4\">",
"      Multiple fx",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6613|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?28/62/29667\" title=\"figure 1\">",
"      Corner fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?22/53/23391\" title=\"figure 2\">",
"      Components of a long bone",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/2/39983\" title=\"figure 3\">",
"      Metaphyseal lesions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6613|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/14/15595\" title=\"table 1\">",
"      Standard skeletal survey",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?33/0/33803\" title=\"table 2\">",
"      Fracture stages of healing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/31/2555\" title=\"table 3\">",
"      Risk of spine injury in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32985?source=related_link\">",
"      Child abuse: Epidemiology, mechanisms, and types of abusive head trauma in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/62/18408?source=related_link\">",
"      Child neglect and emotional abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/17/14618?source=related_link\">",
"      Detailed neurologic assessment of infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/27/23990?source=related_link\">",
"      Differential diagnosis of suspected child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/23/11641?source=related_link\">",
"      Differential diagnosis of the orthopedic manifestations of child abuse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38040?source=related_link\">",
"      Osteogenesis imperfecta: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/19/24890?source=related_link\">",
"      Physical abuse in children: Diagnostic evaluation and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/54/26473?source=related_link\">",
"      Physical abuse in children: Epidemiology and clinical manifestations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/52/12106?source=related_link\">",
"      Prevention of falls in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_30_13803="Heat and cold therapy indications";
var content_f13_30_13803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F86679&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F86679&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Indications for heat and cold therapeutic modalities",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"2\" width=\"50%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Heat",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cold",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Analgesia",
"       </td>",
"       <td>",
"        Analgesia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Muscle relaxation",
"       </td>",
"       <td>",
"        Muscle relaxation (eg, spasticity)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Assist with connective tissue extensibility (ie, joint contracture, musculotendinous stretching)",
"       </td>",
"       <td>",
"        Edema/hemorrhage resolution (eg, initial 24 to 48 hours after acute musculoskeletal trauma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperemia/acceleration of metabolic processes (eg, tenosynovitis, bursitis)",
"       </td>",
"       <td rowspan=\"2\">",
"        Reduction of metabolic processes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hematoma resolution",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: DeLisa's Physcial Medicine and Rehabilitation: Principles and Practice, 5th edition, Frontera WR (Ed), Lippincott Williams &amp; Wilkins, 2010. Copyright &copy; 2010 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13803=[""].join("\n");
var outline_f13_30_13803=null;
var title_f13_30_13804="Sinusitis clinical severity score";
var content_f13_30_13804=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F83453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F83453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical severity score for acute bacterial rhinosinusitis in children and adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Symptom or sign",
"       </td>",
"       <td class=\"subtitle1\">",
"        Points",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Abnormal nasal or postnasal discharge",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Minimal",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Severe",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nasal congestion",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cough",
"       </td>",
"       <td class=\"centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Malodorous breath",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Facial tenderness",
"       </td>",
"       <td class=\"centered\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Erythematous nasal mucosa",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Fever*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &lt;38.5&deg;C",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        &ge;38.5&deg;C",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Headache (retroorbital)/irritability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Severe",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mild",
"       </td>",
"       <td class=\"sublist_other_centered\">",
"        1",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    A total score &lt;8 indicates mild/moderate disease. A total score &ge;8 indicates severe disease.",
"    <br>",
"     * Within 24 hours of presentation, either observed or according to history and documented with thermometer.",
"     <div class=\"footnotes\">",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: Wald ER, Nash D, Eickhoff J. Effectiveness of amoxicillin/clavulanate potassium in the treatment of acute bacterial sinusitis in children. Pediatrics 2009; 124:9. Copyright &copy; 2009 by the AAP.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13804=[""].join("\n");
var outline_f13_30_13804=null;
var title_f13_30_13805="Incid cardiotox adjuv trial";
var content_f13_30_13805=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F73709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F73709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Incidence of trastuzumab-induced cardiotoxicity in adjuvant breast cancer trials",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Trial/arm",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cardiac events*",
"        <br/>",
"        (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Symptomatic HF",
"        <br/>",
"        (percent)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Asymptomatic decreased LVEF",
"        <sup>",
"         &bull;",
"        </sup>",
"        <br/>",
"        (percent)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        NSABP B-31",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        AC/paclitaxel",
"       </td>",
"       <td>",
"        0.8",
"       </td>",
"       <td>",
"        1.0",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        AC/paclitaxel plus trastuzumab",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        4.1",
"       </td>",
"       <td>",
"        5.1",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        14",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        NCCTG N9831",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        AC/paclitaxel",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        AC/paclitaxel plus trastuzumab (concurrent)",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        3.3",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        10.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        AC/paclitaxel plus trastuzumab (sequential)",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td>",
"        2.8",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        HERA",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chemotherapy",
"       </td>",
"       <td>",
"        0.06",
"       </td>",
"       <td>",
"        0.2",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td>",
"        2.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chemotherapy plus trastuzumab",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td>",
"        0.6",
"       </td>",
"       <td>",
"        2.1",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td>",
"        7.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        BCIRG 006**",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        AC/docetaxel",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        0.7",
"       </td>",
"       <td>",
"        11.2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        AC/docetaxel plus trastuzumab",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        2.0",
"       </td>",
"       <td>",
"        18.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Docetaxel plus carboplatin plus trastuzumab",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        0.4",
"       </td>",
"       <td>",
"        9.4",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     HF: heart failure; LVEF: left ventricular ejection fraction; AC: doxorubicin plus cyclophosphamide.",
"     <br/>",
"     * \"Cardiac events\" includes grade III or IV heart failure and deaths from cardiac causes; the HERA trial required a concomitant decrease in LVEF to &lt;50 percent, with a decrease of &ge;10 percent from baseline.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     Asymptomatic decreases in LVEF typically transient.",
"     <br/>",
"     &Delta; Symptoms of cardiac dysfunction not meeting criteria for a cardiac event.",
"     <br/>",
"     <span class=\"lozenge\">",
"      &loz;",
"     </span>",
"     Trastuzumab begun concurrently with taxane chemotherapy.",
"     <br/>",
"     &sect; Cardiotoxicity results from third arm in which trastuzumab was not initiated until after completing paclitaxel not yet reported.",
"     <br/>",
"     &yen; Sequential trastuzumab plus paclitaxel.",
"     <br/>",
"     &Dagger; Symptomatic heart failure of any degree, including those with a cardiac event.",
"     <br/>",
"     &dagger; Trastuzumab begun after completion of adjuvant chemotherapy; data limited to patients treated with trastuzumab for one year.",
"     <br/>",
"     ** Data from: Slamon D, et al. N Engl J Med 2011; 365:14.",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: Telli ML, et al. J Clin Oncol 2007; 25:3525; Perez EA, et al. J Clin Oncol 2008; 26:1231.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13805=[""].join("\n");
var outline_f13_30_13805=null;
var title_f13_30_13806="FALDH catalytic pathway";
var content_f13_30_13806=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F66427&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F66427&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 542px\">",
"   <div class=\"ttl\">",
"    FALDH catalytic pathway",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 522px; height: 480px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    FALDH catalyzes the oxidation of long-chain fatty aldehydes (here, octadecanal) to the corresponding carboxylic acid.",
"    <div class=\"footnotes\">",
"     FALDH: fatty aldehyde dehydrogenase.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Willemsen, MA, Van Der, Graaf M, Van Der, Knaap MS, et al. MR imaging and proton MR spectroscopic studies in Sjogren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol 2004; 25:649. Copyright &copy; 2004 American Society of Neuroradiology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13806=[""].join("\n");
var outline_f13_30_13806=null;
var title_f13_30_13807="Antihypertensive drugs";
var content_f13_30_13807=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F71466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F71466&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Antihypertensive drugs for outpatient management of hypertension in children 1 to 17 years old",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"15%\">",
"     </colgroup>",
"     <colgroup width=\"40%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Class",
"       </td>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dosing interval",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"11\">",
"        ACE inhibitor",
"       </td>",
"       <td rowspan=\"2\">",
"        Benazepril",
"       </td>",
"       <td>",
"        Initial: 0.2 mg/kg per day up to 10 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"       <td rowspan=\"11\">",
"        <p>",
"         1. All ACE inhibitors are contraindicated in pregnancy; females of childbearing age should use reliable contraception.",
"        </p>",
"        <p>",
"         2. Check serum potassium and creatinine periodically to monitor for hyperkalemia and azotemia.",
"        </p>",
"        <p>",
"         3. Cough and angioedema are reportedly less common with newer members of this class than with captopril.",
"        </p>",
"        <p>",
"         4. Benazepril, enalapril, and lisinopril labels contain information on the preparation of a suspension; captopril may also be compounded into a suspension.",
"        </p>",
"        <p>",
"         5. FDA approval for ACE inhibitors with pediatric labeling is limited to children&nbsp;six years of age and to children with creatinine clearance 30 mL/min per 1.73 m",
"         <sup>",
"          2",
"         </sup>",
"         .",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 0.6 mg/kg per day up to 40 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Captopril",
"       </td>",
"       <td>",
"        Initial: 0.3 to 0.5 mg/kg per dose",
"       </td>",
"       <td rowspan=\"2\">",
"        Three times daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 6 mg/kg per day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Enalapril",
"       </td>",
"       <td>",
"        Initial: 0.08 mg/kg per day up to 5 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once to twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 0.6 mg/kg per day up to 40 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fosinopril",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Children &gt;50 kg:",
"         </strong>",
"        </p>",
"        <p>",
"         Initial: 5 to 10 mg/day",
"        </p>",
"        Maximum: 40 mg/day",
"       </td>",
"       <td>",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Lisinopril",
"       </td>",
"       <td>",
"        Initial: 0.07 mg/kg per d up to 5 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 0.6 mg/kg per day up to 40 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Quinapril",
"       </td>",
"       <td>",
"        Initial: 5 to 10 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 80 mg/day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Angiotensin-receptor blocker",
"       </td>",
"       <td rowspan=\"2\">",
"        Irbesartan",
"       </td>",
"       <td>",
"        6 to 12 years: 75 to 150 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         1. All ARBs are contraindicated in pregnancy; females of childbearing age should use reliable contraception.",
"        </p>",
"        <p>",
"         2. Check serum potassium and creatinine periodically to monitor for hyperkalemia and azotemia.",
"        </p>",
"        <p>",
"         3. Losartan label contains information on the preparation of a suspension.",
"        </p>",
"        <p>",
"         4. FDA approval for ARBs is limited to children&nbsp;six years of age and to children with creatinine clearance 30 mL/min per 1.73 m",
"         <sup>",
"          2",
"         </sup>",
"         .",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &ge;13 years: 150 to 300 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Losartan",
"       </td>",
"       <td>",
"        Initial: 0.7 mg/kg per day up to 50 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 1.4 mg/kg per day up to 100 mg/day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Alpha- and beta-blocker",
"       </td>",
"       <td rowspan=\"2\">",
"        Labetalol",
"       </td>",
"       <td>",
"        Initial: 1 to 3 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Twice daily",
"       </td>",
"       <td rowspan=\"2\">",
"        <p>",
"         1. Asthma and overt heart failure are contraindications.",
"        </p>",
"        <p>",
"         2. Heart rate is dose-limiting.",
"        </p>",
"        <p>",
"         3. May impair athletic performance.",
"        </p>",
"        <p>",
"         4. Should not be used in insulin-dependent diabetics.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 10 to 12 mg/kg per day up to 1200 mg/day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"8\">",
"        Beta-blocker",
"       </td>",
"       <td rowspan=\"2\">",
"        Atenolol",
"       </td>",
"       <td>",
"        Initial: 0.5 to 1 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once to twice daily",
"       </td>",
"       <td rowspan=\"8\">",
"        <p>",
"         1. Noncardioselective agents (propranolol) are contraindicated in asthma and heart failure.",
"        </p>",
"        <p>",
"         2. Heart rate is dose-limiting.",
"        </p>",
"        <p>",
"         3. May impair athletic performance.",
"        </p>",
"        <p>",
"         4. Should not be used in insulin-dependent diabetics.",
"        </p>",
"        <p>",
"         5. A sustained-release formulation of propranolol is available that is dosed once daily.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 2 mg/kg per day up to 100 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Bisoprolol/HCTZ",
"       </td>",
"       <td>",
"        Initial: 2.5/6.25 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 10/6.25 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Metoprolol",
"       </td>",
"       <td>",
"        Initial: 1 to 2 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 6 mg/kg per day up to 200 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Propranolol",
"       </td>",
"       <td>",
"        Initial: 1 to 2 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Two to three times daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 4 mg/kg per day up to 640 mg/day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"7\">",
"        Calcium channel blocker",
"       </td>",
"       <td>",
"        Amlodipine",
"       </td>",
"       <td>",
"        Children 6 to 17 years: 2.5 to 5 mg once daily",
"       </td>",
"       <td>",
"        Once daily",
"       </td>",
"       <td rowspan=\"7\">",
"        <p>",
"         1. Amlodipine and isradipine can be compounded into stable extemporaneous suspensions.",
"        </p>",
"        <p>",
"         2. Felodipine and extended-release nifedipine tablets must be swallowed whole.",
"        </p>",
"        <p>",
"         3. Isradipine is available in both immediate-release and sustained-release formulations; sustained-release form is dosed once or twice daily.",
"        </p>",
"        <p>",
"         4. May cause tachycardia.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Felodipine",
"       </td>",
"       <td>",
"        Initial: 2.5 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 10 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Isradipine",
"       </td>",
"       <td>",
"        Initial: 0.15 to 0.2 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Three to four times daily (immediate release formulation)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 0.8 mg/kg per day up to 20 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Extended-release nifedipine",
"       </td>",
"       <td>",
"        Initial: 0.25 to 0.5 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once to twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 3 mg/kg per day up to 120 mg/day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Central alpha-agonist",
"       </td>",
"       <td>",
"        Clonidine",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Children &ge;12 years:",
"         </strong>",
"        </p>",
"        <p>",
"         Initial: 0.2 mg/day",
"        </p>",
"        Maximum: 2.4 mg/day",
"       </td>",
"       <td>",
"        Twice daily",
"       </td>",
"       <td>",
"        <p>",
"         1. May cause dry mouth and/or sedation.",
"        </p>",
"        <p>",
"         2. Transdermal preparation also available.",
"        </p>",
"        <p>",
"         3. Sudden cessation of therapy can lead to severe rebound hypertension.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"12\">",
"        Diuretic",
"       </td>",
"       <td rowspan=\"2\">",
"        HCTZ",
"       </td>",
"       <td>",
"        Initial: 1 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"       <td rowspan=\"12\">",
"        <p>",
"         1. All patients treated with diuretics should have electrolytes monitored shortly after initiating therapy and periodically thereafter.",
"        </p>",
"        <p>",
"         2. Useful as add-on therapy in patients being treated with drugs from other drug classes.",
"        </p>",
"        <p>",
"         3. Potassium-sparing diuretics (spironolactone, triamterene, amiloride) may cause severe hyperkalemia, especially if given with ACE inhibitor or ARB.",
"        </p>",
"        <p>",
"         4. Furosemide is labeled only for treatment of edema, but may be useful as add-on therapy in children with resistant hypertension, particularly in children with renal disease.",
"        </p>",
"        <p>",
"         5. Chlorthalidone may precipitate azotemia in patients with renal diseases and should be used with caution in those with severe renal impairment.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 3 mg/kg per day up to 50 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Chlorthalidone",
"       </td>",
"       <td>",
"        Initial: 0.3 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 2 mg/kg per day up to 50 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Furosemide",
"       </td>",
"       <td>",
"        Initial: 0.5 to 2.0 mg/kg per dose",
"       </td>",
"       <td rowspan=\"2\">",
"        Once to twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 6 mg/kg per day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Spironolactone",
"       </td>",
"       <td>",
"        Initial: 1 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once to twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 3.3 mg/kg per day up to 100 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Triamterene",
"       </td>",
"       <td>",
"        Initial: 1 to 2 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Twice daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 3 to 4 mg/kg per day up to 300 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Amiloride",
"       </td>",
"       <td>",
"        Initial: 0.4 to 0.625 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 20 mg/day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        Alpha 1-antagonist",
"       </td>",
"       <td rowspan=\"2\">",
"        Doxazosin",
"       </td>",
"       <td>",
"        Initial: 1 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"       <td rowspan=\"6\">",
"        May cause hypotension and syncope, especially after first dose.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 4 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Prazosin",
"       </td>",
"       <td>",
"        Initial: 0.05 to 0.1 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Three times daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 0.5 mg/kg per day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Terazosin",
"       </td>",
"       <td>",
"        Initial: 1 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        Once daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 20 mg/day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Vasodilator",
"       </td>",
"       <td rowspan=\"2\">",
"        Hydralazine",
"       </td>",
"       <td>",
"        Initial: 0.75 mg/kg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Four times daily",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         1. Tachycardia and fluid retention are common side effects.",
"        </p>",
"        <p>",
"         2. Hydralazine can cause a lupus-like syndrome in slow acetylators.",
"        </p>",
"        <p>",
"         3. Prolonged use of minoxidil can cause hypertrichosis.",
"        </p>",
"        <p>",
"         4. Minoxidil is usually reserved for patients with hypertension resistant to multiple drugs.",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximum: 7.5 mg/kg per day up to 200 mg/day",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        Minoxidil",
"       </td>",
"       <td>",
"        <p>",
"         <strong>",
"          Children &lt;12 years:",
"         </strong>",
"        </p>",
"        <p>",
"         Initial: 0.2 mg/kg per day",
"        </p>",
"        Maximum: 50 mg/day",
"       </td>",
"       <td rowspan=\"2\">",
"        One to three times daily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Children &ge;12 years:",
"         </strong>",
"        </p>",
"        <p>",
"         Initial: 5 mg/day",
"        </p>",
"        Maximum: 100 mg/day",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FDA: US Food &amp; Drug Administration; ARB: angiotensin-receptor blocker; HCTZ: hydrochlorothiazide.",
"     <br>",
"      * The maximum recommended adult dose should not be exceeded in routine clinical practice.",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       Comments apply to all members of each drug class except where otherwise stated. Includes drugs with prior pediatric experience or recently completed clinical trials.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114 (2 Suppl 4th Report):555.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_30_13807=[""].join("\n");
var outline_f13_30_13807=null;
